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SUMMARY 
 
Thiopeptides are posttranslationally-processed macrocyclic peptide metabolites, 
characterized by extensive backbone and side chain modifications that include a six-
membered nitrogenous ring, thioazol(in)e/oxazol(in)e rings, and dehydrated amino acid 
residues. Thiostrepton A, produced by Streptomyces laurentii ATCC 31255, is one of 
the more structurally complex thiopeptides, containing a second macrocycle bearing a 
quinaldic acid. Thiostrepton A and other thiopeptides are of great interest due to their 
potent activities against emerging antibiotic-resistant Gram-positive pathogens, in 
addition to their antimalarial and anticancer properties.  
The ribosomal origins for thiopeptides have been established, however, few 
details are known concerning the posttranslational modification steps. Alteration to the 
primary amino acid sequence of the precursor peptide provides an avenue to probe the 
substrate specificity of the thiostrepton posttranslational machinery. Due to the 
difficulties in the genetic manipulation of S. laurentii, the heterologous production of 
thiostrepton A from alternate streptomycete hosts (Streptomyces actuosus ATCC 25421, 
Streptomyces coelicolor CH999, and Streptomyces lividans TK24) was sought to 
facilitate the biosynthetic investigations of the peptide metabolite. The production of 
thiostrepton A from the non-cognate hosts did not lend itself to be as robust as S. 
laurentii-based production, therefore an alternate strategy was pursued for the 
production of thiostrepton variants. The introduction of a fosmid used in the 
heterologous production of thiostrepton A, harboring the entire thiostrepton biosynthetic 
gene cluster, into the tsrA deletion mutant permitted restoration of thiostrepton A 
production to that of the wild-type level. The fosmid was then engineered to enable the 
  xviii 
replacement of wild-type tsrA. Introduction of expression fosmids encoding alternate 
TsrA sequences into the S. laurentii tsrA deletion mutant led to the production of 
thiostrepton variants retaining antibacterial activity, demonstrating the utility of this 
expression platform toward thiopeptide engineering. This work was published in Mol. 
BioSyst. in 2011. 
 The seventh residue of thiostrepton A is predicted to be critical for the 
metabolite’s antibacterial activity. Using the previously developed mutagenesis 
platform, the Thr7 position was targeted, and variants of TsrA at the biologically critical 
Thr7 residue were successfully generated. Substitution of Thr7 in the thiostrepton A 
precursor peptide disrupts both biological activity and successful biosynthesis of the 
analogs. A shunt metabolite, SL105-1, was produced by S. laurentii TsrA Thr7Ala 
variant. The identification of this analog grants insight into the late stages of thiostrepton 
biosynthesis, suggesting that epoxidation of quinaldic acid and subsequent closure of 
this loop occur late during thiostrepton maturation. This work was published in Chem. 
Commun. in 2012. 
A mutation of the TsrA core peptide, Ala4Gly, supported the successful 
production of the corresponding thiostrepton variant. To more thoroughly probe the 
thiostrepton biosynthetic machinery’s tolerance toward structural variation at the fourth 
position of the TsrA core peptide, we reported the saturation mutagenesis of this residue 
using a fosmid-dependent biosynthetic engineering method and the isolation of 16 
thiostrepton analogs. Several types of side chain substitutions at the fourth position, 
including those that introduce polar or branched, hydrophobic residues, are accepted, 
albeit with varied preferences. In contrast, proline and amino acid residues inherently 
  xix 
charged at physiological pH are not well-tolerated at the fourth position by the 
thiostrepton biosynthetic system. These newly generated thiostrepton analogs were 
assessed for their water solubilities, antibacterial activities, and abilities to inhibit the 
proteolytic functions of the 20S proteasome. We demonstrate that the identity of the 
amino acid residue at the fourth position in the thiostrepton scaffold is not critical to 
effectively inhibit either the ribosome or the proteasome in vitro. This work is currently 
being prepared for publication. 
Prior efforts in engineering the thiostrepton precursor peptide, TsrA, led to 
production of thiostrepton Ala2Gly, which demonstrated strong antibacterial activity. 
This observation prompted a systematic study of the proteinogenic amino acid residues at 
the second position of TsrA core peptide that will support the production of a mature 
thiostrepton A analog. Only eight thiostrepton Ala2 variants were isolated, suggesting 
that the thiostrepton biosynthetic system is somewhat restrictive towards structural 
modifications at this position, and. Two thiostrepton analogs truncated at the N-terminus 
by one amino acid, bearing a shortened quinaldic acid-containing macrocycle, resulted 
from the Ala2Ile and Ala2Val substitutions in the precursor peptide. This is the first 
report revealing that the size of the quinaldic acid loop is amenable to alteration. 
Although the identity of the residue at the second position of the core peptide does 
influence thiostrepton analog biosynthesis, it may not be crucial for the antibacterial and 
proteasome inhibitory activities of the full-length variants. The quinaldic acid loop size 
does affect thiostrepton’s antibacterial potency as revealed by the greatly diminished 
abilities of Ala2Ile-ΔIle1 and Ala2Val-ΔIle1 analogs to inhibit bacterial growth and in 
vitro protein synthesis. In contrast, these two ΔIle1 analogs retained their inhibitory 
  xx 
activities against the proteasome, albeit slightly reduced. This work is currently being 
prepared for publication. 
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CHAPTER 1: INTRODUCTION 
 
 
Adapted from the publication: 
 
Zhang, F.; Kelly, W. L. In vivo generation of thiopeptide variants. Methods Enzymol. 
2012, 516, 3-24. 
 
1.1 Thiopeptides 
Anti-infective agents have been successfully used to treat bacterial and malarial 
infections. However, emerging microorganism resistance to common drugs has 
complicated their clinical treatment. Currently, there is a pressing need for the 
development of new compounds, especially molecules displaying new modes of action, 
which could be incorporated into human medicine to fight against ever-adapting 
pathogens.
1
 Great interest has been placed on a class of ribosomally synthesized and 
posttranslationally modified peptide metabolites (RiPP), thiopeptides (Figure 1.1), since 
their discovery in 1948.
2
 More than 100 thiopeptides have been identified from several 
genera of marine and terrestrial Gram-positive bacteria.
3-7
 Thiopeptides, also referred to 
as polythiazolyl peptides, are distinguished from other peptide metabolites by their six-
membered central nitrogen-containing ring substituted by up to three thiazolyl groups to 
form a rigid central molecular framework.
8-9
 In addition to multiple azol(in)e rings, 
dehydroalanine (Dha) and dehydrobutyrine (Dhb) residues are often present within the 
thiopeptide scaffold.  
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Figure 1.1. Examples of thiopeptides. The central six-membered nitrogenous ring is 
highlighted in red. The names of the thiopeptides with known biosynthetic gene clusters 
are shown in blue. The thiostrepton A residues are abbreviated using a three-letter code 
and labeled in grey. Dha, Dhb, Tzn, and QA refer to dehydroalanine, dehydrobutyrine, 
thiazoline, and quinaldic acid, respectively. 
 
1.2 Structural classification of thiopeptides 
Thiopeptides are divided into five classes based on the oxidation state and 
substitution pattern of the central nitrogen-containing ring (Figure 1.1).
8, 10
 A 
tetrasubstituted piperidine ring characterizes series a thiopeptides, while in series b, the 
piperidine is replaced by a dehydropiperidine, as observed in thiostrepton A (Figure 1.1). 
Series c contains a single member, Sch 40832, with an unusual dihydroimidazopiperidine 
ring system.
11
 Series d, the largest subfamily, includes a trisubstituted pyridine. Series e 
metabolites display a hydroxypyridine or alkoxypyridine moiety. Only one macrocycle is 
found in series d thiopeptides (e.g. thiocillin I, Figure 1.1) but the other series incorporate 
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both the core thiopeptide macrocycle and a second macrocycle harboring an L-
tryptophan-derived quinaldic or indolic acid residue (Figure 1.1).  
 
1.3 Biological activities of thiopeptides  
The thiopeptides are best recognized for their antibacterial activities, owing to 
their potent inhibition of drug-resistant Gram-positive bacterial pathogens such as 
methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci, and 
penicillin-resistant Streptococcus pneumonia.
8, 12
 They typically disrupt bacterial protein 
synthesis by one of two mechanisms. One group, including thiostrepton A, nosiheptide, 
and thiocillin I, binds to the 50S ribosomal subunit adjacent to the GTPase-associated 
center (Figure 1.2).
13-18
 This region of the ribosome interacts with a number of translation 
factors, including elongation factor G (EF-G) that utilizes GTP hydrolysis to drive the 
movement of the A and P site tRNA-mRNA complex to the P and E sites of the 
ribosome. Thiopeptides interfere with the conformational changes required for this 
translocation.
14, 16, 19-20
 A second mode of action is exemplified by GE2270 A, which 
binds to elongation factor Tu (EF-Tu) and prevents the formation of a stable EF-
Tu·GTP·aminoacyl-tRNA complex, thus impeding the delivery of aminoacyl tRNAs to 
the ribosomal A site following translocation.
21-22
 








Figure 1.2. Thiostrepton A bound to the 50S ribosome. (A) Local view of the binding 
site of thiostrepton A on the 50S ribosome.
14
 (B) Enlarged view of thiostrepton A in the 
complex. Thiostrepton A is abbreviated as TSR and labeled in green. The 23S rRNA and 
ribosomal proteins are shown in orange and green, respectively. 
In addition to their antibacterial activities, thiopeptides have antimalarial and 
anticancer properties. Thiostrepton A exerts its antimalarial activity by targeting two 
aspects of protein homeostasis in Plasmodium falciparum (P. falciparum). Thiostrepton 
A and other thiopeptides prevent the prokaryotic-like translational machinery within the 
apicoplast, a plastid-like organelle essential for the survival of P. falciparum.
23-26
 In 
addition, thiostrepton A inhibits the P. falciparum 20S proteasome within the cytosol, 
interfering with protein degradation and recycling.
27-28
 The anticancer activity recently 
reported for thiostrepton A also likely results from the engagement of two cellular targets. 
Here, thiostrepton A induces apoptosis both by proteasome inhibition and by direct 





1.4 Thiopeptide biosynthesis 
For more than 60 years, it was unclear whether the thiopeptides were the products 
of a nonribosomal peptide synthetase assembly-line or the extensive posttranslational 
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modification of a ribosomally-synthesized precursor peptide. In 2009, five thiopeptide 
biosynthetic gene clusters were identified, revealing that these metabolites are derived 
from genetically-encoded precursor peptides (Figure 1.3).
32-36
 Since these initial reports, 
several other thiopeptide biosynthetic gene clusters have been uncovered (Figure 1.3).
37-42
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Figure 1.3. Genetic organization of the reported thiopeptide gene clusters. The precursor 
peptide encoding genes are highlighted in red. LanB-type dehydratase homologs are 
shown in green. Putative cyclodehydratases and dehydrogenases are presented in dark 
blue and light blue, respectively. Two gene products that are likely involved in the central 


























Each thiopeptide biosynthetic gene cluster contains a small precursor peptide-
encoding gene and six genes conserved among all thiopeptide biosynthetic gene clusters. 
The nomenclature proposed by our group for the thiostrepton A biosynthetic gene (tsr) 
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cluster will be used here in an overview of thiopeptide biosynthesis.
32
 The precursor 
peptides (TsrA) are composed of two regions: an N-terminal leader peptide that is 
cleaved during the course of precursor peptide processing and a C-terminal core peptide 
that supplies the backbone for the mature thiopeptide. TsrCDEFGH appear to be the 
minimal set of proteins needed to construct the thiopeptide scaffold. TsrC and TsrD 
resemble LanB-type lanthipeptide dehydratases, and one or both of them likely effects 
the dehydration of Ser and Thr residues to provide Dha and Dhb residues, respectively 
(Figure 1.4).
43
 In contrast to the well-known phosphorylation mechanism involved in the 
dehydrations catalyzed by other families of lanthipeptide dehydratases, LanB-type NisB 
dehydrates the Ser and Thr residues in the precursor peptide, NisA, via a glutamylated 
intermediate, and it is expected that the thiopeptide LanB-like dehydratases would also 




Figure 1.4. Proposed generation of a Dha or Dhb residue by the thiopeptide 
dehydratase(s). Dha and Dhb stand for dehydroalanine and dehydrobutyrine, respectively. 
Bioinformatic analyses revealed a putative cyclodehydratase (TsrH) and a 
dehydrogenase (TsrF), both resembling enzymes that introduce the azoline and azole 
rings in the E. coli peptide microcin B17 (Figure 1.5).
48
 Two independent mechanistic 
studies have been performed with other RIPP cyclodehydratases: TruD from the 
cyanobactin biosynthetic pathway and BalhD from a thiazole/oxazole-modified microcin 
(TOMM) biosynthetic pathway.
49-50
 The Naismith group suggested that TruD generates 
an azoline group using an adenylation-type mechanism (Figure 1.5A).
49
 In contrast, 
Mitchell et al. demonstrated that, in the heterocyclization catalyzed by BahlD, ATP 
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directly phosphorylates the substrate (Figure 1.5B).
50
 The thiopeptide cyclodehydratase, 
TsrH, more closely aligned to TruD, likely adapts a similar adenylation strategy to 
effectuate an azoline formation.  
 
Figure 1.5. Proposed generation of a thiazole or oxazole moiety by thiopeptide 
cyclodehydratase(s) and dehydrogenase(s). Two mechanisms involved in the formation 
of an azoline moiety (A) using ATP as a molecular machine. (B) using ATP to 
phosphorylate the substrate.  
The central piperidine/dehydropiperidine/pyridine ring and core macrocycle of the 
thiopeptides are suggested to arise from a [4+2] cycloaddition of two dehydroalanine 
residues in a linear precursor peptide, but this mechanism is cryptic (Figure 1.6). One 
hypothesis is that the central ring could be closed by a concerted hetero-Diels-Alder 
cyclization (Figure 1.6, pathway A).
51
 Alternatively, Kelly et al. proposed that the 
nitrogenous ring could be formed via a stepwise fashion by adapting the neighboring 
thiazole group as an electron sink as seen in the reactions catalyzed by thiamine 
pyrophosphate-dependent enzymes (Figure 1.6, pathway B).
32, 52
 Inactivation of tclM, a 
tsrE homolog, in a thiocillin-producing Bacillus cereus strain led to the accumulation of a 
linear peptide bearing multiple posttranslational modifications, including the two 
anticipated dehydroalanine residues.
53
 This metabolite implicates a role for TclM/TsrE in 
forming the central nitrogen-containing ring, suggesting that installation of thiazoles, 
dehydroamino acid residues, and other core peptide modifications may very likely 
precede intramolecular cyclization.
53
 The sixth conserved protein, TsrG, has no strong 
similarity to proteins of known function. 
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Figure 1.6. Two proposed biosynthetic pathways to the central six-membered nitrogen-
containing ring. 
Other modifications in individual metabolites include hydroxylations, 
methylations, and modifications to the C-terminus. Although there is general knowledge 
of the steps involved in thiopeptide maturation, detailed biochemical studies are still 
needed to decipher the relative timing of the various posttranslational modification steps.  
1.4.1 Biosynthesis of thiostrepton A 
Thiostrepton A (Figure 1.1) is produced by at least two species: Streptomyces 
azureus ATCC 14291 and Streptomyces laurentii ATCC 31255 (S. laurentii), and is one 
of the best studied thiopeptides.
7, 54
 A prototypical example for series b thiopeptides, 
thiostrepton A bears a dehydropiperidine ring and a second highly modified macrocycle 
wherein a quinaldic acid moiety links a Thr side chain from the core thiopeptide 
macrocycle to the N-terminus.
10, 55-56
 The S. laurentii thiostrepton A biosynthetic gene 
(tsr) cluster consists of 21 open reading frames, spanning nearly 30 kb.
32, 34
 TsrA, a 58-
amino acid precursor peptide, is composed of a 41-amino acid leader peptide followed by 
a 17-amino acid core peptide.
32
 The apparent minimal set of biosynthetic proteins 
encoded by tsrCDEFGH presumably installs the core thiopeptide framework and the 
remaining proteins likely mediate additional modifications, including the generation and 
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Table 1.1. Deduced functions of the open reading frames in the tsr locus 































 Earlier feeding studies demonstrated that the quinaldic acid moiety in thiostrepton 
A is derived from L-tryptophan.
57
 It was originally proposed that the biosynthesis of the 
quinaldic acid begins with forming L-2-methyltryptophan from L-tryptophan catalyzed by 
an S-adenosyl-L-methionine (SAM)-dependent methyltransferase, TsrM (Figure 1.7).
32, 58
 
Feeding studies completed by Floss et al. revealed that the methyl group retained its 
stereochemistry upon transfer, suggesting the participation of a radical SAM enzyme.
59
 
This hypothesis was recently confirmed by the Berteau group. TsrM was biochemically 
characterized as a novel radical SAM enzyme using methyl-cobalmine as the direct 
methyl group donor.
60
 Next, TsrV, a pyridoxal 5’-phosphate (PLP)-dependent 
aminotransferase, converts 2-methyltryptophan to 3-(2-methylindolyl)pyruvic acid 
(Figure 1.7).
32
 This intermediate is oxidized by TsrQ followed by a ring rearrangement 
(Figure 1.7).
61
 An oxidoreductase TsrN further reduces the ketone to an alcohol in a 
stereospecific manner, forming 4-(1-hydroxyethyl)quinoline-2-carboxylate, which is 
  10 
thought to be activated by a putative adenylation enzyme TsrJ prior to its attachment to 




Figure 1.7. Proposed biosynthetic pathway for the thiostrepton quinaldic acid moiety. 
 
1.5. Semi-synthesis of thiopeptides 
Despite thiopeptides’ promising biological activities, development of these 
metabolites into clinically useful agents is hindered, at least in part, by their poor water 
solubility. Structural modifications of the thiopeptide scaffold may generate biologically 
active analogs that overcome solubility limitations. Total syntheses of several 
thiopeptides have been achieved, but often involve complicated procedures with low net 
yields.
63-65
 Thus, semi-synthetic modification of naturally-occurring thiopeptides may be 
a more viable solution. The Arndt and the Balasubramanian groups have successfully 
generated a series of thiostrepton analogs by semi-synthetic derivatization.
27-28, 31, 66-69
 It 
was reported that selective removal or modification of the thiostrepton C-terminal Dha 
residues resulted in the analogs generally with retained antibacterial and proteasome 
inhibitory activities.
27-28, 66, 68
 In contrast, at least one of the two C-terminal Dha residues 
was suggested to be important for thiostrepton’s binding to the FOXM1 target.
31
 
Converting the Ile10 dihydroxyl groups of thiostrepton A to a ketal form resulted in the 
formation of an analog with retained anticancer activity, whereas reacting the endocyclic 
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quinaldic acid double bond with Danishefsky’s diene led to cycloaddition products 





 thiazoline to an aromatic thiazole gave rise to active thiostrepton 
derivatives against proteasome inhibition, while a thiostrepton analog in which the ester 
bond connecting Thr12 to the quinaldic acid moiety was opened resulted in a less 
effective proteasome inhibitor (Figure 1.1).
68
 The D-configured thiazoline at position 9 is 
likely to be important for the inhibitory activity of thiostrepton A against protein 
synthesis, as suggested by the greatly reduced binding affinity of the L-epimer to the 
ribosome.
28
 Interestingly, a thiostrepton analog obtained by reducing the central 
dehydropiperidine to a piperidine demonstrated an increased affinity for the L11/rRNA 
complex (Figure 1.1).
28
 Among the efforts placed on developing thiopeptides as 
antibiotics, the C-terminal tail has been a popular region by introducing polar functional 
groups.
70-74
 Indeed, semi-synthetic nocathiacin derivatives have been prepared that retain 
potent antibacterial activity with improved aqueous solubility and a GE2270 A derivative 
is currently being investigated for the treatment of gastrointestinal Clostridium difficile 
infections.
73-74
 However, the semi-synthetic derivatization usually operates within the 
restrictions of the naturally occurring scaffold of a thiopeptide and no analog has been 
made with alternations to the peptide backbone.  
 
1.6 Biosynthetic engineering of thiopeptides 
Biosynthetic engineering offers a feasible strategy to augment semi-synthetic 
efforts toward generation of thiopeptide derivatives. One advantage of producing variants 
in vivo by site-directed mutagenesis of a precursor peptide is that the engineered 
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thiopeptide can be obtained from bacterial fermentation, potentially in high yield. 
Moreover, it reveals the collective posttranslational machinery’s tolerance toward 
alternate substrates and may provide insights into the thiopeptide maturation process. 
There are several platforms to access thiopeptide analogs by precursor peptide 
engineering.
38, 41-42, 53, 75-79
 Biosynthetic engineering of thiostrepton A is the focus of my 
thesis project and my results will be described in detail in the following chapters. Here, 
only the efforts toward generating thiocillin analogs via mutating precursor peptide, and 
providing thiostrepton and nosiheptide variants by gene inactivation are briefly discussed.  
1.6.1 Thiocillin analogs obtained by precursor peptide mutagenesis 
The thiocillins, series d thiopeptides, provide an exquisite illustration of broad 
thiopeptide production across bacterial genera and ecological niches. The thiocillins 
closely resembling micrococcin P1 and P2 were first reported in 1976 from a variety of 
terrestrial Bacillus strains, and metabolites YM-266183 and YM-266184 were later 
isolated from a marine-derived Bacillus species.
5-6
 A micrococcin was the very first 
thiopeptide identified, obtained from an Oxford sewage Micrococcus isolate in 1948 and 
closely related analogs have also been reported from Bacillus pumilis and Staphylococcus 
equorum WS 2733.
80-82
 A close inspection of the thiocillins, micrococcins P1 and P2, 
YM-266183 and YM-266184 reveals that they could all stem from an identical core 
peptide sequence. Using a genome-mining approach, two groups identified a thiocillin 
biosynthetic gene cluster in Bacillus cereus ATCC 14579 (Figure 1.3).
33-34
 Walsh and 
coworkers established that this strain produces eight thiocillin derivatives, including 
thiocillin I (Figure 1.1), the previously identified micrococcins, YM-26618, and YM-
266184.
33
 The conserved set of thiopeptide biosynthetic proteins is encoded by 
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tclIJKLMN. The thiocillin precursor peptide is encoded in four identical gene copies 
(tclE-H) and is composed of a 38-amino acid leader peptide and a 14-amino acid core 
peptide.
33-34
 To access thiocillin analogs by precursor peptide engineering, Walsh et al. 
constructed a B. cereus tclE-H deletion mutant, permitting introduction of a single variant 
copy of tclE on a plasmid via Campbell integration. Each residue of the TclE core peptide 




1.6.2 Gene inactivation to produce nosiheptide analogs 
Nosiheptide, produced by Streptomyces actuosus ATCC 25421 (S. actuosus), is a 
representative member of the series e thiopeptides and is sold as a feed additive in animal 
husbandry (Figure 1.1).
83-85
 Nosiheptide features a hydroxypyridine within the core 
scaffold and a second macrocycle in which an indolic acid residue is linked to two side 
chains from the core macrocycle. The indolic acid appendage is tethered by thioester and 
ester bonds to a cysteinyl thiol and the γ-carboxyl of a hydroxylated glutamyl residue, 
respectively. The region encompassing the nosiheptide biosynthetic gene (nos) cluster 
spans nearly 35 kb and contains 26 genes (Figure 1.3).
36
 The minimal set of proteins 
needed to install the thiopeptide scaffold is proposed to be encoded by nosDEFGHO. The 
nosiheptide precursor peptide, NosM, is composed of a 50-amino acid leader peptide and 
a 13-amino acid core peptide.
36
 Only the first 12 amino acids of the NosM core peptide 
are found in nosiheptide and the 13
th
 residue is cleaved during maturation.
36, 86
  
  14 
 
Figure 1.8. Nosiheptide and analogs generated by gene inactivation. The modified C-
terminus is circled and the alterations to the indolic acid residue and glutamyl side chain 
are indicated with a hashed arc and solid arc, respectively. 
Nosiheptide analogs have been generated either by supplementing fermentation 
medium with an analog of L-tryptophan, the precursor to the indolic acid residue, or by 
inactivating tailoring genes.
36, 86-87
 NosL was recently demonstrated to be a radical S-
adenosyl-L-methionine (SAM)-dependent enzyme that rearranges the L-tryptophan 
carbon skeleton to provide 3-methyl-2-indolic acid and it accepts 5- and 6-fluoro-DL-
tryptophan as substrates.
87
 This promiscuity was exploited in S. actuosus to generate the 
first halogenated thiopeptide (Figure 1.8).
87
 Inactivation of genes encoding nosiheptide 
tailoring enzymes also yielded nosiheptide analogs in two separate studies. NosN, 
proposed to be a radical SAM-dependent methyltransferase, is proposed to install the 4-
methyl group on the indolic acid residue.
36
 Deletion of nosN leads to the accumulation of 
a nosiheptide analog with an indolic appendage lacking the anticipated 4-methyl group 
and, as a consequence, an incomplete second macrocycle (Figure 1.8).
36
 NosA catalyzes 
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formation of the C-terminal amide by an eneamide dealkylation.
86
 Deletion of nosA 
permits interception of a nosiheptide biosynthetic intermediate bearing the cryptic 13
th
 
residue at the C-terminus (Figure 1.8).
86
  
1.6.3 Gene inactivation to produce thiostrepton analogs  
Thiostrepton derivatives have also been obtained by inactivation of genes 
encoding enzymes that elaborate the thiopeptide scaffold late during the maturation 
process. Our group and Liu et al. have deployed this strategy to obtain what appear to be 
intermediates in thiostrepton A biosynthesis.
32, 88
 TsrU resembles members of the α/β 
hydrolase superfamily, and disruption of the corresponding gene leads to accumulation of 
a thiostrepton derivative bearing a methyl ester at the peptide’s C-terminus (Figure 
1.9).
32, 88
 In vitro biochemical analysis of TsrU verified this enzyme is an esterase that 
hydrolyzes the C-terminal methyl ester to liberate methanol and the carboxylate-
containing thiostrepton C (Figure 1.9).
88
 Inactivation of tsrT, which encodes a protein 
homologous to amidotransferases, abrogates thiostrepton A production and permits 
accumulation of thiostrepton C.
32
 The metabolites isolated following inactivation of tsrU 
and tsrT suggest that formation of the C-terminal amide may be a late, if not the final, 
step of thiostrepton A biosynthesis.
32, 88
 Thiostrepton C is ca. 50% more water soluble 
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Figure 1.9. Thiostrepton A and analogs generated by gene inactivation. The modified C-
terminus in each variant is highlighted in blue. 
 
1.7 Scope of this work 
Despite the potent biological activities described for thiostrepton A, its clinical 
application is currently limited due, at least in part, to poor water solubility and 
bioavailability.  In contrast to the general structural knowledge of how thiopeptides affect 
protein translation, rather limited information is available concerning how a thiopeptide is 
also able to engage the recently recognized 20S proteasome and FOXM1 targets. It is 
therefore unknown whether the same or differing structural regions of thiostrepton A are 
critical for each of the three major biological activities. However, the limitations posed 
by naturally available chemical handles for modification of thiostrepton A have 
prevented its structure-activity relationships from being fully explored. Here, a fosmid-
dependent biosynthetic engineering platform for thiostrepton A was developed and a 
series of thiostrepton analogs were successfully produced adapting this method. The 
newly generated thiostrepton variants were then interrogated for their water solubilities, 
antibacterial and proteasome inhibition properties. The information gathered from current 
studies will be used to refine thiostrepton’s structure-activity relationship, providing 
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Thiostrepton A is one of the more extensively studied members of the thiopeptide 
antibiotics.
1
 The proposed thiostrepton biosynthetic gene (tsr) cluster is nearly 30 kb in 
length, containing 21 open reading frames.
2-3
 TsrA encodes the precursor peptide which 
is composed of a leader peptide and a core peptide.
2
 Considerably more genetic and 
biochemical studies are required to uncover the details concerning the transformation of 
the precursor peptide into thiostrepton A, a process requiring over one dozen chemical 
modifications. Although gene inactivation can be performed in the thiostrepton producer 
Streptomyces laurentii ATCC 31255 (S. laurentii), this strain has been recalcitrant to 
further manipulation of the thiostrepton biosynthetic locus, including attempts to replace 
the gene encoding the precursor peptide with one encoding an alternate amino acid 
sequence.
2, 4
 One strategy to circumvent this limitation of S. laurentii is to heterologously 
express the entire tsr cluster in a more genetically tractable host bacterium. Such an 
approach may permit the multiple genetic manipulations that would be necessary to 
engineer the production of thiostrepton analogs. In this chapter, the heterologous 
production of thiostrepton A by two Streptomyces host strains is discussed. 
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2.2 Materials and Methods 
2.2.1 General 
Unless specified, common chemicals, solvents, enzymes and other materials were 
purchased from standard commercial sources and used as provided. The QIAprep Spin 
Miniprep Kit (Qiagen, Valencia, CA) was used for the isolation of plasmids and fosmids 
from E. coli strains. Streptomyces genomic DNA was isolated using the Wizard
®
 
Genomic DNA Purification Kit (Promega, Madison, WI) according to the manufacturer’s 
recommendations. High performance liquid chromatography (HPLC) analysis was 
performed on a Beckman Coulter System Gold instrument. HPLC-MS was performed at 
the Georgia Institute of Technology Bioanalytical Mass Spectrometry Facility with a 
Phenomenex Syngeri RP column (250 mm × 2 mm, 4 µm) (Torrance, CA) and developed 
with 20% solvent B in solvent A for 8 min followed by a gradient from 20-100% solvent 
B over 35 min (solvent A: 5% acetonitrile and 0.1% formic acid; solvent B: 95% 
acetonitrile and 0.1% formic acid) at 0.25 mL/min.  
2.2.2 Bacterial strains, plasmids and growth medium 
Streptomyces laurentii ATCC 31255 (S. laurentii) and Streptomyces actuosus 
ATCC 25421 (S. actuosus) were obtained from American Type Culture Collection 
(ATCC). All strains and plasmids are listed in Table A.1, and primers are listed in Table 
A.2. All Escherichia coli (E. coli) strains were grown in Luria-Bertani liquid or solid 
medium with the appropriate antibiotic(s). For the selective growth of E. coli or 
Streptomyces, the following antibiotics and concentrations were used: kanamycin (50 
μg/mL), apramycin (50 μg/mL), ampicillin (100 μg/mL), nalidixic acid (25 μg/mL), and 
chloramphenicol (30 μg/mL). R2YE solid medium was used for the growth and 
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sporulation of S. lividans and S. actuosus, and for the protoplast transformation of S. 
lividans.
5
 MS agar was used for the intergeneric conjugation of all Streptomyces strains.
6  
 
2.2.3 Fosmid engineering  
Fosmids pCC1FOS and JA3A10 were retrofitted for integration into the 
chromosome of various Streptomyces hosts by employing λ Red-mediated 
recombination.
6-7
 First, a 4.4 kb fragment containing aac(3)IV, int, attP and oriT was 
amplified from pSET152 by polymerase chain reaction (PCR) using the primers 
CTSR1-F and CTSR1-R. Next, the resulting PCR product was used to replace the 
chloramphenicol resistance gene (chl
R
) located on the fosmid backbone, generating the 
fosmids int-3A10 and int-pCC1FOS. The allelic replacements in the resulting fosmids 
were confirmed by PCR and by sequence analysis of the amplified products. 
2.2.4 Heterologous production of thiostrepton 
As an initial step for S. lividans only, pSE34 was introduced by protoplast 
transformation following established protocol.
5
 Each fosmid (int-3A10 or int-pCC1FOS) 
was introduced by intergeneric conjugation into S. lividans and S. actuosus, providing the 
strains S. lividans FZ1, S. lividans FZ2, S. actuosus FZ1 and S. actuosus FZ2. The 
presence of int-3A10 in S. lividans FZ1 and S. actuosus FZ1 was confirmed by PCR 
amplification of tsrK, tsrN, and tsrV, and by sequence analysis of the amplified products.  
2.4.5 Evaluation of thiostrepton A production in Streptomyces 
The fermentation of S. actuosus was carried out in a three-step process. Briefly, 
50 mL of tryptic soy broth (TSB) was inoculated with 50 µL of S. actuosus mycelium 
glycerolic stock and grown at 28 °C and 220 rpm for 7 days in a 250-mL Erlenmeyer 
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flask. Next, 500 µL of the S. actuosus preculture was inoculated to 50 mL seed medium 
(30.0 g/L glucose, 0.234 g/L MgSO4, 20.0 g/L soytone, 20.0 g/L corn steep liquor, 3.0 
g/L (NH4)2SO4, and 5.0 g/L CaCO3, pH 6.8)
8
 in a 250-mL Erlenmeyer flask. After 96 h 
of incubation at 28 °C and 220 rpm, 1 mL of the seed culture was inoculated to 100 mL 
fermentation medium (5.0 g/L L-glutamate, 1.0 g/L L-arginine, 1.0 g/L L-aspartate, 0.29 
g/L K2HPO4, 0.469 g/L MgSO4, 2.0 g/L Na2SO4, 0.01 g/L ZnSO4·7 H2O, 0.02 g/L 
FeSO4·7H2O, 3.0 g/L CaCO3, and 40.0 g/L glucose, pH 7.25)
8
 in a 500-mL Erlenmeyer 
flask. The fermentation culture was incubated at 28 °C and 220 rpm for 7 days.  
The fermentation of S. lividans was carried out in a three-step process. First, 50 
mL of tryptic soy broth in a 250-mL Erlenmeyer flask was inoculated with 50 µL of S. 
lividans mycelium glycerolic stock and grown at 28 °C and 220 rpm for 48 h. Next, 0.5 
mL of the S. lividans preculture was used to inoculate 50 mL of seed medium (50 g/L 
glucose, 15 g/L
 
soybean flour, 15 g/L
 
soluble starch, pH 7.2)
9
 in a 250-mL Erlenmeyer 
flask. After 7 days at 28 °C and 220 rpm, 1 mL of this seed culture was then used to 
inoculate 100 mL of fermentation medium (5.0 g/L L-glutamate, 1.0 g/L L-arginine, 1.0 
g/L L-aspartate, 0.29 g/L K2HPO4, 0.469 g/L MgSO4, 2.0 g/L Na2SO4, 0.01 g/L ZnSO4·7 
H2O, 0.02 g/L FeSO4·7H2O, 3.0 g/L CaCO3, and 40.0 g/L glucose, pH 7.25) in a 500-mL 
Erlenmeyer flask.
8
 The resulting culture was incubated at 28 °C and 220 rpm for 7 days. 
S. coelicolor strains were cultivated following the same conditions used for S. lividans 
and S. actuosus. To harvest thiostrepton A, the whole culture was extracted twice with an 
equal volume of chloroform. The chloroform layers were pooled together and solvent 
removed in vacuo. The solid residue was dissolved in 2 mL of chloroform. Samples were 
analyzed by HPLC with a Phenomenex Luna C18(2) column (250 × 4.6 mm, 5 μm). The 
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column was developed using a gradient of 0-100% acetonitrile in water over 30 min at a 
flow rate of 1 mL/min. Absorbance was monitored at 254 nm. Under these conditions, 
thiostrepton elutes with a tR of about 22 min. Under the conditions used for HPLC-MS, 










 was only a minor species. 
 
2.3 Results and Discussion 
An S. laurentii genomic fosmid library was previously constructed using the 
vector pCC1FOS, and it was determined that fosmid JA3A10 possessed the entire 
proposed tsr cluster.
2
 Using λ Red-mediated recombination, the fosmid was retrofitted 
with the elements necessary to support the intergeneric transfer from E. coli into a 
Streptomyces species and the integration into a Streptomyces chromosome.
6-7, 10-11
 The 
chloramphenicol resistance-imparting gene of the fosmid backbone was replaced with a 
cassette from pSET152 containing an integrase (int), an attP sequence, an origin of 
transfer (oriT), and an apramycin-resistance gene (aac(3)IV) to yield int-3A10 (Figure 
2.1).
12
 A control fosmid was also prepared in this fashion from pCC1FOS to provide int-
pCC1FOS. 
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Figure 2.1. Construction of int-3A10. A fragment containing aac(3)IV, int, attP, and oriT 
was amplified from pSET152 and used to exchange the chloramphenicol resistance gene 
(chl
R
) on JA3A10, yielding int-3A10. Location of the tsr cluster within the fosmid is 
indicated by “tsr.” 
The heterologous hosts chosen for this study were Streptomyces lividans TK24 
(S. lividans) and Streptomyces actuosus ATCC 25421 (S. actuosus). Since the established 
resistance-imparting gene for thiostrepton A is not co-localized with the tsr cluster, it was 
necessary to take additional measures in S. lividans to avoid any toxicity that would result 
from thiostrepton A production.
2, 13
 The vector pSE34, which harbors the rRNA 
methyltransferase imparting thiostrepton A resistance, was introduced into S. lividans to 
yield S. lividans/pSE34. S. actuosus, on the other hand, produces another thiopeptide, 
nosiheptide.
14
 This strain is inherently cross-resistant to thiostrepton A, negating the need 
to introduce a gene specifically conferring thiostrepton A resistance.
15-16
 The retrofitted 
fosmids were then introduced into S. lividans/pSE34 and S. actuosus by intergeneric 
conjugation to provide S. lividans FZ1 and S. actuosus FZ1 (strains containing int-3A10) 
and S. lividans FZ2 and S. actuosus FZ2 (strains containing int-pCC1FOS). The presence 
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of int-3A10 in S. lividans FZ1 and S. actuosus FZ1 was confirmed by PCR amplification 
of tsrK, tsrN, and tsrV (Figure 2.2), 
A                                  B                                        C









Figure 2.2. PCR analysis of S. actuosus FZ1 and S. lividans FZ1. (A) Amplification of 
tsrK using primers TSRK-F and TSRK-R. (B) Amplification of tsrV using primers 
TSRV-F and TSRV-R. (C) Amplification of tsrN using primers TSRN-F and TSRN-R. 
Lanes: (M) 1 kb ladder; (1) JA3A10; (2) pCC1FOS; (3) S. actuosus FZ1; (4) S. actuosus 
FZ2; (5) S. lividans FZ1; (6) S. lividans FZ2. 
 Analysis of the culture extracts by HPLC (Figure 2.3) and HPLC-MS (Figures 
B.1 and B.2) revealed that thiostrepton A was indeed produced in S. actuosus FZ1 and 
S. lividans FZ1. In contrast, none of the strains possessing int-pCC1FOS, which lacks the 
tsr cluster, produced thiostrepton A (Figure 2.3). Parallel with these studies, int-3A10 and 
int-pCC1FOS were introduced into Streptomyces coelicolor CH999 (S. coelicolor), but 
no thiostrepton A was detected in the culture extract from the S. coelicolor host strain 
(data not shown). The ability of int-3A10 to impart thiostrepton-production capabilities 
upon its heterologous host demonstrates that all essential genes for the biosynthesis of 
thiostrepton A are contained within the fosmid int-3A10. Unfortunately, the production 
of thiostrepton A in S. lividans FZ1 (0.2 mg/L) and S. actuosus 3A10 (1.0 mg/L) was 
significantly lower than the level of thiostrepton A production in S. laurentii (44 mg/L). 
A potential complication to the heterologous production of thiostrepton A and other 
thiopeptides is the presence of the thiostrepton-inducible proteins in various 
streptomycetes, including strains of S. lividans and S. coelicolor.
16-18
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Figure 2.3. HPLC analysis of culture extracts from (A) wild-type S. laurentii, (B) S. 
lividans FZ2, (C) S. lividans FZ1, (D) S. actuosus FZ2, (E) S. actuosus FZ1. The 
asterisks indicate thiostrepton A. Absorbance was monitored at 254 nm. 
The TipAS and TipAL proteins from S. lividans 66 have been characterized to 
some detail. In response to complexation with thiostrepton A, TipAL activates its own 
promoter, ptipA, and induces the expression of two alternate translation products from the 
tipA gene: TipAL (itself) and TipAS.
19
 TipAS, the dominant thiostrepton-induced protein 
in S. lividans 66, forms an irreversible lanthionine adduct upon binding thiostrepton A, 
using a TipAS cysteine residue to attack a thiostrepton A dehydrolanine residue and 
sequester the thiopeptide.
20
 Although this may explain one limitation to achieving high-
yield production of thiostrepton A from non-cognate streptomycetes, it is unlikely to be 
the sole contributing factor. In addition to its interactions with TipAL and TipAS, 
thiostrepton A has been implicated in modulating the expression of other genes in 
actinomycetes.
17-19
 Furthermore, it is not unusual to observe lower titers of a metabolite 
from a heterologous host versus that of the native producer, and optimization of the 
fermentation conditions may overcome low production of the metabolite.
21-22
 For 
example, the production of epothilone D in Myxococcus xanthus was increased from less 
than 0.2 mg/L to 23 mg/L through a series of modifications to the culture conditions.
23
 In 
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any event, the low titre of thiostrepton A production in S. lividans FZ1 and S. actuosus 
FZ1 restricts the utility of this integrative fosmid-based heterologous production platform 
to query the roles of the thiostrepton biosynthetic genes or to engineer thiostrepton 
derivatives. Genetic manipulations of the tsr cluster are apt to generate biosynthetic 
intermediates or analogs produced at lower levels relative to the wild-type biosynthetic 
system, and such metabolites may easily escape the limits of detection if using the 
heterologous hosts developed here.  
 
2.4 Conclusions 
Due to the difficulties in the genetic manipulation of S. laurentii, the heterologous 
production of thiostrepton A from an alternate streptomycete host was sought to facilitate 
the biosynthetic investigations of the peptide metabolite. We have been able to develop a 
methodology for the heterologous production of thiostrepton A in a Streptomyces host 
and the successful production of thiostrepton in the heterologous hosts demonstrates that 
all essential genes for the biosynthesis of the antibiotic are contained within the fosmid 
int-3A10. Unfortunately, the production of thiostrepton A in S. lividans FZ1 and S. 
actuosus 3A10 was low, which hinders further application of this platform to generate 
thiostrepton analogs. Therefore, rather than undergoing a complex and likely extensive 
effort in an attempt to improve thiostrepton production in either heterologous host, the 
same methodology toward the engineering of thiostrepton variants in the native 
thiostrepton-producing bacterium, S. laurentii, will be discussed in the next chapter. 
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CHAPTER 3: SITE-DIRECTED MUTAGENESIS OF THE 




From the publications: 
 
Li, C.*; Zhang, F.*; Kelly, W. L. Heterologous production of thiostrepton A and 
biosynthetic engineering of thiostrepton analogs. Mol. BioSyst. 2011, 7, 82-90. (*Authors 
contributed equally to this work) 
Li, C.; Zhang, F.; Kelly, W. L. Mutagenesis of the thiostrepton precursor peptide at Thr7 
impacts both biosynthesis and function. Chem. Commun. 2012, 48, 558-560 . 
 
3.1 Introduction 
The heterologous production of thiostrepton A was described previously, 
however, with low yields. Here, we adapted the platform developed for heterologous 
production toward a pliable system for the generation of thiostrepton analogs from S. 
laurentii itself. The thiostrepton A precursor peptide, TsrA, contains a 17 amino acid core 
peptide region that is incorporated into the final thiostrepton scaffold.
1
 Of the seventeen 
amino acids remaining in thiostrepton A, only three residues are unaltered by the 
posttranslational modification machinery: Ala2, Ala4, and Thr7. These three residues 
were chosen for the initial round of mutagenesis, since none are expected to be directly 
involved in a potentially critical transformation in precursor peptide processing, such as 
dehydration or cyclization. Conservative alterations at these positions may therefore elicit 
a minimal disturbance upon the maturation of a thiopeptide variant.  
Thiostrepton A exerts its antibacterial effect by binding the prokaryotic 50S 
ribosomal subunit near the GTPase-associated center and disrupting the action 
coordinated between the ribosome and its initiation and elongation factors.
2-3
 The binding 
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pocket for thiostrepton A includes both the 23S rRNA and the ribosomal protein L11.
4
 
The Ala2 and Ala4 residues of thiostrepton A appear to be solvent-exposed while the 
Thr7 residue makes critical contacts with the 23S rRNA.
4
 Despite the implication that the 
thiostrepton Thr7 plays an important role in the antibacterial function of thiostrepton A, 
no analogs with alterations to this residue have yet been generated. To probe the 
importance of the Thr7 residue, this position was targeted for additional modifications. 
The newly isolated thiostrepton analogs were further assayed for their antibacterial 
activities.  
 
3.2 Materials and Methods 
3.2.1 General  
Unless specified, common chemicals, solvents, enzymes and other materials were 
purchased from standard commercial sources and used as provided. The QIAprep Spin 
Miniprep Kit (Qiagen, Valencia, CA) was used for the isolation of plasmids and fosmids 
from E. coli strains. Streptomyces genomic DNA was isolated using the Wizard
®
 
Genomic DNA Purification Kit (Promega, Madison, WI) according to the manufacturer’s 
recommendations. High performance liquid chromatography (HPLC) analysis was 
performed on a Beckman Coulter System Gold instrument. HPLC-MS was performed at 
the Georgia Institute of Technology Bioanalytical Mass Spectrometry Facility with a 
Phenomenex Syngeri RP column (250 mm × 2 mm, 4 µm) (Torrance, CA) and developed 
with 20% solvent B in solvent A for 8 min followed by a gradient from 20-100% solvent 
B over 35 min at 0.25 mL/min
 
(solvent A: 5% acetonitrile and 0.1% formic acid; solvent 
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B: 95% acetonitrile and 0.1% formic acid). High-resolution matrix-assisted laser 
desorption/ionization mass spectrometry (HR-MALDI-MS), and MALDI-MS/MS were 
also performed at the Georgia Institute of Technology Bioanalytical Mass Spectrometry 
Facility. High-resolution electrospray ionization mass spectrometry (HR-ESI-MS) was 
performed at the Emory University Mass Spectrometry Center. Proton and carbon NMR 
spectra were recorded on a Bruker 500 MHz spectrometer. All NMR experiments were 
performed according to standard pulse sequences supplied with the instrument. 
3.2.2 Bacterial strains, plasmids and growth medium  
Streptomyces laurentii ATCC 31255 (S. laurentii) was obtained from American 
Type Culture Collection (ATCC). S. laurentii NDS1 (∆tsrA), S. laurentii NDS1/int-3A10 
(encoding wild-type TsrA), int-3A101 (encoding TsrA Ala2Gly), int-3A102 (encoding 
TsrA Ala4Gly), int-3A103 (encoding TsrA Thr7Gly), int-3A104 (encoding TsrA 
Thr7Ser), int-3A105 (encoding TsrA Thr7Ala) and int-3A106 (encoding TsrA Thr7Val) 
were all generated by Dr. Chaoxuan Li. All strains and plasmids are listed in Table A.1, 
and primers are listed in Table A.2, All Escherichia coli (E. coli) strains were grown in 
Luria-Bertani liquid or solid medium with the appropriate antibiotic(s). For the selective 
growth of E. coli or Streptomyces, the following antibiotics and concentrations were 
used: kanamycin (50 μg/mL), apramycin (50 μg/mL), ampicillin (100 μg/mL), nalidixic 
acid (25 μg/mL), and chloramphenicol (30 μg/mL). MS agar was used for the 
intergeneric conjugation of S. laurentii NDS1.
5  
 
3.2.3 Fermentation of S. laurentii  
The fermentations of S. laurentii mutant strains were carried out in a three-step 
process as described previously.
1
 First, 50 mL tryptic soy broth (TSB) with apramycin 
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was inoculated with 50 µL of glycerolic mycelium stock of a S. laurentii mutant strain 
and grown at 28 °C and 220 rpm for 24 h in a 250-mL Erlenmeyer flask. Next, 500 µL of 
the S. laurentii variant preculture was inoculated to 50 mL seed medium (15 g/L soybean 
flour, 50 g/L glucose, 15 g/L soluble starch, pH 7.2) in a 250-mL Erlenmeyer flask. After 
48 h incubation at 28 °C and 220 rpm, 10 mL of the seed culture was inoculated to 100 
mL fermentation medium (11 g/L yeast extract, 50 g/L glucose, 15 g/L TSB, 1 g/L trace 
elements solution (5 g/L CoCl2·6H2O, 0.5 g/L Na2MoO4, 0.5 g/L H3BO3, 1.0 g/L 
CuSO4·2H2O, 1.0 g/L ZnSO4·7H2O)) in a 500-mL Erlenmeyer flask. The fermentation 
culture was incubated at 28 °C and 220 rpm for 4 days and extracted twice with an equal 
volume of chloroform. The chloroform layers were pooled and removed in vacuo. The 
solid residue was dissolved in 4 mL chloroform for HPLC and HPLC-MS analyses. 
Crude culture extracts were analyzed by HPLC with a Phenomenex Luna C18(2) column 
(250 × 4.6 mm, 5 μm). The column was developed with a gradient of 0-100% acetonitrile 
in water over 30 min at 1 mL/min and absorbance was monitored at 254 nm.  
3.2.4 Purification and structural determination of thiostrepton analogs  
Crude extracts from S. laurentii NDS1/int-3A101 (encoding TsrA Ala2Gly) (5 L) 
and S. laurentii NDS1/int-3A102
 
(encoding TsrA Ala4Gly) (4 L) fermentation culture 
were purified by HPLC with a semi-preparative Phenomenex Luna C18(2) column (250 x 
10 mm, 5 μm) while monitoring absorbance at 254 nm. For the purification of 
thiostrepton Ala2Gly, column was developed using solvents A (water) and B 
(acetonitrile) at a flow rate of 4.7 mL/min
 
as follows: the mobile phase was increased 
from 10% to 40% solvent B over 5 min, then held constant at 40% solvent B for 5 min, 
then increased from 40% to 50% solvent B over 5 min, then held constant at 50% solvent 
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B for 5 min, then increased from 50% to 100% solvent B over 5 min, and finally held 
constant at 100% solvent B for 5 min. For the purification of thiostrepton Ala4Gly, the 
column was equilibrated with 10% solvent B and developed as follows: the mobile phase 
was increased to 40% solvent B over 5 min, then held constant at 40% solvent B for 5 
min, then increased to 45% solvent B over 5 min, then held constant at 45% solvent B for 
5 min, then increased to 100% solvent B over 2 min, and finally held at 100% solvent B 
for 5 min. Thiostrepton Thr7Ala and SL105-1 from the culture extract of S. laurentii 
NDS1/int-3A105, and thiostrepton Thr7Val and SL106-1 from the culture extract of S. 
laurentii NDS1/int-3A106 were all purified by Dr. Chaoxuan Li.
6
 All samples were 
stored under argon at -80 °C. Thiostreptons Ala2Gly and Ala4Gly were analyzed by 
HPLC-MS, HR-ESI-MS and NMR. Thiostreptons Thr7Ala, Thr7Val, SL105-1 and 
SL106-1 were analyzed by HPLC-MS, HR-ESI-MS or HR-MALDI-MS, and MALDI-
MS/MS. NMR experiments were also performed with thiostrepton Thr7Ala and SL105-1. 
The spectral data are included in Appendix C and HR-MS data are included in Table F.1.  
3.2.5 Antibacterial activity of thiostrepton analogs  
Antimicrobial activity of S. laurentii culture extracts was qualitatively assessed by 
solid agar disc-diffusion assays. 3 mL of Luria-Bertani (LB) liquid medium was 
inoculated with 3 µL of a cell stock of either Bacillus sp. ATCC 27859 (Bacillus sp.), or 
E. coli ATCC 27856 (E. coli 27856). Brain heart infusion broth (3 mL) was inoculated 
with 3 µL of a cell stock of vancomycin-resistant Enterococcus faecium ATCC 12952 
(VRE) or methicillin-resistant Staphylococcus aureus ATCC 10537 (MRSA). All strains 
were incubated at 37 ºC and 220 rpm for 18 h. Infused solid medium was prepared by 
adding 200 μL of overnight bacterial culture to 20 mL of respective molten medium agar 
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cooled to 42 °C. Eight 7 mm filter paper disks were spaced evenly on the surface of the 
solid medium. To each disk, 10 μL of S. laurentii strain extract in DMSO was deposited 
and the plates were incubated at 37 °C for 18 h. The positive antibiotic control used for 
Bacillus sp., E. coli 27856, and VRE was 10 μL of chloramphenicol (1 mg/mL) and the 
positive antibiotic control used for MRSA was 10 μL of vancomycin (0.5 mg/mL). The 
negative control used for all bacterial strains was 10 μL of DMSO. Antibacterial activity 
was qualitatively determined by the presence or absence of a growth inhibition zone.  
Minimum inhibitory concentrations (MICs) of thiostrepton analogs against 
MRSA, VRE and Bacillus sp. were further determined using liquid microdilution 
method. Briefly, MRSA, VRE, and Bacillus sp. were grown overnight at 37 °C in 
nutrient broth, brain heart infusion and LB broth, respectively. Overnight cultures of the 
individual strains were each diluted 1000-fold with the respective medium and 
transferred to a 96-well plate. Thiostrepton A and its analogs were prepared in DMSO 
and quantified by UV spectroscopy using the extinction coefficient ε280 = 0.027 /(cm 
μM).
7
 Serial dilutions of test samples and controls were performed to assess growth 
inhibition. The positive antibiotic control used for Bacillus sp. and VRE was 
chloramphenicol, whereas the positive control for MRSA was vancomycin. DMSO was 
used as the negative control in all assays. Cell growth was monitored by comparing the 
optical density at 600 nm at the time of treatment and after 18 h incubation at 37 °C. A 
difference in OD600 was considered grown and lowest concentration causing complete 
suppression of visible bacterial growth defined MIC. 
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3.3 Results and Discussion 
3.3.1 Deletion of tsrA in S. laurentii 
Given the concentration-dependent limitations of thiostrepton production 
encountered in the heterologous hosts (see Chapter 2), the approach used for the genetic 
inactivation of tsrA was reevaluated. Previously, an apramycin resistance cassette was 
inserted into the tsrA sequence, leading to the loss of thiostrepton production.
1
 In trans 
complementation of tsrA in this mutant strain, however, never met with success, raising 
the possibility of a secondary effect within the insertional mutant.
8
 In an effort to 
overcome this limitation of complementation and, ultimately, to spur the production of 
thiostrepton variants, Dr. Chaoxuan Li constructed a markerless, in-frame deletion 
mutant of tsrA to provide S. laurentii NDS1. As observed in the tsrA insertional mutant, 
deletion of tsrA in S. laurentii also abolished thiostrepton production (Figure 3.1). 
Unfortunately, the re-introduction of tsrA alone into S. laurentii NDS1 was still 
insufficient to revive thiostrepton production (experiment performed by Dr. Chaoxuan Li 
and data not shown). Introduction of the integrative fosmid int-3A10 into S. laurentii 
NDS1 to yield S. laurentii NDS1/int-3A10 by Dr. Chaoxuan Li, however, did permit the 
robust production of thiostrepton A at 113 ± 35 mg/L (Figure 3.1).  
3.3.2 Production of thiostrepton analogs in S. laurentii 
With a functional platform in hand for complementation of S. laurentii NDS1, it 
is now feasible to interrogate the tolerance of the thiostrepton biosynthetic machinery 
toward alternate precursor peptide substrates. To facilitate the substitution of the 
precursor peptide-encoding gene, wild-type tsrA in int-3A10 was replaced with a dual-
selection cassette imparting resistance to chloramphenicol (chl
R
) and a widely-used 
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counterselection marker, the Bacillus subtilis sacB gene by Dr. Chaoxuan Li, to provide 
int-3A100.
9
 When E. coli and other Gram-negative bacteria are grown in media 
containing sucrose, the presence of sacB inflicts a lethal effect upon its host.
9-10
 Thus, the 
loss of sacB permits growth of E. coli on sucrose-containing medium and provides a 
useful screen for its allelic replacement. An advantage to this fosmid-based system for 
tsrA replacement is that all genetic manipulations involving tsrA can now be conducted in 
E. coli in a comparatively facile manner by PCR-targeted gene replacement.
11
 Following 
the successful replacement of wild-type tsrA with a variant tsrA, Dr. Chaoxuan Li 
introduced the engineered fosmid into S. laurentii NDS1 to assess analog production.  
Minutes































Figure 3.1. HPLC analysis of culture extracts from (A) wild-type S. laurentii, (B) S. 
laurentii NDS1 (∆tsrA), (C) S. laurentii NDS1/int-3A10 (endoding wild-type TsrA), (D) 
S. laurentii NDS1/int-3A101 (endoding TsrA Ala2Gly), (E) S. laurentii NDS1/int-3A102 
(endoding TsrA Ala4Gly), (F) S. laurentii NDS1/int-3A103 (endoding TsrA Thr7Gly). 
The asterisks indicate either thiostrepton A or a thiostrepton analog. Absorbance was 
monitored at 254 nm. 
Three integrative fosmids, each encoding a separate mutant of TsrA, were 
constructed by Dr. Chaoxuan Li and designated as follows: int-3A101 (encoding TsrA 
Ala2Gly), int-3A102 (encoding TsrA Ala4Gly), and int-3A103 (encoding TsrA Thr7Gly) 
(Figure 3.2). Dr. Chaoxuan Li individually introduced the fosmids int-3A101 to int-
3A103 into S. laurentii NDS1 by intergeneric conjugation to provide S. laurentii 
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NDS1/int-3A101 to S. laurentii NDS1/int-3A103, respectively. Two new metabolites 
with similar UV-visible absorption spectra to thiostrepton A were observed in the HPLC 
analysis of the culture extracts of S. laurentii NDS1/int-3A101 and S. laurentii NDS1/int-
3A102 by Dr. Chaoxuan Li (Figure 3.1). Further analysis of the extracts by HPLC-MS 
confirmed that the masses of the two metabolites were consistent with those expected for 
the engineered thiostreptons Ala2Gly and Ala4Gly.
12
 In contrast, Dr. Chaoxuan Li did 
not detect thiostrepton Thr7Gly in the culture extract of S. laurentii NDS1/int-3A103 
either by HPLC or HPLC-MS.  
(A)
(B)
Wild-type  TsrA H2N-Leader Peptide IASASCTTCICTCSCSS
int-3A101  TsrA Ala2Gly H2N-Leader Peptide IGSASCTTCICTCSCSS
int-3A102  TsrA Ala4Gly H2N-Leader Peptide IASGSCTTCICTCSCSS
int-3A103  TsrA Thr7Gly H2N-Leader Peptide IASASCGTCICTCSCSS
Leader Peptide Core Peptide
-41              -1 1               17 
 
Figure 3.2. Thiostrepton A and the expected analogs to be generated by site-directed 
mutagenesis of TsrA. (A) Comparison of wild-type TsrA with the TsrA mutants encoded 
in the three fosmids (int-3A101 to int-3A103). The mutated amino acid residues are 
indicated in red, blue and green. (B) Structures of the expected thiostrepton analogs. 
3.3.3 Antibacterial activities of thiostreptons Ala2Gly and Ala4Gly 
An initial assessment of the antibacterial activity of the new thiostrepton variants 
by disc-diffusion of the S. laurentii culture extracts against bacteria-infused solid media 
revealed that thiostreptons Ala2Gly and Ala4Gly both retained antibacterial properties 
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(Figure 3.3). Thiostreptons Ala2Gly and Ala4Gly were purified and their structures were 
verified by one-dimensional and two-dimensional NMR analyses (Appendix C). The 
minimum inhibitory concentrations (MICs) of the thiostrepton analogs were determined 
against methicillin-resistant Staphylococcus aureus ATCC 10537, vancomycin-resistant 
Enterococcus faecium ATCC 12952, Bacillus sp. ATCC 27859, and Escherichia coli 
ATCC 27856 (E. coli 27856) (Table 3.1). None of the thiostreptons demonstrated 
antibacterial activity against E. coli 27856 (Data not shown). Both engineered 
thiopeptides retained antibacterial activity against the tested Gram-positive strains, 



















Figure 3.3. Disc diffusion antimicrobial assays of culture extracts from S. laurentii 
strains producing thiostrepton variants. (A) Enterococcus faecium ATCC 12952, (B) 
Staphylococcus aureus ATCC 10537 and (C) Bacillus sp. ATCC 27859. For region 1 
through region 4, culture extracts of the following strains were added, respectively: wild-
type S. laurentii, S. laurentii NDS1, S. laurentii NDS1/int-3A101, and S. laurentii 
NDS1/int-3A102; region 5, chloramphenicol (in A and C), vancomycin (in B); region 6, 
dimethyl sulfoxide. 
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Thiostrepton A 0.012 0.012 0.025 
Thiostrepton Ala2Gly 0.023 0.019 0.19 




Chloramphenicol ND 3.9 0.98 
a 
Minimum inhibitory concentration.  
b Staphylococcus aureus ATCC 10537.  
c Enterococcus faecium ATCC 12952. 
d Bacillus sp. ATCC 27859.  
e Not determined. 
Both Ala2 and Ala4 reside within thiostrepton’s second macrocycle, the quinaldic 
acid loop. Much of this region, excepting quinaldic acid, is likely exposed to solvent 
upon binding to the ribosome and is not likely to participate in any direct interactions 
with either the ribosomal protein L11 or the 23S rRNA.
4
 Retention of antibacterial 
activity in the Ala4Gly and Ala2Gly variants is consistent with this expectation. The 
position of the core thiopeptide macrocycle corresponding to Thr7 of thiostrepton A does 
appear to be critical for antibacterial activity. This unmodified amino acid residue of the 
ribosome-binding thiopeptides is highly conserved and substitutions at the corresponding 
position of thiocillin I resulted in a loss of antibacterial activity.
13-14
 The precise 
orientation of the thiopeptide macrocycle, when bound to the ribosome, appears to dictate 
the specific contacts assigned to this conserved threonine residue. For micrococcin P1 and 
thiocillin I, it is presumed that the threonine-containing edge of the macrocyclic loop 
forms several contacts with ribosomal protein L11.
4, 14
 In contrast, this conserved edge in 
thiostrepton A macrocycle forms several contacts with the 23S rRNA.
4, 15
 Furthermore, 
the Thr7 side chain comes within 4-5 Å of A1067 and A1095, two RNA nucleotides 
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3.3.4 Generation of additional thiostrepton Thr7 analogs 
Earlier efforts toward generating thiostrepton Thr7Gly was unsuccessful.
12
 It was 
therefore uncertain whether or not variants of Thr7 could be generated and used to probe 
the importance of this residue for thiostrepton’s antibacterial activity. Here, Thr7 residue 
was targeted with additional modifications. Three mutant strains, S. laurentii NDS1/int-
3A104 (encoding TsrA Thr7Ser), S. laurentii NDS1/int-3A105 (encoding TsrA Thr7Ala) 
and S. laurentii NDS1/int-3A106 (encoding TsrA Thr7Val) were constructed by Dr. 
Chaoxuan Li as previously described. Dr. Chaoxuan Li also evaluated the culture extracts 
of the three strains for the presence of thiostrepton-related metabolites by both HPLC and 
HPLC-MS (Figures 3.4 and C.17). Thiostrepton Thr7Ser (Figure 3.5) was only faintly 
detected by HPLC-MS and was not observable by HPLC analysis, precluding isolation of 
this analog in a quantity sufficient to support biological or structural evaluation. 
Minutes













































Figure 3.4. HPLC analysis of cultures extracts from (A) wild-type S. laurentii, (B) S. 
laurentii NDS1, (C) S. laurentii NDS1/int-3A104 (encoding TsrA Thr7Ser), (D) S. 
laurentii NDS1/int-3A105 (encoding TsrA Thr7Ala), and (E) S. laurentii NDS1/int-
3A106 (encoding TsrA Thr7Val). The asterisk indicates thiostrepton A. Absorbance was 
monitored at 254 nm. 
In the case of the extract from S. laurentii NDS1/int-3A105, two new metabolites, 
A and B were observed by HPLC eluting with a tR of 16.9 min and 18.5 min, respectively 
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(Figure 3.4). Metabolite A, a minor component of this culture extract, possesses an UV-
visible absorption spectrum similar to that of thiostrepton A and further analysis by 
HPLC-MS confirmed that the mass of A was consistent with that expected for 
thiostrepton Thr7Ala, with an m/z 817.9 [M+2H]
2+
. On this basis, A was purified by Dr. 
Chaoxuan Li and analyzed by mass spectrometry (Appendix C). 
 
Figure 3.5. Thiostrepton A and analogs to be generated by mutagenesis of TsrA. Thr7 is 
indicated in green. 
3.3.5 Structural characterization of SL105-1 
The UV-visible absorption spectrum of B, on the other hand, revealed a strong 
absorbance at 242 nm that is absent from mature thiostrepton analogs (Figure C.17). 
Compound B was isolated by Dr. Chaoxuan Li, designated as SL105-1, and deduced to 
have a molecular formula of C62H67N16O15S5 by HR-MALDI-MS (m/z 1435.3575 
[M+H]
+
, calculated m/z 1435.3618). One- and two-dimensional NMR experiments for 
compounds A and B were carried out by Feifei Zhang. Dr. Wendy L. Kelly analyzed the 
NMR data for compound B and examination of the NMR spectra for compound A was 




C NMR spectra of 
thiostrepton Thr7Ala and SL105-1 suggested some structural similarities.
6
 However, 
  51 
several distinctions were noted, including differences in the resonances correlating to the 
thiostrepton quinaldic acid residue and an absence of the first three residues (Ile1, Ala2, 
and Dha3) in SL105-1.
16-17
 Further analysis of SL105-1 by DEPT-135, COSY, HMBC, 
HSQC and MALDI MS/MS suggested the presence of 4-(1-hydroxyethyl)quinolone-2-
carboxylic acid (HEQ) moiety that, unlike thiostrepton A and Thr7Ala analog, is not 
connected to the N-terminal amine of the peptide backbone.  
 
Figure 3.6. Proposed biosynthesis of thiostrepton Thr7Ala and SL105-1. The positions 
corresponding to the pyruvyl residue (Pyr3) and HEQ are shown in red and blue, 
respectively. 
Notably, a MALDI MS/MS spectrum of SL105-1 indicated elimination of the 
HEQ moiety by the appearance of a fragment ion at m/z 1218.1, a loss of 217 Da from the 




 A carbon at δC 196.3 and a singlet integrating to three 
protons at δH 2.14 indicate the presence of a methyl group adjacent to a ketone. HMBC 
correlations from the methyl group at δH 2.14 to δC 196.3 and δC 159.6 support this 
conclusion and suggest the presence of a pyruvyl moiety at the N-terminus of the peptide. 
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Together with additional NMR and MS analyses, these data support the molecular 
formula suggested by HR-MALDI-MS (Table F.1) and the structure proposed for SL105-
1 by Dr. Wendy L. Kelly (Figure 3.6). 
To evaluate the effect of a Thr side chain isostere, S. laurentii NDS1/int-3A106, 
encoding TsrA Thr7Val, was prepared by Dr. Chaoxuan Li. HPLC (Figure 3.4) and 
HPLC-MS analysis of the culture extract from this strain revealed the presence of 
thiostrepton Thr7Val and SL106-1, a Val-containing analog of SL105-1. Metabolites C 
(thiostrepton Thr7Val) and D (SL106-1) were isolated by Dr. Chaoxuan Li and subjected 
to HR-MS and MALDI-MS/MS analysis.
6
 
3.3.6 Antibacterial activities of thiostrepton Thr7 analogs  
Thiostrepton Thr7Ala, Thr7Val, SL105-1, and SL106-1 were evaluated for their 
antibacterial properties. As expected, all thiostrepton analogs were devoid of activity 
toward E. coli. The MIC of each analog was at least 300-fold greater than that of 
thiostrepton A (Table 3.2). The diminished antibacterial activities for thiostreptons 
Thr7Ala and Thr7Val are consistent with the critical role proposed for the Thr7 residue. 
An unmodified threonine residue in the corresponding position within Loop 1 (Figure 
3.5) is highly conserved among ribosome-binding thiopeptides, and this side chain likely 
participates in critical contacts in the thiopeptide binding pocket.
4
 The exact nature of that 
contact, however, differs according to the individual thiopeptide.
4
 Thiocillin I, another 
ribosome-binding thiopeptide, contains an unmodified threonine residue analogous in 
location to Thr7 of thiostrepton A.
4
 While Thr7 of thiostrepton A appears to interface 
with the 23S rRNA, the corresponding thiocillin I threonine (Thr3) instead approaches 
the ribosomal protein L11, reflecting the differences in how individual thiopeptides can 
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bind to the prokaryotic ribosome.
4
 Mutagenesis of Thr3 in the thiocillin precursor peptide 
to Ala, Asp, and Lys led to generation of thiocillin analogs that, like thiostreptons 
Thr7Ala and Thr7Val, were all impaired in their antibacterial activities, whereas the 
serine variant retained activity.
13-14
 Irrespective of the exact binding mode adopted by a 
thiopeptide core macrocycle to the 50S ribosome, the conserved threonine residue is 
indeed essential for the thiopeptide’s antibacterial function.  











Thiostrepton A 0.012 0.012 0.025 
Thiostrepton Thr7Ala >3.4 >3.4 >3.4 
SL105-1 >3.4 >3.4 >3.4 
Thiostrepton Thr7Val >3.4 >3.4 >3.4 




Chloramphenicol ND 3.9 0.98 
a 
Minimum inhibitory concentration.  
b Staphylococcus aureus ATCC 10537.  
c Enterococcus faecium ATCC 12952. 
d Bacillus sp. ATCC 27859.  
e Not determined. 
Although the Thr7Ala substitution may contribute to the diminished antibacterial 
efficacy for SL105-1, this analog also lacks an intact quinaldic acid-containing loop. 
Indeed, Arndt et al. revealed that linearization of Loop 2 (Figure 3.5) by cleavage of the 
ester bond between Thr12 and the quinaldic acid moiety of thiostrepton A yields an 
thiostrepton variant devoid of antibacterial activity.
18-19
 The crystal structure of 
thiostrepton A indicates that the hydroxyl group in the quinaldic acid forms an 
intramolecular hydrogen bond with the Thr7 hydroxyl side chain, and this interaction 
likely contributes to thiostrepton A’s overall conformation.
20
 Furthermore, the X-ray 
crystal structure of thiostrepton A bound to the ribosome reveals that the quinaldic acid of 
is within 3.5 Ǻ of A1067 of the 23S rRNA.
4
 The exact parameters leading to the 
diminished activity remain to be determined, however, it is possible that the absence of 
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an intact Loop 2 leads to in improper orientation of the quinaldic acid moiety, preventing 
the analog from effectually binding to the ribosome.  
HEQ is a discrete intermediate in the biosynthesis of thiostrepton A. Floss and 
coworkers reported the presence of an enzyme in S. laurentii cell-free extracts that 
activates HEQ in an ATP-dependent manner, presumably, immediately prior to the 
tethering of HEQ to the Thr12 side chain.
21-22
 The proposed epoxidation of HEQ 
followed by a nucleophilic attack from the Ile1 N-terminal amine, released following 
cleavage of the TsrA leader peptide, could then forge the quinaldic acid-containing 
macrocycle (Figure 3.6).
17, 22
 In the case of the TsrA Thr7Ala variant, this process 
appears to largely derail at an advanced stage of thiostrepton maturation, likely preceding 
the proposed epoxidation of HEQ (Figure 3.6). Following peptidolysis of the leader 
peptide and the two N-terminal proteinogenic amino acids, a dehydroalanine is 
transiently exposed at the N-terminus prior to tautomerization and hydrolysis to provide 
the shunt product SL105-1 (Figure 3.6). 
The alterations to TsrA Thr7 explored thus far do not permit the robust production 
of alternative thiostreptons. Furthermore, this residue appears to be critical not only for 
the biological activity of thiostrepton, but also for efficient maturation of the thiostrepton 
precursor peptide. The Thr7Gly substitution completely abrogates production of a mature 
thiostrepton, whereas the Thr7Ser variant permits only trace quantities of the final 
metabolite.
6, 12
 The reason(s) these TsrA Thr7 variants failed to be processed to a 
thiostrepton analog is(are) not yet clear, and inefficient processing of alternate precursor 
peptides can occur at any transformation steps during thiostrepton biosynthesis. The 
intramolecular hydrogen bond between Thr7 and the quinaldic acid may play a key role 
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during thiostrepton maturation by stabilizing an intermediate’s conformation for 
enzymatic processing. The production level of thiostrepton A is typically 115 ± 35 mg/L. 
The mature thiostrepton analogs Thr7Ala and Thr7Val were produced at 6 ± 2 and 12 ± 3 
mg/L, respectively. During posttranslational processing, a notable portion of the TsrA 
Thr7Ala and Thr7Val precursor peptides are diverted toward shunt products SL105-1 and 
SL106-1 (9 ± 3 and 3 ± 1 mg/L, respectively). 
 
3.4 Conclusions 
A fosmid-dependent method to rapidly generate variants of thiostrepton A was 
developed and alteration to the primary amino acid sequence of the precursor peptide 
provides an avenue to probe the substrate specificity of the thiostrepton posttranslational 
machinery. The introduction of a fosmid used in the heterologous production of 
thiostrepton A, harboring the entire thiostrepton biosynthetic gene cluster, into the tsrA 
deletion mutant, S. laurentii NDS1, permitted restoration of thiostrepton A production to 
that of the wild-type level. The fosmid was then engineered to enable the rapid 
replacement of wild-type tsrA. Introduction of fosmids encoding alternate TsrA 
sequences into the S. laurentii NDS1 led to the production of thiostreptons Ala2Gly and 
Ala4Gly with retained antibacterial activities. These results demonstrated the utility of 
this expression platform toward thiopeptide engineering. Furthermore, we successfully 
generated thiostrepton analogs at the biologically critical Thr7 residue. Although low 
levels of mature thiostreptons resulted from these mutations, thiostreptons Thr7Ala and 
Thr7Val did accumulate to levels sufficient to permit both structural characterization and 
assessment of their biological activities. As predicted by the crystal structure of 
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thiostrepton A bound to the ribosome, the Thr7Ala and Thr7Val substitutions indeed 
result in greatly impaired antibacterial activities. The presences of SL105-1 and SL106-1 
grant insights into thiostrepton biosynthesis, and suggest that epoxidation of HEQ and 
quinaldic acid loop closure occurs late during thiostrepton maturation. 
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CHAPTER 4: SATURATION MUTAGENESIS OF TSRA ALA4 
UNVEILS A HIGHLY MUTABLE RESIDUE OF THIOSTREPTON A 
 
From the work: 
 
Zhang, F.; Kelly, W. L. Saturation mutagenesis of TsrA Ala4 unveils a highly mutable 
residue of thiostrepton A. 2014, In preparation. 
 
4.1 Introduction 
Thiostrepton A (Figure 4.1) is one of the more extensively studied metabolites of 
thiopeptides and has exhibited antibacterial, antimalarial, and anticancer properties.
1-4
 It 
contains a dehydropiperidine ring and a quinaldic acid loop, in addition to the core 
macrocycle that is observed in all thiopeptides.
5
 In contrast to the general structural 
knowledge of how thiostrepton A affects protein translation, rather limited information is 
available concerning how it is also able to engage the recently recognized 20S 
proteasome and the forkhead box M1 (FOXM1) transcription factor. It is therefore 
unknown whether the same or differing structural regions of thiostrepton A are critical 
for each of the three major biological activities. Recently, we developed a biosynthetic 
engineering platform to produce thiostrepton analogs in Streptomyces laurentii ATCC 
31255 (S. laurentii) by the site-directed mutagenesis of TsrA.
6-7
 In this initial study, 
mutation of the fourth residue of the TsrA core peptide from alanine to glycine supported 
the production of thiostrepton Ala4Gly that retained antibacterial activity, suggesting that 
this residue is amenable to substitution.
6
 Herein, we more thoroughly probe the range of 
amino acid residues tolerated at the fourth position of the TsrA core peptide by saturation 
mutagenesis. The newly generated thiostrepton variants are then interrogated for their 
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antibacterial and proteasome inhibition properties to determine whether or not the 
identity of the fourth residue is critical for either activity. 
 
Figure 4.1. Examples of thiopeptides. The thiostrepton A residues are abbreviated using 
a three-letter code and labeled in grey. The quinaldic acid (QA)-containing loop and the 
C-terminal dehydroalanine residues are highlighted in green and blue, respectively. The 
Ala4 residue of thiostrepton A is shown in red. 
 
4.2 Materials and Methods 
4.2.1 General  
Unless otherwise indicated, all chemicals and solvents were reagent grade, 
purchased from common vendors, and used as received. Enzymes and buffers were 
purchased from New England Biolabs (Beverly, MA). The QIAprep Spin Miniprep Kit 
and DirectPrep 96 MiniPrep Kit from Qiagen (Valencia, CA) were used to prepare 
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plasmids and fosmids from E. coli strains. Streptomyces genomic DNA isolation was 
performed using the Wizard
®
 Genomic DNA Purification Kit (Promega, Madison, WI). 
The StrataClone Blunt PCR Cloning Kit (Agilent Technologies, La Jolla, CA) was 
adapted for PCR product cloning purposes. 96-well tissue culture plates and 96-well 
black with clear flat bottom plates were obtained from Becton Dickson (Franklin Lakes, 
NJ) and Corning (Tewksbury, MA), respectively. 384-well black plates were purchased 
from PerkinElmer (Waltham, MA). A BioTek H4 Multi-Mode Microplate Reader 
(Winooski, VT) was used for optical density, fluorescence, and luminescence 
measurements. 
High performance liquid chromatography (HPLC) analysis was performed on a 
Beckman Coulter System Gold instrument. HPLC-mass spectrometry (HPLC-MS) was 
completed on Micromass Quattro LC at the Georgia Institute of Technology 
Bioanalytical Mass Spectrometry Facility with a Phenomenex Synergi RP column (250 
mm x 2 mm, 4 μm; Torrance, CA). The column was developed with 20% solvent B in 
solvent A for 8 min followed by a gradient from 20-100% solvent B over 35 min at 0.25 
mL/min (solvent A: 5% acetonitrile and 0.1% formic acid in water; solvent B: 5% water 
and 0.1% formic acid in acetonitrile). Unless indicated otherwise, high-resolution matrix-
assisted laser desorption/ionization mass spectrometry (HR-MALDI-MS), and MALDI-
MS/MS were conducted on Applied Biosystems 4700 Proteomics Analyzer at the 
Georgia Institute of Technology Bioanalytical Mass Spectrometry Facility. High-
resolution electrospray ionization mass spectrometry (HR-ESI-MS) was performed on 
Thermo LTQ-FTMS at the Emory University Mass Spectrometry Center. Proton and 
carbon NMR experiments were conducted on a Bruker 500 MHz spectrometer (School of 
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Chemistry and Biochemistry, Georgia Institute of Technology) according to standard 
pulse sequences supplied with the instrument. 
All oligonucleotides were synthesized by Integrated DNA Technologies 
(Coralville, IA) and DNA sequencing was completed by Eurofins MWG Operon 
(Huntsville, AL). Sequence analysis was performed using the VectorNTI
®
 software 
package from Invitrogen (Carlsbad, CA). 
4.2.2 Bacterial strains, plasmids, and growth media 
Streptomyces laurentii ATCC 31255 (S. laurentii), methicillin-resistant 
Staphylococcus aureus ATCC 10357 (MRSA), vancomycin-resistant Enterococcus 
faecium ATCC 12952 (VRE), Bacillus sp. ATCC 27859 (Bacillus) and Escherichia coli 
(E. coli) ATCC 27856 were obtained from American Type Culture Collection (ATCC). 
E. coli EPI300 was purchased from Epicentre
®
 (Madison, WI). All strains, plasmids, and 
fosmids are itemized in Table A.1, and primers are listed in Table A.2. All E. coli strains 
were grown in Luria-Bertani liquid or solid medium with the appropriate antibiotic(s). 
For the selective growth of E. coli or Streptomyces, the following antibiotics and 
concentrations were used: apramycin (50 μg/mL), kanamycin (50 μg/mL), ampicillin 
(100 μg/mL), nalidixic acid (25 μg/mL), and chloramphenicol (12.5 μg/mL). ISP3 agar 
was used for the sporulation of S. laurentii strains and MS agar was used for the 
intergeneric conjugation of S. laurentii NDS1. 
4.2.3 Engineering TsrA Ala4 variants in S. laurentii  
A synthetic ultramer, containing a degenerate codon (NNS) at the fourth position 
of the tsrA core peptide-encoding region and regions homologous to fosmid int-3A100, 
was used as the template for the initial amplification of mutant tsrA genes by polymerase 
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chain reaction (PCR), using the primers Amp-TsrA-SP-F and -R. The amplicons were 
cloned into pSC-B-amp/kan and the resulting plasmids were analyzed by DNA 
sequencing. Inserts containing the highest percentage of synonymous codon usage for 
Streptomyces were selected for further studies.
8
 The mutant plasmids served as the 
templates for amplification for each mutant tsrA gene, using the primers Amp-TsrA-SP-F 
and -R. The resulting amplicons were used to replace the dual-marker disruption cassette 
in fosmid int-3A100 by PCR-targeted gene replacement.
9-10
 Fosmids from the 
chloramphenicol-sensitive and sucrose-tolerant colonies were transformed into 
chemically competent E. coli EPI300 cells to induce high copy number before isolation 
and further analysis by restriction digestion with EcoRI. Samples that displayed the same 
restriction digestion pattern as fosmid int-3A10 were selected for DNA sequence analysis 
to confirm the allelic replacement of wild-type tsrA by each mutant tsrA gene. Mutant 
int-A4X fosmids were transformed into E. coli ET12567/pUZ8002, and then introduced 
into S. laurentii NDS1 through intergeneric conjugation.
10-11
 Colonies resistant to 
apramycin were confirmed by PCR using the primers SD3-F and -R, and the strains were 
annotated as S. laurentii NDS1/int-A4X, according to the introduced mutation. 
4.2.4 Evaluation of thiostrepton Ala4 analog production in S. laurentii 
Growth of S. laurentii was carried out in a three-step process as described 
previously.
12
 First, 50 mL tryptic soy broth (TSB) containing apramycin in a 250-mL 
Erlenmeyer flask was inoculated with 50 μL of glycerolic mycelium stock of the S. 
laurentii strain of interest and grown at 28 °C and 220 rpm for 24 h. Next, 0.5 mL of this 
preculture was used to inoculate 50 mL seed medium (15 g/L soybean flour, 50 g/L 
glucose, 15 g/L soluble starch, pH 7.2) in a 250 mL-Erlenmeyer flask. After 48 h 
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incubation at 28 °C and 220 rpm, 10 mL of this seed culture was used to inoculate 100 
mL fermentation medium (11 g/L yeast extract, 50 g/L glucose, 15 g/L TSB, 1 g/L trace 
elements solution (5 g/L CoCl2·6H2O, 0.5 g/L Na2MoO4, 0.5 g/L H3BO3, 1 g/L 
CuSO4·2H2O, 1 g/L ZnSO4·7H2O)) in a 500-mL Erlenmeyer flask. The resulting culture 
was incubated at 28 °C and 220 rpm for 4 days. The whole culture was extracted twice 
with an equal volume of chloroform. The chloroform layers were pooled together and the 
solvent was removed in vacuo. The solid residue was dissolved in 4 mL chloroform for 
HPLC analysis. Samples were analyzed by HPLC with a Phenomenex Luna C18(2) 
column (250 x 4.6 mm, 5 μm) which was developed at 1 mL/min using a gradient of 0-
100% acetonitrile in water over 30 min. Absorbance was monitored at 254 nm. 
4.2.5 Purification and mass spectrometric analyses of thiostrepton Ala4 analogs 
Crude culture extracts from S. laurentii variant fermentations were first 
crystallized as described previously.
13
 Briefly, each crude culture extract was dissolved in 
a minimum volume of chloroform and 10 volumes of n-hexane was added to the sample 
before centrifugation at 4000 rpm (2559 x g) for 5 min at 25 °C. Next, the precipitate was 
resuspended with a minimum volume of dichloromethane:ethanol at a ratio of 4:1. 
Diethyl ether (5 volumes) was then added to the sample and the resulting mixture 
centrifuged at 4000 rpm (2559 x g) for 5 min at 25 °C. Finally, the precipitated sample 
was dissolved in chloroform:methanol (4:1) and was further purified by semi-preparative 
HPLC with a Phenomenex Luna C18(2) column (250 x 10 mm, 5 μm) while monitoring 
absorbance at 254 nm and using gradients of acetonitrile (solvent B) in water (solvent A) 
as described below.  
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For the purification of thiostreptons Ala4Asn Ala4Dha, Ala4Ile, Ala4Leu, 
Ala4Ser, and Ala4Val, the column was developed using a gradient of solvent B in solvent 
A at 4.5 mL/min as follows: 0% to 50% solvent B over 10 min, then 50% to 60% solvent 
B over 5 min, then held at 60% solvent B for 5 min, then 60% to 100% solvent B over 5 
min, and the mobile phase was finally held constant at 100% solvent B for 3 min. For the 
purification of thiostreptons Ala4Cys F1, Ala4Cys F2, Ala4Gln, Ala4His, Ala4Met, 
Ala4Phe, Ala4Trp, and Ala4Tyr, the column was developed at 4.3 mL/min using a 
gradient of 0-100% solvent B in solvent A over 30 min. For the purification of 
thiostrepton Ala4Dhb, the column was developed at 4.5 mL/min using a gradient of 
solvent B in solvent A as follows: 0% to 40% solvent B over 5 min, then 40% to 50% 
solvent B over 10 min, then 50% to 100% solvent B over 2 min, and the mobile phase 
was finally held constant at 100% solvent B for 3 min. Purified samples were stored 
under argon at -80 °C and analyzed by HPLC-MS, MALDI-MS/MS, and either HR-
MALDI-MS or HR-ESI-MS (Table F.1 and Appendix D). 
4.2.6 Truncation of thiostrepton A and thiostrepton analogs  
The C-terminal truncations of thiostrepton A and its analogs (Ala4Asn, Ala4Cys 
F1, and Ala4Cys F2) were performed following published procedures with slight 
modifications.
14-15
 Briefly, 0.48 mmol of thiostrepton analog was dissolved in 160 μL 
chloroform. Following the addition of 16 μL diethylamine, the resulting solution was 
gently mixed before incubation at 0 °C for 24 h. The reaction mixture was dried under 
argon. The residue was dissolved in 200 μL chloroform and analyzed by HPLC-MS. 
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4.2.7 Kinetic solubility of thiostrepton analogs  
The kinetic aqueous solubilites of thiostrepton A and its analogs were measured 
following a previously described protocol.
16
 First, the thiostrepton A analog was 
dissolved in DMSO and quantified by absorption at 280 nm using an extinction 
coefficient of 0.027/ (cm µM) to make a 1 mM stock solution.
17
 The thiostrepton sample 
was diluted in the assay buffer (10 mM MOPS, 5 mM MgCl2, and 200 mM KCl, pH 7.0) 
to a nominal concentration of 20 μM, containing 5% DMSO. The resulting sample was 
incubated at 25 °C for 2 h followed by centrifugation at 25 °C and 14,000 rpm (18,000 x 
g) for 10 min to remove any precipitate. The UV absorbance of the supernatant at 280 nm 
was used to calculate the solubility of the thiostrepton analog and each analysis was 
performed in triplicate. The aqueous solution of the shunt metabolites SL105-1 and 
SL106-1 were similarly prepared, but with the concentrations quantified by HPLC 
against a standard calibration curve of SL105-1 and assuming comparable spectral 
properties for the two metabolites.
7
 
4.2.8 Antibacterial activity assay 
Minimum inhibitory concentrations (MICs) of thiostrepton analogs against 
indicator strains (MRSA, VRE, Bacillus, and E. coli ATCC 27854) were determined 
following the liquid microdilution method described previously.
6
 Thiostrepton A and its 
analogs were prepared in DMSO and quantified by absorbance at 280 nm as described 
above. Chloramphenicol was used as a positive control for Bacillus and VRE, whereas 
vancomycin served as a positive control for MRSA. DMSO was used as the negative 
control in all assays. Cell growth was evaluated by comparing the optical density at 600 
nm (OD600) at the time of inoculation and after 18 h incubation at 37 °C. A difference in 
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OD600 was considered growth, and the lowest concentration that completely inhibited 
bacterial growth defined the MIC.  
4.2.9 In vitro trancsription-translation coupled assay 
In vitro transcription-translation coupled assays were completed using the E. coli 
S30 Extract System for Circular DNA and Luciferase Assay System from Promega 
(Madison, WI). The inhibition assays were conducted according to manufacturer’s 
protocol, except that the experiment was performed using a 10 μL reaction volume 
containing 1 μL amino acid mixture, 4 μL S30 premix, 3 μL S30 E. coli extract, 1.25 μL 
nuclease-free water, 0.25 μL thiostrepton analog, and 0.5 μL pBESTLuc
TM
 template. The 
luciferase substrate was reconstituted as recommended by the manufacturer. Thiostrepton 
A and its analogs were prepared in a range of concentrations in DMSO and quantified by 
absorbance at 280 nm or HPLC as described above. The reaction was incubated at 37 °C 
for 1 h, at which time 5 μL of the reaction mixture was transferred to a well in a 96-well 
plate. Luciferase substrate (50 μL) was added to each well immediately before 
luminescence was measured. Relative activity, obtained by normalizing luminescence to 
that of a DMSO control, was plotted against compound concentration. Each assay was 
performed in triplicate and the half maximal inhibitory concentration (IC50) was 
calculated for each compound by fitting the data to the Hill equation using GraphPad 
Prism 5 (La Jolla, CA). 
4.2.10. Structural modeling  
The crystal structure of thiostrepton A complexed with the ribosome from 
Deinococcus radiodurans (D. radiodurans) (PDB entry: 3CF5) was used as the source to 
build the in silico model of the thiostrepton Ala4Cys analogs bound to the ribosome.
3
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Thiostrepton A interacts with helices 43 and 44 (H43/44) of D. radiodurans 23S rRNA 
and ribosomal protein L11. By visual inspection, the local complex structure, including 
thiostrepton A, H43/44, and L11, were extracted from the crystal structure and exported 
to ChemDraw 3D Ultra 12.0 (CambridgeSoft, Cambridge, U.K.) The thiostrepton 
analogs, Ala4Cys F1 and F2, were manually built in ChemDraw 3D using the crystal 
structure of thiostrepton A complexed to the ribosome (PDB entry: 3CF5) as the 
template.
18
 The analog structures were energy minimized using the MM2 force field in 
ChemDraw 3D, where H43/44 and L11 were immobilized during minimization.
19
 The 
energy minimized structures of the thiostrepton Ala4Cys analogs were modeled into the 
ribosome, and the interactions of the complex, were visualized using PyMOL.
20
 
4.2.11 20S Proteasome inhibition assay  
Components used to assay inhibition of the 20S proteasome were acquired from 
Enzo Life Sciences (Farmingdale, NY), including the purified human 20S proteasome 
and the fluorogenic substrates Boc-Leu-Arg-Arg-AMC (AMC: 7-amino-4-
methylcoumarin),  Suc-Leu-Leu-Val-Tyr-AMC, and Ac-Nle-Pro-Nle-Asp-AMC, which 
were used to measure the trypsin-like, chymotrypsin-like, and caspase-like activities of 
the 20S proteasome, respectively. Thiostrepton A and its analogs were prepared in 
DMSO and quantified by absorption at 280 nm or HPLC as described above. DMSO and 
bortezomib were included as controls. The assay was executed in a final volume of 50 μL 
in a 384-well plate consisting of: 5 μL test compound, 10 μL 1 μg/mL 20S proteasome, 
10 μL 50 uM fluorogenic substrate and 25 μL assay buffer (20 mM Tris-HCl, 1 mM 
EDTA, pH 7.5) and each assay was performed in triplicate. The 20S proteasome was 
incubated with the test compound for 15 min at 37 °C, followed by the addition of the 
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appropriate fluorogenic substrate. Fluorescence was measured using an excitation 
wavelength of 360 nm and an emission wavelength of 460 nm. Emissions were 
documented every 50 s for 1 h and the arbitrary fluorescence units (AFU) were plotted 
against time for each compound to acquire the slope of the linear fit. Relative activity, 
obtained by normalizing the compound slope to the DMSO control slope, was plotted 
against compound concentration and fit to the Hill equation using GraphPad Prism 5 to 
calculate IC50. 
 
4.3 Results and Discussion 
4.3.1 Engineering tsrA variants in S. laurentii 
The thiostrepton biosynthetic engineering platform utilizes a tsrA deletion mutant 
of S. laurentii (S. laurentii NDS1) and an E. coli-Streptomyces shuttle fosmid, int-3A100, 
allowing for tsrA mutagenesis to be carried out in E. coli.
6
 Fosmid int-3A100 harbors the 
entire tsr biosynthetic gene cluster, except that the TsrA core peptide-encoding region is 
replaced by a dual-marker selection cassette consisting of chl
R
 (a chloramphenicol 
resistance gene) and a levansucrase-encoding sacB gene.
6
 The tsrA genes varying at the 
position encoding the core peptide’s fourth residue were introduced into the fosmid by 
PCR-targeted gene replacement and the resulting fosmids were transferred into S. 
laurentii NDS1 by intergeneric conjugation.
9-10
 By this method, 18 different S. laurentii 
NDS1/int-A4X (where “X” is the one-letter amino acid code for the introduced mutation) 
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 (A) 
int-3A10  Wild-type TsrA H2N-Leader Peptide IASASCTTCICTCSCSS
int-A4R   TsrA Ala4Arg H2N-Leader Peptide IASRSCTTCICTCSCSS
int-A4N   TsrA Ala4Asn H2N-Leader Peptide IASNSCTTCICTCSCSS
int-A4D   TsrA Ala4Asp H2N-Leader Peptide IASDSCTTCICTCSCSS
int-A4C   TsrA Ala4Cys H2N-Leader Peptide IASCSCTTCICTCSCSS
int-A4Q   TsrA Ala4Gln H2N-Leader Peptide IASQSCTTCICTCSCSS
int-A4E   TsrA Ala4Glu H2N-Leader Peptide IASESCTTCICTCSCSS
int-A4G   TsrA Ala4Gly H2N-Leader Peptide IASGSCTTCICTCSCSS
int-A4H   TsrA Ala4His H2N-Leader Peptide IASHSCTTCICTCSCSS
int-A4I   TsrA Ala4Ile H2N-Leader Peptide IASISCTTCICTCSCSS
int-A4L   TsrA Ala4Leu H2N-Leader Peptide IASLSCTTCICTCSCSS
int-A4K   TsrA Ala4Lys H2N-Leader Peptide IASKSCTTCICTCSCSS
int-A4M   TsrA Ala4Met H2N-Leader Peptide IASMSCTTCICTCSCSS
int-A4F   TsrA Ala4Phe H2N-Leader Peptide IASFSCTTCICTCSCSS
int-A4P   TsrA Ala4Pro H2N-Leader Peptide IASPSCTTCICTCSCSS
int-A4S   TsrA Ala4Ser H2N-Leader Peptide IASSSCTTCICTCSCSS
int-A4T   TsrA Ala4Thr H2N-Leader Peptide IASTSCTTCICTCSCSS
int-A4W   TsrA Ala4Trp H2N-Leader Peptide IASWSCTTCICTCSCSS
int-A4Y   TsrA Ala4Tyr H2N-Leader Peptide IASYSCTTCICTCSCSS
int-A4V   TsrA Ala4Val H2N-Leader Peptide IASVSCTTCICTCSCSS
Leader Peptide Core peptide




Figure 4.2. Thiostrepton A and the analogs to be generated by site-directed mutagenesis 
of TsrA. (A) Comparison of wild-type TsrA with the TsrA Ala4 variants encoded in the 
mutant fosmids. (B) Structures of thiostrepton Ala4 analogs. The amino acid residue is 
abbreviated using a three-letter code. The analogs in grey are not produced. The observed 
analogs possessing no modification of the variant residue are highlighted in red, while the 
ones resulting from a modification of the variant residue are highlighted in blue. Dha and 
Dhb refer to dehydroalanine and dehydrobutyrine, respectively. 
4.3.2 Production and structural characterization of thiostrepton analogs  
Culture extracts of the S. laurentii strains encoding TsrA Ala4 variants were 
evaluated for thiopeptide production by HPLC and HPLC-MS. Structures of the 
anticipated thiostrepton analogs are shown in Figure 4.2. Mature thiostrepton analogs 
were not detected in the extracts of S. laurentii NDS1/int-A4D, A4E, A4K, and A4R, 
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either by HPLC or HPLC-MS, suggesting that the amino acid residues inherently charged 
at physiological pH are not well-tolerated by the thiostrepton biosynthetic system at the 
fourth position. The Ala4Pro substitution, which introduces conformational constraints 
on the precursor peptide backbone, is also not processed into a mature thiostrepton 
derivative, as thiostrepton Ala4Pro was not present in the S. laurentii NDS1/int-A4P 
extract. A majority of the Ala4 substitutions in TsrA, however, did yield the expected 
mature thiostrepton analogs, including Ala4Asn, Ala4Gln, Ala4Gly, Ala4His, Ala4Ile, 
Ala4Leu, Ala4Met, Ala4Phe, Ala4Trp, Ala4Tyr, and Ala4Val (Figure 4.2). These 
analogs were purified by semi-preparative HPLC and their identities confirmed by HR-
MS and MALDI-MS/MS (Appendix D and Table F.1).  
 
Figure 4.3. Two characteristic fragments from MALDI-MS/MS used to confirm the 
identity of the fourth residue of a thiostrepton analog. Fragment A corresponds to the loss 
of the quinaldic acid (QA) moiety and the three N-terminal residues Ile1, Ala2, and Dha3 
(Dha: dehydroalanine) from the parent ion and fragment B additionally lacks the fourth 
residue (Xxx4). 
Loss of the quinaldic acid (QA) moiety and sequential fragmentation of the newly 
exposed N-terminal residues are consistently observed in most thiostrepton analogs 
during MALDI-MS/MS, often allowing for unambiguous identification of the residues in 
the QA-containing loop.
7
 The mass difference between two key fragments is particularly 
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diagnostic for the identity of the fourth residue: fragment A corresponds to the loss of the 
QA moiety and the three N-terminal residues (Ile1, Ala2, and Dha3 (Dha: 
dehydroalanine)) from the parent ion and fragment B additionally lacks the fourth residue 
(Xxx4) (Figure 4.3 and Appendix D).  
The variant peptides TsrA Ala4Thr and Ala4Ser both led to thiostrepton analogs 
bearing a modification at the newly introduced residue. For S. laurentii NDS1/int-A4T, a 
major metabolite displaying a similar UV-visible absorption spectrum to that of 
thiostrepton A was detected by HPLC analysis of the culture extract. Further 
investigation by HPLC-MS revealed a species 18 Da less than that expected for 
thiostrepton Ala4Thr, suggesting thiostrepton Ala4Dhb (Dhb: dehydrobutyrine) as the 
product of a dehydration of the newly introduced threonine residue (Figure 4.2). 
Meanwhile, two thiostrepton analogs were readily observed by HPLC analysis of the S. 
laurentii NDS1/int-A4S culture extract. Initial HPLC-MS analyses of the extract revealed 
masses consistent with the anticipated thiostrepton Ala4Ser in addition to thiostrepton 
Ala4Dha, resulting from dehydration of the introduced Ser residue (Figure 4.2). These 
three analogs were purified and then analyzed by MALDI-MS/MS and HR-MALDI-MS 
(Appendix D and Table F.1). The proposed structures of thiostreptons Ala4Dha and 
Ala4Dhb were further verified by one- and two-dimensional NMR analyses (Figures 
D.21-D.26 and D.29-D.34). Relative to thiostrepton A, the Ala4Dha analog revealed an 
additional quaternary carbon (δC: 138.2) and an unsaturated CH2 (δC: 102.9 and δH: 5.82, 
5.25), each characteristic of a Dha residue (Table D.3). Additional resonances 
corresponding to a quaternary carbon (δC: 131.8) and an unsaturated CH (δC: 121.8 and 
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δH: 5.87), suggestive of a Dhb residue, were observed in thiostrepton Ala4Dhb (Table 
D.4).  
Dehydration of a Ser or Thr residue at the fourth position of thiostrepton could be 
catalyzed by the dehydratase(s) encoded within the thiostrepton biosynthetic gene (tsr) 
cluster: TsrC, TsrD, and TsrL.
12
 TsrC and TsrD, homologous to NisB and the LanB 
family of lanthipeptide dehydratases, have homologs in all reported thiopeptide 
biosynthetic systems, and are proposed to dehydrate Ser and Thr residues of the core 
peptide during thiopeptide maturation.
21-22
 The additional LanB-type dehydratase, TsrL, 
is not conserved among all thiopeptide biosynthetic gene clusters, and its role is currently 
unclear.
12
 In contrast to other families of lanthipeptide dehydratases, which employ 
phosphorylation to activate the β-hydroxyl as a leaving group, NisB dehydrates the serine 
and threonine residues of the nisin precursor peptide NisA via a glutamylated 
intermediate, and the LanB-like dehydratases involved in thiopeptide maturation likely 
adopt a similar catalytic strategy.
22-24
 The LanB family of dehydratases appear to be 
flexible in their abilities to dehydrate Ser and Thr residues introduced by precursor 
peptide engineering, demonstrating a broad tolerance toward non-native peptide 
substrates.
25-27
 Lys12Ser and Lys12Thr mutants of the nisin A precursor peptide both led 
to the production of a mixture of nisin analogs either unprocessed or dehydrated at the 
twelfth position, with dehydration of the threonine residue predominating.
28
 An in silico 
analysis of 37 lanthipeptides has suggested that Ser residues may be more likely than the 
Thr side chain to be incompletely processed.
29
 Consistent with these lanthipeptide 
observations, S. laurentii expressing TsrA Ala4Thr only yielded the Ala4Dhb derivative, 
but the strain expressing TsrA Ala4Ser supported the production of both thiostreptons 
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Ala4Ser and Ala4Dha at about a 1:14 ratio. All thiopeptides isolated thus far from the 
structural series a and b contain an unmodified Ala4 residue, but the lone member 
reported for series c, Sch 40832 possesses a Dha4.
5
 The naturally-occurring and 
engineered thiopeptides from series a-c suggest that the dehydratases for the QA loop-
containing thiopeptides may be biased toward dehydration if a suitable residue presents at 
the fourth position of the core peptide.
30
 Insertion of Ser residues in the precursor peptide 
for thiocillin, a series d thiopeptide, also led to dehydration of the newly introduced 
residue.
31
 It therefore appears that, like their lanthipeptide dehydratase counterparts, 
thiopeptide dehydratases are not highly restrictive in their substrate specificities and this 
flexibility can be further explored for directing the introduction of dehydrated amino 
acids into engineered thiopeptides. 
Several metabolites with UV-visible absorption spectra comparable to that of 
thiostrepton A were observed during the HPLC analyses of the S. laurentii NDS1/int-
A4C culture extract. We focused on two of the more abundant metabolites whose masses 
were consistent with that expected for thiostrepton Ala4Cys and those two compounds 
were assigned as thiostreptons Ala4Cys F1 and F2. The identical masses could result 
from two scenarios: either Cys4 retains the umodified thiol group or, via a Michael 
addition, the Cys4 thiol attacked one of the thiostrepton dehydro residues to form a 
lanthionine or methyllanthioine (Lan or MeLan, respectively) bridge, as observed in 
lanthipeptides.
32
 To distinguish between these two possibilities, both Ala4Cys analogs 
were analyzed by MALDI-MS/MS. If the newly introduced Cys4 residue remains 
unmodified, the two distinguishing A and B fragments would be observed (Figure 4.3). 
However, MS/MS fragments of thiostreptons Ala4Cys F1 and F2 both revealed only the 
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presence of fragment A (Figures D.3 and D.11). This observation suggested that the Cys4 
residue was probably now contained within either a Lan or MeLan residue. A lanthionine 
ring likely does not involve Dha3, which would otherwise result only in the formation of 
fragment B. There are three additional dehydrated amino acid residues in the thiostrepton 
scaffold: Dhb8, Dha16, and Dha17. Cys4 is not expected to form a thioether linkage with 
Dhb8 due to the relative positioning of the core macrocycle and the QA loop, which 
places the two residues on opposing faces of the molecule.
33
 One- and two-dimensional 
NMR studies were further performed with purified thiostreptons Ala4Cys F1 and F2 




C resonances for Dha3 and Dhb8 in both F1 and 
F2 analogs were indeed present, confirming that these two residues remain intact.
34
 In 
contrast, the resonances corresponding to one of the C-terminal Dha residues of 
thiostrepton A changed dramatically. The β proton resonances of a Dha residue typically 
appear between 6.7 and 5.2 ppm, whereas the resonances of a Lan residue’s β protons 
should occur upfield, around 3 ppm.
6-7, 34-36
  The NMR analyses revealed only two 
unsaturated CH2’s in both thiostreptons Ala4Cys F1 and F2, as opposed to three in 
thiostrepton A (Dha3, Dha16, and Dha17). The absence of proton signals corresponding 
to one of the C-terminal Dha residues and the appearance of new resonances near 3 ppm 
in the 
1
H spectra of thiostreptons Ala4Cys F1 and F2 suggested that a Lan ring could be 
formed between Cys4 and either Dha16 or Dha17. 




 residue of 
thiostreptons Ala4Cys F1 and F2 are incorporated into the Cys4-initiated Lan rings, the 
analaogs were subjected to a diethylamine-mediated truncation of their C-termini and the 
reactions monitored by HPLC-MS.
14-15
 Using this method, the two C-terminal Dha 
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residues can be sequentially removed from the thiostrepton to provide two truncated 
products lacking Dha17 or both Dha17 and Dha16.
14-15
 If the Lan ring was formed from 
Dha17, no truncated product would be observed; however, if Dha16 was attacked by 
Cys4 instead, a product shortened by the loss of Dha17 would be generated. The expected 
Dha17 and Dha17 plus Dha16 truncation products were identified by HPLC-MS in the 
positive control reactions of thiostrepton A and thiostrepton Ala4Asn (Figure D.2). 
Following exposure of thiostreptons Ala4Cys F1 and F2 to the truncation conditions,
14-15
 
ions suggestive of the corresponding diethylamine adducts of the intact metabolites were 
observed, but no products consistent with a C-terminal cleavage event were detected 
(Figure D.2). Based on the MS, NMR, and chemical modification studies, we propose 
that thiostreptons Ala4Cys F1 and F2 are stereoisomers and, in each analog, the Lan 
residue is formed by the adventitious Michael addition of the Cys4 β-thiolate to the 
terminal alkene of Dha17. 
 
Figure 4.4. Structures of thiostreptons Ala4Cys F1 and F2. Thiostreptons Ala4Cys F1 
and F2 are proposed to be diastereomers differing in configuration at the α carbon of the 
17
th
 residue. The residues comprising the lanthionine are each annotated in the structure 
as “Ala” and are highlighted in red. 
The thiazoline residue (Tzn9) of thiostrepton A occurs in a D-configuration, 
however, nonenzymatic epimerization at this site has been reported.
34, 37
 For a D-
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configured Tzn9, the chemical shift of the α proton appears at approximately 4.8 ppm and 
the resonances of the β protons appear at about 3.5 ppm and 3.0 ppm. In contrast, the 
corresponding resonances for an L-configured Tzn9 appear at about 4.6, 3.4, and 3.1 
ppm, respectively.
37
 Examination of the 
1
H resonances of Tzn9 in the two Ala4Cys 
analogs revealed chemical shifts closely aligned to those of thiostrepton A and our 
previously reported thiostrepton analogs, which presumably all adopt the D-configuration 
(Tables D.1 and D.2).
6-7, 34
 Collectively, the data suggest that thiostreptons Ala4Cys F1 
and F2 are diastereomers differing in the configuration at the α-carbon of the 17
th
 residue, 
however, their absolute configurations were not determined (Figure 4.4). 
In class I lanthipeptide biosynthesis a Ser or Thr residue is first dehydrated by a 
LanB-dehydratase and then a LanC-cyclase mediates Lan or MeLan ring closure between 
the dehydrated amino acid and Cys residues.
38
 Although no lanthionine cyclase homolog 
is encoded in the tsr cluster, a LanC homolog encoded elsewhere in the S. laurentii 
chromosome that could affect Lan formation for the thiostrepton Ala4Cys analogs cannot 
be definitively ruled out. Lanthipeptide synthesis has revealed that Lan ring formation 
from a free cysteine thiol and a dehydrated residue can be readily achieved near 
physiological pH.
39-40
 A nonenzymatic 1,4-addition of the Cys4 thiol to the α,β-
unsaturated alkene of Dha17 seems to be the most reasonable explanation for the Lan 
ring observed in thiostreptons Ala4Cys F1 and F2. 
In total, sixteen thiostrepton analogs have been successfully produced from the 
saturation mutagenesis of TsrA Ala4, however, the titers of these analogs varied 
significantly (Table F.2). TsrA Ala4 variant peptides with hydrophobic alkyl or linear 
thioether chains (Ile, Leu, Met, and Val) are well-tolerated by the thiostrepton 
  78 
biosynthetic system, as suggested by their robust production titers (> 40 mg/L) compared 
to that of wild-type thiostrepton A (115 ± 35 mg/L). Exchanging Ala4 of TsrA with a β-
heteroatom-containing residue also enables maturation of the precursor peptide to a 
thiostrepton at a reasonable overall quantity. TsrA Ala4Ser and Ala4Thr were efficiently 
channeled to thiopeptide derivatives dehydrated at the engineered site whereas the 
Ala4Cys metabolites detected suggest that this residue largely escaped posttranslational 
processing by the thiopeptide cyclodehydratase. When the polar residues Asn, Gln, and 
His are used to replace Ala4, the anticipated thiostrepton analogs are generated, but these 
species were produced at levels ranging from abundant (near 40 mg/L for Asn) to 
relatively impaired (< 5 mg/L for Gln and His). Likewise, substitution of Ala4 with the 
aromatic residues Phe, Trp, and Tyr only supported analog production reduced nearly 40-
fold from wild-type thiostrepton A, suggesting that, while permitted, aromatic residues at 
the fourth residue are not favored by the collective thiostrepton biosynthetic machinery. 
In contrast, TsrA core peptides bearing a positively or negatively charged residue (Arg, 
Lys, Asp, and Glu) or Pro at the fourth position were not transformed into a mature 
thiopeptide. At this time, it is not known which step(s) contribute(s) to low or failed 
thiostrepton analog production, and it is certainly possible that multiple enzymes are not 
able to efficiently accommodate the alternate substrates. 
4.3.3 Aqueous solubility of the thiostrepton Ala4 analogs  
One of the goals behind the biosynthetic engineering of thiostrepton variants is to 
enable development of analogs with improved aqueous solubility while retaining the 
desired bioactivity. The thiostrepton analogs prepared here were therefore assessed for 
their kinetic solubilities, a method widely used in the prescreening process during drug 
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development, to inform on any trends within this family of derivatives.
41
 As expected, the 
polar side chains introduced into thiostreptons Ala4Asn, Ala4Gln, and Ala4Ser 
contributed to slightly improved aqueous solubilities compared to thiostrepton A, and the 
loss of the methyl side chain in thiostrepton Ala4Gly also led to a moderate improvement 
(Table 4.1). Not surprisingly, analogs bearing aromatic or hydrophobic alkyl chains at the 
fourth residue exhibited reduced water solubility compared to the parent compound, 
consistent with the decreased polarity of the introduced side chains relative to the Ala 
methyl group. These data suggested that the identity of the fourth residue can indeed 
influence the solubility of a corresponding thiostrepton derivative. 
Table 4.1. Water solubility of thiostrepton analogs 
 
 
4.3.4 Antibacterial activities of the thiostrepton analogs  
The antibacterial activities of the purified thiostrepton Ala4 variants were 
evaluated using a previously described liquid microdilution method.
6-7
 When Ala4 is 
Compound Water solubility (µM) 
Thiostrepton A 8.10 ± 0.24 
Ala4Asn 12.28 ± 0.46 
Ala4Cys F1 8.16 ± 0.87 
Ala4Cys F2 11.02 ± 0.21 
Ala4Dha
 
7.38 ± 0.53 
Ala4Dhb 6.61 ± 0.21 
Ala4Gln
 
10.70 ± 0.26 
Ala4Gly
 
11.78 ± 0.87 
Ala4His 7.06 ± 0.16 
Ala4Ile
 
2.22 ± 0.29 
Ala4Leu 1.51 ± 0.15 
Ala4Met 0.59 ± 0.11 
Ala4Phe
 
1.37 ± 0.06 
Ala4Ser 10.36 ± 0.27 
Ala4Trp 0.19 ± 0.04 
Ala4Tyr 0.84 ± 0.08 
Ala4Val 1.84 ± 0.22 
Thr7Ala 19.29 ± 0.80 
SL105-1 6.17 ± 1.70 
Thr7Val 17.61 ± 1.82 
SL106-1 11.01 ± 0.87 
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substituted by nonpolar aliphatic or aromatic amino acids, the resulting thiostrepton 
analogs showed minimum inhibitory concentrations (MICs) comparable to the values for 
thiostrepton A against three indicator strains of Staphylococcus aureus, Bacillus sp. and 
Enterococcus faecium (Table 4.2). The antibacterial activities of thiostreptons Ala4His, 
Ala4Ser, Ala4Dha, and Ala4Dhb decreased moderately by approximately 10 to 50-fold, 
whereas the amide side-chain containing Ala4Asn and Ala4Gln variants were reduced in 
activity between 100 to 300-fold. Among all the Ala4 analogs tested, thiostreptons 
Ala4Cys F1 and F2 suffered the greatest impairments in their MIC values, by as much as 
300-fold. Neither thiostrepton A nor its Ala4 variants displayed any antibacterial activity 
against the E. coli indicator strain ATCC 27856 (Data not shown). 











Thiostrepton A 0.012 0.012 0.025 
Ala4Asn 1.6 3.3 3.3 
Ala4Cys F1 >3.4 >3.4 >3.4 
Ala4Cys F2 >3.4 >3.4 >3.4 
Ala4Dha 0.10 0.20 0.40 
Ala4Dhb 0.25 0.25 0.50 
Ala4Gln 1.3 2.7 2.7 
Ala4Gly 0.12 0.12 0.46 
Ala4His 0.16 0.43 1.30 
Ala4Ile 0.026 0.026 0.013 
Ala4Leu 0.015 0.015 0.029 
Ala4Met 0.014 0.014 0.029 
Ala4Phe 0.013 0.013 0.013 
Ala4Ser 0.42 0.21 1.04 
Ala4Trp 0.014 0.007 0.014 
Ala4Tyr 0.028 0.007 0.055 
Ala4Val 0.015 0.015 0.015 
Thr7Ala >3.4 >3.4 >3.4 
SL105-1 >3.4 >3.4 >3.4 
Thr7Val >3.4 >3.4 >3.4 




Chloramphenicol ND 3.9 0.98 
a Minimum inhibitory concentration. 
b Staphylococcus aureus ATCC 10537. 
c Enterococcus faecium ATCC 12952. 
d Bacillus sp. ATCC 27859. 
e Not determined. 
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The observed loss of antibacterial activity could be due to either a diminished 
capacity of the newly generated analogs to bind the target ribosomal site, or instead be 
caused by off-target effects, such as cell permeability or metabolite stability. To 
distinguish between these possibilities and to more directly assess the inhibition of 
protein synthesis by the thiopeptide derivatives, a coupled in vitro transcription-
translation assay was employed using a luciferase reporter system and the translation 
inhibition curves are shown in Figure G.2. Surprisingly, all thiostrepton Ala4 derivatives 
revealed half-maximal inhibitory concentrations (IC50
’
s) against in vitro protein synthesis 
comparable to that of the parent compound, thiostrepton A (Table 4.3). The IC50 for the 
Ala4Trp variant could not be measured due to solubility limitation; however, its MIC 
values against the indicator strains suggest that binding of this analog to the ribosome is 
not dramatically affected (Tables 4.2 and 4.3).  
Table 4.3. In vitro translation inhibition by thiostrepton analogs 
Compound IC50 (µM) 
Thiostrepton A 0.63 ± 0.01 
Ala4Asn 0.64 ± 0.01 
Ala4Cys F1 0.66 ± 0.03 
Ala4Cys F2 0.64 ± 0.01 
Ala4Dha 0.44 ± 0.02 
Ala4Dhb 0.69 ± 0.02 
Ala4Gln 0.41 ± 0.01 
Ala4Gly 0.44 ± 0.02 
Ala4His 0.35 ± 0.02 
Ala4Ile 0.49 ± 0.02 
Ala4Leu 0.50 ± 0.04 
Ala4Met 0.33 ± 0.01 
Ala4Phe 0.67 ± 0.01 




Ala4Tyr 0.56 ± 0.02 













a IC50 not determined due to solubility limitation. 
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To rule out any non-specific inhibition of the in vitro transcription-translation 
system by the thiostrepton scaffold, four Thr7 variants were examined, and the aqueous 
solubilities of these analogs are included in Table 4.1. The unmodified threonine residue 
is highly conserved among ribosome-binding thiopeptides and it is expected to contribute 
key interactions for inhibition of translation.
3, 42-43
 An earlier mutagenesis effort 
confirmed that thiostreptons Thr7Ala, Thr7Val, and the corresponding shunt metabolites 
lacking an intact QA loop, SL105-1 and SL106-1 (for shunt metabolite structures, see 
Figure D.45), were substantially diminished in their abilities to inhibit bacterial growth 
(Table 4.2).
7
 Consistent with their poor MIC values, the abilities of the Thr7 analogs to 
inhibit in vitro protein synthesis was also abrogated (Table 4.3). Collectively, the 
bacterial growth and protein synthesis inhibition assays indicate that the identity of the 
fourth residue within the architecture of thiostrepton is not critical for ribosome binding, 
but may impact other factors key to potent in vivo activity, such as cell membrane 
permeability or metabolic stability. The X-ray crystal structure of thiostrepton A bound to 
the large ribosomal subunit reveals a solvent-exposed Ala4 residue that does not engage 
in any contacts with the ribosome.
3, 7
 This positioning of the fourth residue may explain 
the in vitro activity of thiostreptons presenting an assortment of modifications at this site.  
4.3.5 Structural modeling of thiostrepton Ala4Cys analogs  
Although the in vitro activity of most thiostrepton Ala4 analogs could be 
rationalized from structure-based knowledge of thiopeptide-ribosome interactions, it is 
less obvious how thiostreptons Ala4Cys F1 and F2, containing a third macrocycle, 
preserve their abilities to inhibit protein synthesis. To explain the apparent inconsistency 
between the in vivo and in vitro experiments, we modeled the R and S stereoisomers at 
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Ala17 α-carbon of the two Ala4Cys analogs into the 50S ribosome, adapting the reported 
crystal structure in which thiostrepton A is bound.
3
 Figure 4.5 shows a view of 
thiostrepton A complexed to the ribosome and the interactions proposed between the 
thiostrepton Ala4Cys analogs and the ribosome. Based on these models, the core 
macrocycle and QA-containing loops of thiostrepton A and its analogs are expected to 
adopt similar overall conformations (Figures 4.5 and D.46). In thiostrepton A, the Thr7 
hydroxyl group contributes to the thiopeptide fold by participating in a hydrogen bond 
with the quinaldic acid 9-OH.
33
 This hydrogen bond appears to be maintained in the 
models for the Ala4Cys analogs, as the distances between the Thr7 and quinaldic acid 
hydroxyl groups remain within hydrogen bonding distances, at 2.8 and 2.9 Å in the R-
form and S-form variants, respectively (Figure D.46).  
(A)
(B)                                                                                 (C)
 
Figure 4.5. Thiostrepton A, Ala4Cys F1 and Ala4Cys F2 bound to the ribosome. (A) 
Thiostrepton A (Cyan) bound to the ribosome adapted from PDB 3CF5.
3
 (B) 
Thiostrepton Ala4Cys with the R configuration at the α-carbon of the 17
th
 residue 
(magenta) modeled into the ribosome. (C) Thiostrepton Ala4Cys with the S configuration 
at the α-carbon of the 17
th
 residue (blue) modeled into the ribosome. Helices 43 and 44 of 
23S rRNA are colored in orange and ribosomal protein L11 is shown in green. 
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In addition, Thr7 of the three thiostreptons contact the N1 of A1095 of 23S rRNA 
similarly (within 5 Å) in both the reported X-ray crystal structure and the modeled 
structures (Figure 4.5).
44
 When thiostrepton A binds to the ribosome Thz11 and Thz15 
approach Pro22 and Pro26 of L11, respectively, and appear to contribute hydrophobic 
interactions (Figure 4.5A).
3
 In the structures modeled for the Ala4Cys variants, Thz11 
and Thz15 move away from the two L11 prolines, while the dehydropiperidine ring (Pip) 
approaches Pro26 and may provide a compensating hydrophobic interaction for the 
complex (Figures 4.5B and 4.5C). More importantly, the carbonyl of Tzn9 in the 
Ala4Cys variants are now within hydrogen bonding distance (2.8 Å) to the A1067 2’-OH 
of 23S rRNA, an interaction not observed in the crystal structure of thiostrepton A bound 
to the ribosome due to the greater distance between the two groups (3.8 Å) (Figure 4.5).
3
 
In addition, the stacking interaction between Thz6 and A1095 as seen in the original 
complex is retained in the modeled structures.
3
 The quinaldic acid moiety of the 
thiostrepton Ala4Cys analogs appears to remain close to A1067 to provide a hydrophobic 
interaction as reported previously for the parent thiopeptide.
3
 Overall, the major binding 
interactions between the wild-type thiostrepton A and the ribosome are expected to be 
conserved in the modeled structures for the two Ala4Cys variants, in addition to a new 
hydrogen bond. As a result, these interactions may justify the retained in vitro translation 
inhibition efficacy of the thiostrepton Ala4Cys analogs. 
4.3.6 20S proteasome inhibitory activities of the thiostrepton analogs  
The 20S proteasome is a multi-subunit complex that plays a key role in eukaryotic 
protein degradation.
45
 Different proteolytic activities (trypsin-, chymotrypsin-, and 
caspase-like) are conferred by three distinct types of β-subunits, and most reported 
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nonpeptidic molecules inhibit the chymotrypsin-like activity.
45
 A prior investigation by 
Arndt and coworkers revealed that thiostrepton A displays 20S proteasome inhibitory 
properties.
46
 The thiostrepton analogs described here were tested for their abilities to 
inhibit the 20S proteasome using fluorogenic substrates for all three proteolytic functions. 
One sample calculation for the IC50 values is included in Figure G.1 and the proteasome 
inhibition curves are shown in Figure G.3. Overall, the identity of the fourth residue of 
the thiostrepton scaffold does not appear to be absolutely critical for proteasome 
inhibition, since the IC50 values for most of the thiostrepton Ala4 analogs are comparable 
to that of thiostrepton A (Table 4.4).  











Thiostrepton A 0.95 ± 0.15 1.02 ± 0.12 0.59 ± 0.06 
Ala4Asn 0.38 ± 0.06 0.89 ± 0.17 0.86 ± 0.14 
Ala4Cys F1 1.75 ± 0.23 1.54 ± 0.18 0.32 ± 0.03 
Ala4Cys F2 0.83 ± 0.05 1.38 ± 0.23 0.70 ± 0.06 
Ala4Dha 2.46 ± 0.43 2.73 ± 0.20 2.43 ± 0.30 
Ala4Dhb 0.29 ± 0.03 0.25 ± 0.02 0.28 ± 0.02 
Ala4Gln > 10.7
a
 4.19 ± 0.48 0.31 ± 0.02 
Ala4Gly 0.41 ±  0.05 0.77 ± 0.04 0.48 ± 0.04 
Ala4His 0.51 ± 0.09 0.76 ± 0.15 0.53 ± 0.03 
Ala4Ile 0.24 ± 0.05 0.27 ± 0.03 0.20 ± 0.04 





 0.46 ± 0.05 
Ala4Phe 0.24 ± 0.03 0.37 ± 0.09 0.27 ± 0.05 
Ala4Ser 0.39 ± 0.03 1.11 ± 0.06   0.40 ± 0.06 
Ala4Trp > 0.19
a





Ala4Tyr 0.25 ± 0.02 0.63 ± 0.09 0.36 ± 0.03 
Ala4Val 0.59 ± 0.04 0.49 ± 0.03 0.18 ± 0.03 
Thr7Ala 0.71 ± 0.07 0.57 ± 0.05 0.28 ± 0.04 
SL105-1 0.77 ± 0.12 0.77 ± 0.12 0.56 ± 0.09 
Thr7Val 1.33 ± 0.27 5.38 ± 0.97 1.68 ± 0.19 
SL106-1 > 11
a
 6.30 ± 0.95 6.72 ± 0.40 
Bortezomib 1.62 ± 0.20 0.005 ± 0.001 0.049 ± 0.003 
                               aIC50 not determined due to solubility limitation. 
The inhibitory properties of thiostreptons Ala4Met and Ala4Trp could not be fully 
addressed due to solubility limitations; however, the Ala4Met variant did retain anti-
caspase activity (Table 4.4). Aside from these two variants, thiostrepton Ala4 analogs 
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bearing an unmodified side chain, with the exception of thiostrepton Ala4Gln, are 
associated with similar or slightly enhanced abilities to inhibit the three proteolytic 
activities of the proteasome. The potencies of thiostrepton Ala4Gln against the 
chymotrypsin and trypsin-like functions were somewhat impaired relative to the parent 
compound, reduced by 4-and at least 11-fold, respectively, but this analog did reveal 
about a 2-fold improvement in inhibition of the caspase-like activity of the proteasome 
(Table 4.4). Modifications introduced at the fourth residue side chain, present in the 
Ala4Dha, Ala4Dhb, and the Ala4Cys variants, also do not contribute to any dramatic 
change in proteasome inhibition, as the IC50 values for this subset of analogs remained 
within a 5-fold range relative to that of thiostrepton A (Table 4.4). Semisynthetic 
thiostrepton A derivatives, including those with modifications to the C-terminus and an 
aromatic thiazole in the core macrocycle in lieu of the more reduced thiazoline (position 
9), are reported to retain their proteasome inhibitory activities, and, like the parent 
analog, several exhibit a bias against the caspase-like activity.
46
 Likewise, our current 
study revealed thiostrepton Ala4 analogs also tend to demonstrate a more pronounced 
effect on caspase-like function. These results suggest that thiostrepton A and its analogs 
either adopt differing binding modes to the individual β-subunits or may instead 
allosterically modulate 20S proteasome activity. 
The thiostrepton Thr7 variants and their two shunt metabolites were also 
evaluated as 20S proteasome inhibitors. Unlike its key role for ribosome binding, a 
residue with hydrogen bonding capability at the seventh position of thiostrepton A does 
not appear to be obligatory in order to disrupt proteasome function.
7
 Both thiostrepton 
Thr7 variants retained activity against the proteasome, with the inhibitory properties of 
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thiostrepton Thr7Ala slightly enhanced and those of thiostrepton Thr7Val reduced 
relative to the wild-type metabolite (Table 4.4). Previously, it was demonstrated that a 
thiostrepton A derivative in which the ester bond connecting Thr12 to the QA moiety was 
opened via methanolysis resulted in a less effective proteasome inhibitor, as the IC50 
against caspase-like activity increased over 10-fold.
46
 Our current study reinforces this 
observation: the analogs SL105-1 and SL106-1 (structures shown in Figure D.45),  
lacking the intact QA loop, yet conserving thiostrepton’s ester linkage between Thr12 
and QA, still act as proteasome inhibitors, albeit with decreased efficacy for the Thr7Val 
derivative SL106-1 (Table 4.4). Thiostrepton A and siomycin A (Figure 4.1), both series 
b thiopeptides containing a QA-containing loop, are active proteasome inhibitors, 
whereas series d thiopeptides lacking this additional macrocycle, such as micrococcin P1 
and thiocillin I (Figure 4.1), have not revealed any proteasome inhibitory properties.
1, 47
 It 
appears that the QA macrocycle is indeed important for a thiopeptide’s inhibitory activity 
and that the proper orientation of the QA moiety may contribute to binding interactions 
with the proteasome, as the analogs lacking an intact QA loop do vary in their IC50 
values. Before a comprehensive understanding of thiopeptide-based proteasome 
inhibition can be developed, structural studies are required to provide the molecular 
details into how thiostrepton A binds to the 20S proteasome and to rationalize the varied 
activities for the thiostrepton analogs reported thus far. 
 
4.4 Conclusions 
The realization of the ribosomal origins for thiostrepton prompted us to explore 
biosynthetic engineering as a way to generate thiostrepton analogs inaccessible by 
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semisynthetic modification alone. Saturation mutagenesis at the fourth position of the 
TsrA core peptide has been performed, successfully generating sixteen thiostrepton 
analogs. To our knowledge, this is the first report that thoroughly probed the 
permissiveness of the collective biosynthetic machinery toward modifications to the 
fourth residue in the quinaldic acid loop of a series b thiopeptide, substituting the parent 
alanine residue with the remaining 19 proteinogenic amino acid residues. The in vitro 
inhibition assays of the Ala4 variants reveal that the fourth residue of this thiopeptide is 
not essential for binding either the ribosome or the proteasome. The wide range of 
thiostrepton analogs that retain the ability to complex with the ribosome or the 
proteasome, including Ala4Dha, Ala4Dhb, and Ala4Ser, provide promise for coupling 
that engineered site to semisynthetic modification to acquire a biologically active analog 
with enhanced water solubility. Such a strategy could also facilitate the inclusion of an 
affinity tag or a fluorescent label to probe the mechanism of action, which is currently 
unknown, when thiostrepton A is bound to the proteasome. Modifications to the C-
terminal tail region of thiostrepton A and other thiopeptides, often by conjugate addition 
to a dehydroalanine residue, have been utilized to increase water solubility through the 
introduction of polar side chains.
15, 46, 48-50
 These and other semi-synthetic modifications 
of a thiopeptide scaffold, when introduced at an amenable position, can be broadly 
accepted with retained antibacterial or antimalarial potencies. The results described here 
support further examination of the quinaldic acid-containing macrocycle of thiostrepton 
A and related thiopeptides to generate novel analogs for potential clinical applications. 
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CHAPTER 5: SATURATION MUTAGENESIS OF TSRA ALA2 LED 
TO THE PRODUCTION OF THIOSTREPTON ANALOGS WITH A 
CONTRACTED QUINALDIC ACID-CONTAINING MACROCYCLE  
 
 
From the work: 
 
Zhang, F.; Li, C. Kelly, W. L. Saturation mutagenesis of TsrA Ala2 led to the production 





Thiostrepton A (Figure 5.1), a series b thiopeptides, is among the thiopeptides that 
have exhibited antibacterial, antimalarial, and anticancer properties.
1-4
 Crystallographic 
structural studies of thiostrepton A binding to the large ribosome have greatly enhanced 
researcher’s understanding towards the structure-activity relationship (SAR) of this 
compound for its antibacterial activity.
5
 In contrast, far less information is available to 
illustrate the detailed interactions between thiostrepton A and the 20S proteasome, or 
FOXM1. In order to rationally design a thiostrepton derivative capable of selectively 
disrupting the function of a single cellular process, whether prokaryotic or eukaryotic, it 
will be necessary to decipher the molecular features required to for thiostrepton A’s 
association with each of its major biomolecular targets. Generating thiopeptide analogs 
could be a useful strategy to overcome not only the solubility problem but also to aid in 
understanding the SARs for their specific biological activities. Among these efforts, we 
established a platform to engineer thiostrepton A variants in S. laurentii.
6-7
 Initially, Ala2 
of the TsrA core peptide was replaced by Gly, and this successfully led to the production 
of a corresponding analog, thiostrepton Ala2Gly, which retained high antibacterial 
potency.
7
 In this study, we further interrogated the promiscuity of the tsr biosynthetic 
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system toward structural modifications of the TsrA core peptide second residue via 
saturation mutagenesis. The resulting thiostrepton analogs were subsequently evaluated 
for their water solubilities, antibacterial properties, and inhibition of the 20S proteasome. 
 
Figure 5.1. Examples of thiopeptides. The thiostrepton A residues are abbreviated using 
a three-letter code and labeled in blue. The quinaldic acid loop is highlighted in green. 
 
5.2 Materials and Methods  
5.2.1 General 
Unless otherwise indicated, all chemicals and solvents were purchased from 
common vendors and used as received. Enzymes and buffers were acquired from New 
England Biolabs (Beverly, MA). The Wizard
®
 Genomic DNA Purification Kit (Promega, 
Madison, WI) was used to isolate Streptomyces genomic DNA. Isolation of plasmids and 
fosmids from E. coli strains were performed using the QIAprep Spin Miniprep Kit and 
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DirectPrep 96 MiniPrep Kit from Qiagen (Valencia, CA). PCR products were cloned 
using the StrataClone Blunt PCR Cloning Kit (Agilent Technologies, La Jolla, CA). 96-
well tissue culture plates and 96-well black with clear flat bottom plates were obtained 
from Becton Dickinson (Franklin Lakes, NJ) and Corning (Tewksbury, MA), 
respectively. 384-well black plates were purchased from PekinElmer (Waltham, MA). A 
BioTek H4 Multi-Mode Microplate Reader (Winooski, VT) was used for optical density, 
fluorescence and luminescence measurements. All oligonucleotides were synthesized by 
Integrated DNA Technologies (Coralville, IA). DNA sequencing was performed by 
Eurofins MWG Operon (Huntsville, AL) and sequence analysis was completed using the 
VectorNTI software package from Invitrogen (Carlsbad, CA).  
High performance liquid chromatography (HPLC) analysis was performed on a 
Beckman Coulter System Gold instrument. High-resolution matrix-assisted laser 
desorption/ionization mass spectrometry (HR-MALDI-MS) and MALDI-MS/MS were 
conducted on Applied Biosystems 4700 Proteomics Analyzer at the Georgia Institute of 
Technology Bioanalytical Mass Spectrometry Facility. High-resolution electrospray 
ionization mass spectrometry (HR-ESI-MS) was performed on a Thermo LTQ-FTMS at 
the Emory University Mass Spectrometry Center. High performance liquid 
chromatography-mass spectrometry (HPLC-MS) was completed on Micromass Quattro 
LC at the Georgia Institute of Technology Bioanalytical Mass Spectrometry Facility 
using a Phenomenex Syngeri RP column (250 mm × 2 mm, 4 µm) (Torrance, CA). The 
column was developed at 0.25 mL/min with 20% solvent B in solvent A for 8 min 
followed by a gradient from 20 to 100% solvent B over 35 min (solvent A: 5% 
acetonitrile and 0.1% formic acid in water; solvent B: 5% water and 0.1% formic acid in 
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acetonitrile). NMR experiments were completed on a Bruker 500 MHz spectrometer 
according to standard pulse sequences supplied with the instrument at School of 
Chemistry and Biochemistry, Georgia Institute of Technology.  
5.2.2 Bacterial strains, plasmids, and growth medium 
Streptomyces laurentii ATCC 31255 (S. laurentii), methicillin-resistant 
Staphylococcus aureus ATCC 10537 (MRSA), vancomycin-resistant Enterococcus 
faecium ATCC 12952 (VRE), Bacillus sp. ATCC 27859 (Bacillus) and Escherichia coli 
(E. coli) ATCC 27856 were all purchased from American Type Culture Collection 
(ATCC). E. coli EPI300 was obtained from Epicentre
® 
(Madison, WI). All strains, 
plasmids, and fosmids are itemized in Table A.1, and primers are listed in Table A.2. All 
E. coli strains were grown in Luria-Bertani liquid or solid medium with the appropriate 
antibiotic(s). For the selective growth of E. coli or Streptomyces, the following antibiotics 
and concentrations were used: apramycin (50 µg/mL), kanamycin (50 µg/mL), ampicillin 
(100 µg/mL), nalidixic acid (25 µg/mL), and chloramphenicol (12.5 µg/mL). MS agar 
and ISP3 agar were used for the intergeneric conjugation of S. laurentii NDS1 and 
sporulation of S. laurentii strains, respectively.
8
 
5.2.3 Engineering of TsrA Ala2 variants in S. laurentii  
All the work described in this section was performed by Dr. Chaoxuan Li. A 
synthetic ultramer was designed by containing a degenerate codon (NNS) at the second 
position of the tsrA core peptide-encoding region and regions homologous to fosmid int-
3A100. This ultramer provided the template for amplification of mutant tsrA genes by 
polymerase chain reaction (PCR) with the primers Amp-TsrA-SP-F/R. The amplicons 
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were cloned into pSC-B-amp/kan, and the resulting plasmids were analyzed by DNA 
sequencing. Plasmids with the tsrA inserts containing the highest percentage of 
synonymous codon usage for Streptomyces were chosen as the template for amplification 
of each mutant tsrA gene with the primers Amp-TsrA-SP-F/R.
9
 The PCR products were 
used to substitute the dual-marker disruption cassette in fosmid int-3A100 by PCR-
targeted gene replacement in E. coli BW25113/pKD46.
8, 10
 Fosmids were isolated from 
the chloramphenicol-sensitive and sucrose-tolerant E. coli BW25113 colonies and 
transformed into E. coli EPI300 competent cells to induce high copy numbers of the 
fosmids. The fosmids were digested by EcoRI and samples displaying the same 
restriction digestion pattern as the control (fosmid int-3A10) were analyzed by DNA 
sequencing to confirm the allelic replacement of wild-type tsrA by an Ala2 mutant of 
tsrA. Mutant int-A2X fosmids were first introduced into E. coli ET12567/pUZ8002, and 
then transformed into S. laurentii NDS1 by intergeneric conjugation.
8, 11
 Apramycin-
resistant colonies were confirmed by PCR using the primers SD3-F/R and DNA 
sequencing. The engineered S. laurentii strains were designated as S. laurentii NDS1/int-
A2X, according to the introduced mutation. 
5.2.4 Evaluation of thiostrepton Ala2 analog production in S. laurentii 
Dr. Chaoxuan Li carried out the initial fermentations of all S. laurentii TsrA Ala2 
variants. The fermentations of S. laurentii mutant strains were carried out in a three-step 
process as described previously.
12
 First, 50 mL tryptic soy broth (TSB) with apramycin 
was inoculated with 50 µL of glycerolic mycelium stock of a S. laurentii mutant strain 
and grown at 28 °C and 220 rpm for 24 h in a 250-mL Erlenmeyer flask. Next, 500 µL of 
the S. laurentii preculture was used to inoculate 50 mL seed medium (15 g/L soybean 
  99 
flour, 50 g/L glucose, 15 g/L soluble starch, pH 7.2) in a 250-mL Erlenmeyer flask. After 
a 48 h incubation at 28 °C and 220 rpm, 10 mL of the seed culture was used to inoculate 
100 mL fermentation medium (11 g/L yeast extract, 50 g/L glucose, 15 g/L TSB, 1 g/L 
trace elements solution (5 g/L CoCl2·6H2O, 0.5 g/L Na2MoO4, 0.5 g/L H3BO3, 1.0 g/L 
CuSO4·2H2O, 1.0 g/L ZnSO4·7H2O)) in a 500-mL Erlenmeyer flask. The fermentation 
culture was incubated at 28 °C and 220 rpm for 4 days and extracted twice with an equal 
volume of chloroform. The chloroform layers were pooled together and solvent was 
removed in vacuo. The solid residue was dissolved in 4 mL chloroform for HPLC and 
HPLC-MS analyses. HPLC analyses of the crude culture extracts were performed using a 
Phenomenex Luna C18(2) column (250 × 4.6 mm, 5 μm) developed with a gradient of 0 
to 100% acetonitrile in water over 30 min at 1 mL/min. Absorbance was monitored at 
254 nm. 
5.2.5 Purification and mass spectrometry analyses of thiostrepton Ala2 analogs 
S. laurentii variant culture extracts were first crystallized as previously 
described.
13
 Briefly, the solid residue of the culture extract was dissolved in a minimum 
volume of chloroform and mixed with 10 volumes of n-hexane followed by 
centrifugation for 5 min at 4000 rpm (2559 × g) and 25 °C. The precipitate was then 
dissolved in a minimum volume of dichloromethane:ethanol (4:1). Diethyl ether (5 
volumes) was added into the sample and the mixture was centrifuged at 4000 rpm (2559 
× g) for 5 min at 25 °C. The solid residue was dissolved in chloroform:methanol (4:1) 
and further purified by semi-preparative HPLC using a Phenomenex Luna C18(2) 
column (250 х 10 mm, 5 μm) with water  and acetonitrile, as described below, at 4.3 
mL/min while monitoring absorbance at 254 nm.  
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Purification of thiostreptons Ala2Dha, Ala2Dhb, Ala2Met, Ala2Phe, Ala2Tyr,  
Ala2Ile-ΔIle1, and Ala2Val-ΔIle1 all utilized the same gradient: acetonitrile was 
increased from 0% to 100% in water over 30 min. Thiostreptons Ala2Ile-ΔIle1 and 
Ala2Val-ΔIle1 were subjected to a second round of semi-preparative HPLC purification 
by holding the mobile phase constant at 40% acetonitrile in water for 10 min. Purified 
samples were analyzed by HPLC-MS, MALDI-MS/MS, and either HR-ESI-MS or HR-
MALDI-MS and stored under argon at -80 °C. Thiostreptons Ala2Dha, Ala2Dhb, 
Ala2Ile-ΔIle1 and Ala2Val-ΔIle1 were further analyzed by one- and two-dimensional 
NMR. Mass and NMR spectra are included in Appendix E and Table F.1. 
5.2.6 Aqueous solubility of thiostrepton analogs 
The kinetic solubilities of thiostrepton A and its analogs were measured as 
described previously.
14
 Briefly, 1 mM DMSO stock solutions of thiostrepton A and its 
analogs were quantified by their absorbance at 280 nm using an extinction coefficient of 
0.027 /(cm µΜ), assuming similar spectral properties for the compounds.
15
 The solution 
was diluted with buffer (10 mM MOPS, pH 7.0, 5 mM MgCl2, 200 mM KCl, and 5% 
DMSO) to a nominal concentration of 20 µM. The resulting mixture was incubated at 25 
ºC for 2 h, after which time the sample was centrifuged at 14,000 rpm (18,000 × g) at 
25 ºC for 10 min. The absorbance of the supernatant at 280 nm was used to define the 
solubility of a thiostrepton analog. Each analysis was performed at least in triplicate.   
5.2.7 Antibacterial activity assay 
Minimum inhibitory concentrations (MICs) of thiostrepton analogs against 
different biological indicator strains (MRSA, VRE, Bacillus, and E. coli ATCC27854) 
were determined using the liquid microdilution method.
7 
Thiostrepton A and its analogs 
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were prepared in DMSO and quantified as described above. Chloramphenicol was 
included as the positive antibiotic control for Bacillus and VRE, and vancomycin was 
used as the positive control for MRSA. The negative control in all assays was DMSO. 
Cell growth was determined by comparing the optical density at 600 nm (OD600) at the 
time of inoculation and after 18 h incubation at 37 °C. The OD600 difference defined 
growth, and the lowest concentration able to completely inhibit bacterial growth is the 
MIC. 
5.2.8 In vitro transcription-translation coupled assay 
In vitro transcription-translation coupled assays were completed using the E. coli 
S30 Extract System for Circular DNA and the Luciferase Assay System from Promega 
(Madison, WI). The experiments were performed according to the manufacturer’s 
protocol, except that the reaction was reduced to a 10 µL volume containing 1 µL amino 
acid mixture, 4 µL S30 premix, 3 µL S30 E. coli extract, 1.25 µL nuclease-free water, 
0.25 µL thiostrepton analog, and 0.5 µL pBESTLuc
TM
 template. Thiostrepton A and its 
analogs were prepared in a range of concentrations in DMSO and quantified as described 
above. The reactions were incubated at 37 °C for 1 h, at which time 5 µL of the mixture 
was transferred to a well in a 96-well plate. Luciferase substrate was prepared as 
recommended by the manufacturer. Immediately before luminescence was measured, 50 
µL of the luciferase substrate was added to each well. Relative activity was obtained by 
normalizing luminescence to that of a DMSO control and plotted against compound 
concentration. Each assay was performed in triplicate and the half maximal inhibitory 
concentration (IC50) was calculated for each compound by fitting the data to the Hill 
equation using GraphPad Prism 5 (La Jolla, CA). 
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5.2.9 Structural modeling 
The crystal structure of the thiostrepton A bound to the Deinococcus radiodurans 
(D. radiodurans) ribosome (PDB entry: 3CF5) was used as the template to build the in 
silico models of thiostreptons Ala2Ile-ΔIl1 and Ala2Val-ΔIle1 complexed to the 
ribosome.
5
 Thiostrepton A interacts with helices 43 and 44 (H43/44) of D. radiodurans 
23S rRNA and ribosomal protein L11. By visual inspection, the local complex structure, 
including thiostrepton A, H43/44, and L11, was extracted from the entire crystal structure 
and exported to ChemDraw 3D Ultra 12.0 (CambridgeSoft, Cambridge, U.K.). 
Thiostreptons Ala2Ile-ΔIl1 and Ala2Val-ΔIle1 were constructed in ChemDraw 3D using 
the crystal structure of thiostrepton A complexed to the ribosome (PDB entry: 3CF5) as 
the template.
16
 The MM2 forcefield was used to minimize the energy of the two analogs 
in ChemDraw 3D, keeping the structures of H43/44 and L11 constant during this 
process.
17
 The energy minimized structures of thiostreptons Ala2Ile-ΔIl1 and Ala2Val-




5.2.10 20S Proteasome inhibition assay 
Components used in the 20S proteasome inhibition assay were acquired from 
Enzo Life Sciences (Farmingdale, NY), including the purified human 20S proteasome 
and the fluorogenic substrates Boc-Leu-Arg-Arg-AMC, Suc-Leu-Leu-Val-Tyr-AMC, and 
Ac-Nle-Pro-Nle-Asp-AMC. The proteolytic activities of the 20S proteasome were 
measured using 7-amino-4-methylcoumarin (AMC)-based fluorogenic substrates: Boc-
Leu-Arg-Arg-AMC for trypsin-like activity, Suc-Leu-Leu-Val-Tyr-AMC for 
chymotrypsin-like activity, and Ac-Nle-Pro-Nle-Asp-AMC for caspase-like activity. 
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Thiostrepton A and its analogs were prepared in DMSO and quantified as described 
above. The 20S proteasome was incubated with thiostrepton A or its analog for 15 min at 
37 ºC before the addition of the fluorogenic substrate. The assay was performed in a 
volume of 50 µL in a 384-well plate consisting of: 5 µL thiostrepton analog at different 
concentrations (typically 0.15-500 µM), 10 µL 1 µg/mL 20S proteasome, 10 µL 50 µM 
fluorogenic substrate and 25 µL buffer (20 mM Tris-HCl, 1 mM EDTA, pH 7.5). Each 
analysis was performed at least in triplicate and DMSO was used as a control. 
Fluorescence was measured using an excitation wavelength of 360 nm and an emission 
wavelength of 460 nm. Emissions were recorded every 50 s for 1 h and the arbitrary 
fluorescence units were plotted against time for each compound to acquire the slope of 
the linear fit. Relative activity, obtained by normalizing the compound slope to the 
DMSO control slope, was plotted against compound concentration and fit to the Hill 
equation using GraphPad Prism 5 to calculate IC50. 
. 
5.3 Results and Discussion 
5.3.1 Generation of TsrA Ala2 mutants in S. laurentii 
A previously developed fosmid-based engineering platform in S. laurentii was 
used as the basis for the saturation mutagenesis of TsrA Ala2 by Dr. Chaoxuan Li.
7
 In 
this system, the core peptide-encoding region of tsrA in fosmid int-3A100, an E. coli-
Streptomyces shuttle fosmid containing the entire tsr gene cluster, is substituted with a 
chloramphenicol resistance gene (chl
R
) and a levansucrase-encoding gene (sacB).
7
 A 
synthetic DNA ultramer was designed to incorporate the degenerate codon NNS (N refers 
to any nucleotide, and S refers to G or C) at the second codon of the TsrA core peptide, 
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providing the basis for the generation of a plasmid library of tsrA mutants. Amplicons of 
each variant tsrA gene were used to replace the dual-marker selection cassette in fosmid 
int-3A100 by λ-RED-mediated recombination.
8, 10
 Dr. Chaoxuan Li introduced the 
mutant fosmids each separately into a tsrA deletion mutant of S. laurentii (S. laurentii 
NDS1) by intergeneric conjugation to provide 19 S. laurentii NDS1/int-A2X variants, 
including the previously constructed S. laurentii NDS1/int-A2G.
7
 The introduced 
mutation is represented by the one-letter amino acid abbreviation “X” and each S. 
laurentii variant strain expresses a different version of TsrA. 
5.3.2 Production and characterization of thiostrepton Ala2 analogs 
Initial fermentations were performed with all S. laurentii TsrA Ala2 mutants and 
cultures were extracted with chloroform prior to analysis by Dr. Chaoxuan Li. Figure 5.2 
includes the structures for anticipated thiostrepton Ala2 analogs. In the crude culture 
extracts of S. laurentii NDS1/int-A2D, A2E, A2H, A2K, A2L, A2N, A2Q, A2R and 
A2W, either no or only a trace amount of mature thiostrepton analogs were detected by 
HPLC and HPLC-MS. These results suggest that charged amino acids at physiological 
pH, Leu and Trp residues at the second position are either not accepted or not efficiently 
processed by the collective thiostrepton biosynthetic machinery. HPLC-MS analysis of 
the of S. laurentii NDS1/int-A2P crude extract did not reveal a mass consistent with 
thiostrepton Ala2Pro, suggesting that the conformational constraints imposed on 
polypeptide backbone in the TsrA Ala2Pro mutant may not be tolerated by one or more 
of the thiostrepton biosynthetic enzymes.  
Several low-abundance metabolites with UV-visible absorption spectra similar to 
that of thiostrepton A and masses consistent with a mature thiostrepton Ala2Cys were 
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observed from the HPLC and HPLC-MS analyses of the S. laurentii NDS1/int-A2C 
culture extract. Similar results were observed in our previous study with S. laurentii TsrA 
Ala4Cys, revealing several metabolites with UV-visible absorption spectra resembling 
thiostrepton A.
19
 Two of those analogs, thiostreptons Ala4Cys F1 and F2, were isolated 
and structurally characterized as lanthionine (Lan)-containing diastereomers, in which a 
Lan residue is formed nonenzymatically from Cys4 and Dha17 with varied configuration 




 In the Ala2Cys variant, a Lan ring could also be 
formed which resulted in the formation of metabolites with the same mass as expected for 
the anticipated thiostrepton Ala2Cys. Examination of the HPLC-MS data suggested 
thiostrepton analogs with thiazoline residue at the second position are produced by the 
A2C mutant at a trace level (data not shown). It is likely that a Cys residue at the second 
and the fourth position of the TsrA core peptide is not well recognized by the thiostrepton 
cyclodehydratases and dehydrogenase as the newly introduced Cys residue is not 
efficiently processed to a thiazoline or thiazole group, in contrast to the fate of other Cys 
residues in the TsrA core peptide.
19
 Initial disc diffusion antimicrobial assays with the 
culture extract of S. laurentii TsrA Ala2Cys did revealed growth inhibition against the 
indicator strains (Bacillus sp. and VRE), suggesting that active components are present in 
the extract (data not shown). Despite our best efforts, low titers and difficulties in 
separating the highly similar metabolites hindered further characterization of these 
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(A)  
Wild-type TsrA  MSNAALEIGVEGLTGLDVDTLEISDYMDETLLDGEDLTVTMIASASCTTCICTCSCSS
Leader Peptide Core peptide





Figure 5.2. Thiostrepton A and its analogs to be generated by site-directed mutagenesis 
of TsrA Ala2. (A) Wild-type TsrA sequence with Ala2 of the core peptide highlighted in 
red. (B) Structures of thiostrepton Ala2 analogs. The analogs in grey were not observed 
or only produced at trace levels. The observed analogs possessing no posttranslational 
modification of the variant residue are highlighted in red, while the ones possessing a 
posttranslational modification of the variant residue are highlighted in blue. The analogs 
with a contracted quinaldic acid loop are shown in green. 
 
Thiostreptons Ala2Met, Ala2Phe, and Ala2Tyr were successfully produced by the 
corresponding S. laurentii TsrA Ala2 variants (Figure 5.2).
7
 These three analogs were 
purified by semi-preparative HPLC and their structures were verified by HR-MS and 
MALDI-MS/MS (Appendix E). MALDI-MS/MS of thiostrepton analogs typically leads 
to loss of the quinaldic acid (QA) moiety followed by the successive fragmentation of the 
N-terminal residues from the QA-containing macrocycle toward the dehydropiperidine 
ring, yielding two daughter fragments, A and B, indicative of the second residue’s 
identity (Figure 5.3).
6, 19
 Fragment A corresponds to the loss of QA and Ile1, while 
fragment B also lacks the second residue (-QA, -Ile1, and -Xxx2) (Figure 5.3 and 
Appendix E). During the MALDI-MS/MS analyses for thiostrepton Ala2Met, Ala2Phe, 
and Ala2Tyr, A was not observed, instead a fragment accounting for the cleavage of QA, 
Ile1 and a carbonyl group was detected (Appendix E). This new diagnostic ion together 
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with fragment B was used to deduce the chemical identity of the second residue in these 
three analogs. 
 
Figure 5.3. Two characteristic fragments from MALDI-MS/MS used to confirm the 
identify of the second residue of a thiostrepton analog. 
 
When the culture extracts of S. laurentii NDS1/int-A2S and A2T were analyzed 
by HPLC-MS, the anticipated thiostreptons Aal2Ser and Ala2Thr analogs were not 
detected. Instead, the corresponding dehydrated products, thiostreptons Ala2Dha (Dha: 
dehydroalanine), and Ala2Dhb (Dhb: dehydrobutyrine), were observed (Figure 5.), as 
suggested by an 18 Da reduction in mass for each metabolite relative to the anticipated 
analogs. The two analogs were purified and examined by HR-MS, MALDI-MS/MS and 
NMR analyses (Appendix E). The diagnostic fragments A and B were identified during 
the MALDI-MS/MS analyses for thiostreptons Ala2Dha and Ala2Dhb (Appendix E). In 
the parent compound, thiostrepton A, three Dha residues and one Dhb moiety are present 
(Dha3, Dha16, Dha17 and Dhb8; Figure 5.1). In the NMR spectra for thiostrepton 
Ala2Dha, four Dha residues were instead observed (Appendix E). An additional 
quaternary carbon (δC: 134.2) and an unsaturated CH2 (δC: 100.1 and δH: 6.27, 5.01) are 
indicative of a Dha residue (Table E.1). While the spectra for thiostrepton Ala2Dhb 
reveals new resonances for a quaternary carbon (δC: 128.4) and an unsaturated CH (δC: 
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119.4 and δH: ~5.62), characteristic of a Dhb residue (Table E.2). We recently reported 
that replacing Ala4 with Ser resulted in the formation of both anticipated (Ala4Ser: 93%) 
and dehydrated analogs (Ala4Dha: 7%), while Ala4 to Thr substitution only led to the 
production of the dehydrated product, Ala4Dhb.
19
 In contrast to the studies with S. 
laurentii TsrA Ala4Ser and Ala4Thr, only dehydrated products were observed in the 
mutant strains expressing TsrA Ala2Ser and TsrA Ala2Thr, indicating that the 
thiostrepton dehydratase(s) may be more effective toward dehydrating a Ser residue at the 
second position of TsrA core peptide than the fourth position. Siomycin A, another series 
b thiopeptide (Figure 5.1), naturally harbors a Dha at the second position, whose presence 
suggests that the thiopeptide dehydratases may be naturally evolved to dehydrate a serine 
residue at this position.
20
 Three enzymes (TsrC, TsrD, and TsrL) encoded in the tsr 
biosynthetic gene cluster show homology to LanB-type dehydratases responsible for the 
dehydration of Ser and Thr residues during biosynthesis of lanthipeptides, a separate 
family of RiPP metabolites.
12, 21
 TsrC and TsrD, homologs to which are present in all 
reported thiopeptide biosynthetic systems, are proposed to install the Dha and Dhb 
residues during the thiopeptide maturation process, while the role of TsrL is currently 
unclear.
22
 The lanthipeptide dehydratases can demonstrate broad substrate specificity and 
are often able to catalyze the dehydration of non-native Ser or Thr residues.
23-25
 Likewise, 
a growing body of work relying upon precursor peptide engineering suggests that 




For S. laurentii NDS1/int-A2I and int-A2V, the expected mature products, 
thiostreptons Ala2Ile and Ala2Val, were detected only by HPLC-MS (data not shown). 
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Interestingly, a major metabolite displaying UV-visible absorption spectra comparable to 
that of thiostrepton A was identified from HPLC analysis of the culture extracts of both 
mutants. These two compounds were further purified and structurally characterized by 
HR-MALDI-MS, MALDI-MS/MS, and NMR. MS results suggested that the Ala2Ile and 
Ala2Val metabolites are truncated at the N-terminus, with the Ile1l residue lacking in the 
structures (Figure 5.4 and Appendix E). In MALDI-MS/MS spectra of both thiostrepton 
analogs, a fragment that is 233 Da less than the parent ion was detected, indicative of the 
presence of an N-terminus-linked quinaldic acid moiety (Appendix E). NMR analyses 
were performed to verify the structures proposed for thiostreptons Ala2Ile-ΔIle1 and 
Ala2Val-ΔIle1. As expected for both analogs, the resonances corresponding to Ile1 were 
absent (Appendix E). 
 
 
Figure 5.4. Structures of thiostreptons Ala2Ile-∆Ile1 and Ala2Val-∆Ile1. The quinaldic 
acid loop is highlighted in blue and the mutated residue is shown in red. The numbering 
system used for the quinaldic acid residue is labeled in black.  
 
In both ΔIle1 variants, the chemical shifts corresponding to QA-8 and QA-9 
appeared in the upfield region (δC-8: ~62.8; δH-8: ~3.45 and δC-9: ~73.8; δH-9: ~4.52), 
resembled the resonances observed for other thiostrepton analogs bearing an intact QA 
macrocycle (Tables E.3 and E.4).
6-7, 19, 27
 For thiostrepton Ala2Val-ΔIle, an HMBC 
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correlation was observed between the α-proton of Val2 and the C-8 of the QA moiety, 
confirming further a covalent link between the engineered Val2 residue and the quinaldic 
acid (Appendix E). During the late stages of thiostrepton A maturation, the Thr12 β-
hydroxyl is acylated with the QA derivative, 4-(1-hydroxyethyl)quinoline-2-carboxylic 
acid (HEQ).
13
 Next, it is expected that the HEQ ligand is epoxygenated at C-8 and C-9 
(Figure 5.4).
13
 Peptidolysis of the leader peptide, either before or after attachment and 
modification of the quinaldic acid moiety, deprotects the primary amine of the core 
peptide N terminus, permitting a nucleophilic attack of the epoxy group, and forms the 
second macrocycle that distinguishes thiostrepton and the series b thiopeptides.
6, 28-29
 
Similar to Ile1 in wild-type thiostrepton A, Ile2 and Val2 confer branched, hydrophobic 
side chains. A trace amount of thiostrepton Ala2Leu-ΔIle1 was also observed in the 
culture extract of S. laurentii NDS1/A2L, however, only by HPLC-MS (data not shown). 
Our observation suggests that the identity of the first residue that is ultimately 
incorporated into a mature thiostrepton analog may be important for the recognition by 
the peptidase or protease. It is likely that the peptidase or protease may bind to the late-
stage intermediate during thiostrepton A biosynthesis, pinpoint the branched, 
hydrophobic amino acid residue at the core peptide second position, and cleave the leader 
peptide plus Ile1. The newly freed N-terminal amine of the second residue would attack 
the quinaldic acid epoxide and result in the formation of a thiostrepton analog with a 
contracted quinaldic acid macrocycle, containing only three residues at the N-terminus. 
This hypothesis is supported by the naturally observed Val1 in Siomycin A (series b) and 
thiopeptin A1a (series a) (Figure 5.1).
20, 30
 The presence of a Val or Ile residue at the N-
terminus of a native thiopeptide indicates that the peptidase and the additional thiopeptide 
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posttranslational modification enzymes may have higher specificity toward these two 
amino acids in comparison to a Leu residue at the first position. This would explain the 
robust production of thiostreptons Ala2Ile-ΔIle1 and Ala2Val-ΔIle1, in contrast to the 
trace level of thiostrepton Ala2Leu-ΔIle1 that is only detected by HPLC-MS. The identity 
of this peptidase, however, is unclear. A gene for a functional peptidase is not readily 
identifiable in either the tsr or the sio biosynthetic locus.
12, 31
 A non-specific peptidase or 
protease encoded elsewhere on the genome of S. laurentii may instead execute leader 
peptide cleavage.
12
 Once the peptidase is identified, further biochemical and structural 
studies with this enzyme would permit detailed understanding of how the leader peptide 
is removed. This knowledge will aid in the design of thiostrepton analogs with either 
expanded or contracted quinaldic acid loop, if the thiostrepton posttranslational system 
would collectively tolerate the new precursor peptide variant. 
Table 5.1. Summary of water solubility of thiostrepton analogs 
Compound Water solubility (µM) 
Thiostrepton A 8.10 ± 0.24 
Ala2Dha 4.14 ± 0.28 
Ala2Dhb 11.10 ± 0.27 
Ala2Gly 16.79 ± 0.60 
Ala2Ile-∆Ile1 10.18 ± 0.36 
Ala2Met 13.62 ± 0.38 
 Ala2Phe 4.71 ± 0.13 
Ala2Tyr 0.92 ± 0.10 
Ala2Val-∆Ile1 3.28 ± 0.22 
 
In total, eight thiostrepton Ala2 analogs were isolated during this saturation 
mutagenesis study. The thiostrepton Ala2 analogs were further measured for their kinetic 
aqueous solubility, a parameter commonly assessed in the prescreening process of drug 
development (Table 5.1).
32
 All analogs displayed similar solubilities compared to that of 
thiostrepton A (within 3-fold range), with the exception of the Ala2Tyr variant, which 
suffers a 9-fold impairment in solubility due to the newly introduced non-polar, aromatic 
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side chain. The titer of each analog was used to estimate the tolerance level of the 
collective thiostrepton A biosynthetic pathway toward the mutated residue at the second 
position (Table F.2). In comparison to thiostrepton A production (115 mg/L), introducing 
a serine residue at the second position is highly preferred by the biosynthetic machinery 
and the newly introduced serine was further dehydrated to provide thiostrepton Ala2Dha 
(301 mg/L). Siomycin A has a structure highly similar to that of thiostrepton A, differing 
only at positions 1 and 2 (Val1 and Dha2) (Figure 5.1).
20
 The presence of Dha2 in 
siomycin A suggests that the dehydratase(s) may have a natural tendency to dehydrate a 
serine residue at this position. Further alignment of the LanB-type dehydratases TsrC and 
SioJ from the sio locus reveals 76% identity and 81% similarity between these two 
enzymes, while TsrD demonstrates 77% identity and 87% similarity to SioK.
12, 31
 In 
contrast, the identities and similarities between TsrC or TsrD and its respective homologs 
from the nosiheptide and thiocillin biosynthetic pathways (both lacking the Dha2 residue) 
are greatly reduced (<34% for identities and <48% for similarities).
33-34
 The high 
homologies between the dehydratases from the thiostrepton A and siomycin biosynthetic 
pathways suggest that TsrC and TsrD may favor a Ser residue at the TsrA core peptide 
second position which may account for the nearly 3-fold increase in the titer of Ala2Dha 
variant relative to that of wild-type metabolite. Substituting Ala2 with Thr is also well-
recognized as thiostrepton Ala2Dhb is produced at about 39 mg/L. Replacing Ala2 with 
Ile and Val did permit robust production of the N-terminal truncated thiostrepton analogs 
(34 mg/L for thiostrepton Ala2Ile-∆Ile1 and 51 mg/L for thiostrepton Ala2Ile-∆Ile1). The 
production of thiostrepton Ala2Gly is less efficient (19 ± 3 mg/L) and replacing Ala2 
with residues containing linear or aromatic side chains may not be favored by the tsr 
  113 
maturation system as the titers of thiostreptons Ala2Met, Ala2Phe, and Ala2Tyr are 
significantly reduced to less than 4 mg/L. The second residue of the TsrA core peptide is 
closely located to the leader peptide and introducing a variant residue at this position may 
affect the correct folding of a mutant TsrA. This would render the TsrA Ala2 variant less 
favored by the enzymes involved in the maturation of a thiostrepton analog, thus 
accounting for the moderate restrict of the biosynthetic system toward modifications at 
the second position, in contrast to the highly mutable TsrA Ala4.
19
 
5.3.3 Antibacterial activities of thiostrepton analogs 
A microbroth dilution method was used to determine the antibacterial activities of 
the isolated thiostrepton Ala2 analogs against three indicator strains of Staphylococcous, 
Bacillus, and Enterococcus.
6-7
 Most of the thiostrepton Ala2 analogs showed either 
comparable or modestly reduced ability to inhibit the growth of these test strains relative 
to thiostrepton A, which provided MIC values ranging from 0.012 to 0.025 μg/mL (Table 
5.2). The antibacterial activities of thiostreptons Ala2Dhb and Ala2Tyr did decrease up to 
20-fold, resulting in MIC values ranging from 0.1 to 0.3 μg/mL (Table 5.2). 
Thiostreptons Ala2Ile-ΔIle1 and Ala2Val-ΔIle1, however, lost their abilities to inhibit 
bacterial growth in the concentration range tested (MIC >5.0 μg/mL, Table 5.2). 
Consistent with thiopeptides’ selective activity against Gram-positive bacteria, none of 
Ala2 analogs were able to inhibit the growth of E. coli ATCC 27856 (Data not shown).
7
 
Two explanations can be provided for the inactive thiostreptons Ala2Ile-∆Ile1 and 
Ala2Val-∆Ile1. First, the ∆Ile1 analogs cannot bind the ribosome. An alternative 
explanation for the loss of inhibitory activities is that the analogs are unable to reach the 
ribosome.  
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Thiostrepton A 0.012 0.012 0.025 
Ala2Dha 0.010 0.008 0.042 
Ala2Dhb 0.11 0.11 0.11 
Ala2Gly 0.023 0.019 0.19 
Ala2Ile-∆Ile1 >5.0 >5.0 >5.0 
Ala2Met 0.014 0.007 0.086 
 Ala2Phe 0.022 0.011 0.087 
Ala2Tyr 0.22 0.11 0.27 




Chloramphenicol ND 3.9 0.98 
a Minimum inhibitory concentration.  
b Staphylococcus aureus ATCC 10537.  
c Enterococcus faecium ATCC 12952. 
d Bacillus sp. ATCC 27859. 
e Not determined. 
A coupled in vitro transcription-translation assay was therefore employed to 
directly assess the abilities of the thiostrepton Ala2 variants to inhibit protein synthesis 
and the translation inhibition curves are shown in Figure G.4. Under these conditions, the 
activity observed for thiostrepton A was consistent with  previously reported value.
35
 The 
half maximal inhibitory concentrations (IC50) obtained for most thiostrepton Ala2 analogs 
are comparable to that for thiostrepton A, with an exception that thiostrepton Ala2Ile-
∆Ile1 demonstrate more than a ten-fold increase (Table 5.3). The IC50 for thiostrepton 
Ala2Val-∆Ile1 was not determined due to the solubility limitation. However, thiostrepton 
Ala2Val-∆Ile1 was speculated to have comparable inhibitory activity as thiostrepton 
Ala2Ile-∆Ile1 based on their extremely similar structures. Thiostreptons Ala2Dhb and 
Ala2Tyr, having up to 20-fold reduction in their efficacy toward inhibiting bacterial 
growth in liquid culture, however, demonstrated equivalent abilities to inhibit in vitro 
protein synthesis as thiostrepton A (Tables 5.2 and 5.3). The results observed for 
thiostreptons Ala2Dhb and Ala2Tyr suggested that off-target factors may account for 
their reduced in vivo activities, such as, cell permeability or metabolite stability.  
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Till now, only Ala or Dha is observed at the second position of all reported series 
a and b thiopeptides, which inhibit protein synthesis by interacting with the ribosome.
36
 
Our results here expanded the chemical entities of the second position to other 
hydrophobic residues (Dha, Dhb, Met, Phe, and Tyr) and demonstrated that those analogs 
retained their in vitro potency to inhibit protein synthesis. Overall, the MIC data for the 
analogs generated in this study are in line with their IC50 values. This observation is 
consistent with the X-ray crystal structure of thiostrepton A bound to the ribosome 
revealing a solvent-exposed Ala2 residue.
5
 Even though only limited thiostrepton Ala2 
analogs were produced from current saturation mutagenesis study, our results do suggest 
that the second position of the TsrA core peptide could tolerate further modifications 
without affecting the abilities of the analogs to complex with the 50S ribosome. In 
contrast, the size of the quinaldic acid-containing macrocycle does matter for thiostrepton 
A’s antibacterial potency as indicated by the reduced in vivo and in vitro inhibitory 
activities of thiostreptons Ala2Ile-∆Ile1 and Ala2Val-∆Ile1 (Tables 5.2 and 5.3). 
5.3.4 Structural modeling of the N-terminus truncated thiostrepton analogs 
To further examine the diminished ribosome-inhibiting capabilities of the two 
analogs harboring a contracted QA loop, both thiostreptons Ala2Ile-ΔIle1 and Ala2Val-
Compound IC50 (µM) 
Thiostrepton A 0.63 ± 0.01 
Ala2Dha 0.58 ± 0.03 
Ala2Dhb 0.35 ± 0.04 
Ala2Gly 0.46 ± 0.05 
Ala2Ile-∆Ile1 8.1 ± 1.0 
Ala2Met 0.33 ± 0.03 
 Ala2Phe 0.34 ± 0.02 
Ala2Tyr 0.58 ± 0.08 
Ala2Val-∆Ile1 >3.28
a 
a IC50 not determined due to solubility limitation. 
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ΔIle1 were modeled into the 50S ribosome, using the crystal structure of thiostrepton A 
bound to the ribosome as the template.
5
 Partial views of thiostrepton A bound to the 
ribosome and the modeled complexes of the two ΔIle1 analogs and the ribosome are 
depicted in Figure 5.5. In thiostrepton A, an intramolecular hydrogen bond between the 
Thr7 hydroxyl group and the 9-OH of the quinaldic acid moiety  stabilizes the three-
dimensional conformation (Figure E.36).
37
 In both ΔIle1 thiostrepton variants, the 
distances between the aforementioned two oxygen groups are 3.2 Å preserving this key 
internal hydrogen bond and suggesting that these analogs and thiostrepton A adopt 
similar overall folds (Figure E.36). The quinaldic acid moieties in the two modeled 
complexes remain close to A1067, as is observed in the thiostrepton A complex, and 
likely contribute favorable hydrophobic interactions.
5
 In the crystal structure of 
thiostrepton A bound to the ribosome, Thz15 approaches Pro26 of L11 (within 3.4 Å) and 
Thz11 sits above Pro22 (within 3.6 Å), providing additional hydrophobic interactions 
(Figure 5.5A).
5
 In the structures modeled for the two ΔIle1 analogs bound to the 
ribosome, Thz15 similarly approaches Pro26 (3.7 Å), however, Thz11 is unable to 
interact with Pro22 due to the greater distance (4.8 Å) (Figures 5.5B and 5.5C). In 
addition, the distance between Thz6 and A1095 of 23S rRNA in the reported structure 
(3.7 Å) is elongated to 4.2 Å in the models.
5
 7 In the crystal structure of thiostrepton A 
bound to the ribosome, the Tzn9 carbonyl is 3.7 Å away from the 2’-OH of A1067 
(Figure 5.5A).
5
 In the two models, this distance is reduced to 3.3 Å, permitting a new 
hydrogen-bonding interaction (Figure 5.5). 
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(A)
(B)                                                               (C)
 
Figure 5.5. Thiostrepton A, Ala2Ile-ΔIle1 and Ala2Val-ΔIle1 bound to the 50S 
ribosome. (A) Thiostrepton A (Cyan) bound to the ribosome adapted from PDB 3CF5.
5
 
(B) Model of thiostrepton Ala2Ile-ΔIle1 (magenta) bound to the ribosome. (C) Model of 
thiostrepton Ala2Val-ΔIle1 (blue) bound to the ribosome. Helices 43 and 44 of 23S 
rRNA are colored in orange and ribosomal protein L11 is shown in green. 
It therefore appears only the hydrophobic interaction between Thz15 and Pro26 is 
conserved in the models. The new hydrogen-bond would contribute to the binding of the 
two ∆Ile1 analogs to the ribosome, however, may not be enough to completely 
compensate the loss of other hydrophobic interactions. This may explain the reduced 
inhibitory activities against in vitro protein synthesis. Besides the weakened interactions 
between the two ∆Ile analogs and the ribosome, off-target effects, such as an inability of 
the analogs to reach the ribosome or instability of the analogs, may collectively account 
for the dramatically reduced potencies of thiostreptons Ala2Ile-ΔIle1 and Ala2Val-ΔIle1 
against in vivo bacterial growth.  
 
  118 
5.3.5 20S proteasome inhibitory activities of thiostrepton analogs 
Previously, the Arndt group reported that thiostrepton A and some derivatives are 
active 20S proteasome inhibitors, which partially accounts for the thiopeptide’s 
antimalarial activity.
38-39
 Three fluorogenic substrates were individually used to test for 
inhibition of trypsin-, chymotrypsin-, and caspase-like proteolytic functions of the 
proteasome by the analogs generated in this study. The proteasome inhibition curves are 
shown in Figure G.5. Many of thiostrepton Ala2 analogs isolated and assessed here 
revealed IC50 values analogous to those of thiostrepton A (Table 5.4). The presence of an 
aromatic side chain in thiostreptons Ala2Phe and Ala2Tyr did cause an improvement (3-5 
fold) in inhibiting the trypsin-like activity of the proteasome. The longer, linear side 
chain introduced by thiostrepton Ala2Met likely contributed to enhanced potency against 
all three proteolytic activities of the proteasome, an effect most pronounced for the 
trypsin-like function, by 10-fold. The efficacy of thiostrepton Ala2Dhb toward 
chymotrypsin-like activity of the proteasome was slightly reduced (3 fold) in comparison 
to that of thiostrepton A. Thiostreptons Ala2Ile-ΔIle1 and Ala2Val-ΔIle1 retained their 
inhibitory activities against the proteasome, albeit slightly reduced. The ΔIle1 analogs 
inhibition of the chymotrypsin-like function was most perturbed (up to 6 fold). Earlier 
studies with thiostrepton analogs lacking an intact QA loop revealed that those 
thiopeptides are less active proteasome inhibitors, suggesting that a closed QA 
macrocycle is likely to be important for thiostreptons’ potency against the proteasome.
19, 
39
 Our current results extend the understanding about the significance of the QA loop, 
indicating that the ability of a thiostrepton analog to interfere with proteasome’s function 
may not be critically sensitive to the size of the QA-containing macrocycle. Nonetheless, 
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with a contracted QA loop, the thiostrepton analog may adopt a slightly differed 
conformation which in turn reduces the binding affinity of a thiopeptide to the 
proteasome, as demonstrated by thiostreptons Ala2Ile-ΔIle1 and Ala2Val-ΔIle1. 
Table 5.4. 20S Proteasome inhibitory activities of thiostrepton analogs 
Compound 






Thiostrepton A 0.95 ± 0.15 1.0 ± 0.1 0.59 ± 0.06 
Ala2Dha 0.71 ± 0.07 0.99 ± 0.01 0.51 ± 0.03 
Ala2Dhb 1.3 ± 0.2 3.1 ± 0.3 0.92 ± 0.06 
Ala2Gly 1.2 ± 0.1 0.76 ± 0.12 0.37 ± 0.04 
Ala2Ile-∆Ile1 2.1 ± 0.4 6.3 ± 0.4 1.6 ± 0.3 
Ala2Met 0.09 ± 0.01 0.62 ± 0.01 0.14 ± 0.01 
Ala2Phe 0.18 ± 0.02 0.96 ± 0.03 0.46 ± 0.04 
Ala2Tyr 0.34 ± 0.03 >0.92
a 
0.58 ± 0.09 
Ala2Val-∆Ile1 0.84 ± 0.04 3.9 ± 0.2 1.2 ± 0.04 
Bortezomib 1.6 ± 0.2 0.005 ± 0.001 0.049 ± 0.003 
                                     a IC50 not determined due to solubility limitation. 
It appears that the second residue of thiostrepton may not necessarily be a 
decisive factor in its ability to obstruct 20S proteasome activity. We note, however, that 
only eight thiostrepton Ala2 analogs, all harboring a hydrophobic residue at the variable 
residue. Additional studies are necessary to determine whether or not polar functional 
groups at the second position retain their capacities as proteasome inhibitors. 
Thiostrepton analogs generated previously by semi-synthetically modifying the C-
terminus with alkyl chains or oxidizing the ninth thiazoline to a thiazole all retained their 
inhibitory activities against the proteasome, often demonstrating varied potencies against 
the caspase-like and chymotrypsin-like functions.
39
 Diverse effectiveness against 
individual proteolytic activities was also observed for all Ala2 analogs. It is possible that 
either different thiostrepton binding sites may exist in the proteasome β subunits or 
allosteric interactions occurring to influence proteasome activity. Structural information 
is required to fully articulate the nature by which thiostrepton A engages the proteasome, 
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We have probed the tolerance of the thiostrepton biosynthetic pathway toward 
proteinogenic amino acid residues at the second position of TsrA core peptide by 
saturation mutagenesis. In total, eight thiostrepton Ala2 analogs were isolated, including 
the two analogs with a contracted quinaldic acid loop resulting from ΔIle1. Our results 
suggest that the thiostrepton A biosynthetic machinery is moderately permissive toward 
chemical substitutions at the second position. Most polar residues and a Pro at the second 
position are not effectively processed to the corresponding mature thiostrepton analog. 
Production of thiostreptons Ala2Ile1-ΔIle1 and Ala2Val-ΔIle1 suggest that the 
thiostrepton A biosynthetic system accepts an Ile or Val residue at the second position 
and efficiently converted them to late-stage intermediate. Additionally, Ile2 and Val2 are 
recognized by the protease or peptidase as new cleavage site, resulting in the formation of 
the two analogs with a shorten quinaldic acid-containing loop. This information could 
contribute to the design of thiostrepton analogs with either expanded or contracted 
quinaldic acid macrocycle if the thiostrepton posttranslational system would collectively 
tolerate the new precursor peptide variant. In all series a and b thiopeptides reported thus 
far, only Ala and Dha appear at the second position in the four amino acid-quinaldic acid 
macrocycle. Herein, we have expanded the chemical entities observed at this position to 
include other hydrophobic residues. The nature of the second residue of thiostrepton may 
not be absolutely critical for either the antibacterial or proteasome inhibitory properties of 
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a series b thiopeptide. To further test our hypothesis on the importance of the second 
residue for thiostrepton’s antibacterial and proteasome inhibitory activities, additional 
analogs harboring polar functional groups would need to be accessed. These analogs have 
potentials in solving the water solubility issue associated with thiopeptides while 
retaining their potent biological activities, as exemplified by the encouraging results from 
nocathiacin studies.
40-41
 One opportunity to provide thiostrepton analogs with hydrophilic 
ligands would be to utilize thiostreptons Ala2Dha or Ala2Dhb as a starting substrate, 
adapting previously reported semi-synthetic strategies.
38, 40-42
 Prior to this work, majority 
of the efforts toward generating a thiostrepton analog relied on semi-synthetic 
derivatization and were unable to access the analogs with a contracted quinaldic acid-
containing loop. Our current study expanded the thiostrepton scaffold and introduced new 
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CHAPTER 6: CONCLUSIONS AND OUTLOOK 
 
 
The realization of the ribosomally-synthesized peptide origins for thiostrepton 
prompted us to explore biosynthetic engineering as a way to generate thiostrepton 
analogs that are inaccessible by semisynthetic modification alone. Due to the difficulties 
in the genetic manipulation of S. laurentii, a methodology to heterologously produce 
thiostrepton A was originally designed. The production of thiostrepton A from the non-
cognate hosts, however, did not permit robust production of thiostrepton A. Genetic 
manipulations of the thiostrepton A biosynthetic gene cluster likely will generate 
biosynthetic intermediates or analogs produced at levels lower than the wild-type 
thiopeptide, and such metabolites may easily escape the detection limits if using the 
heterologous hosts developed here. Therefore, the same strategy toward the engineering 
of thiostrepton variants in the native thiostrepton-producing bacterium, S. laurentii, was 
pursued.   
The introduction of a fosmid used in the heterologous production of thiostrepton 
A into S. laurentii NDS1, a tsrA deletion mutant, permitted restoration of thiostrepton A 
production to that of the wild-type level. The fosmid was then engineered to enable the 
replacement of wild-type tsrA. Three residues: Ala2, Ala4 and Thr7 were targeted for 
initial round of mutagenesis, since none are expected to be directly involved in a 
potentially critical transformation in precursor peptide processing. Introduction of a 
fosmid encoding either TsrA Ala2Gly or Ala4Gly into S. laurentii NDS1 led to the 
successful production of the respective thiostrepton variants, with retained antibacterial 
activities. In contrast, thiostrepton Thr7Gly was not detected in culture extract of the 
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corresponding S. laurentii variant. This initial study laid the groundwork for more radical 
substitutions at each of the three unmodified residues in thiostrepton A.  
The seventh residue of thiostrepton A is predicted to be critical for the 
metabolite’s antibacterial activity. Prior effort toward generating thiostrepton Thr7Gly 
was not successful. It was therefore uncertain whether or not variants of Thr7 could be 
successfully generated and used to probe the importance of this residue in antibacterial 
activity. The Thr7 residue was then targeted with additional modifications. However, we 
successfully generated two thiostrepton Thr7 analogs, Thr7Ala and Thr7Val. As 
predicted by the crystal structure of thiostrepton A bound to the ribosome, the 
antibacterial activity of thiostrepton Thr7Ala was indeed greatly impaired. Furthermore, 
the identification of the shunt metabolite SL105-1 grants insight into the late stages 
maturation of a thiostrepton. The production of SL105-1 suggests that epoxidation of 4-
(1-hydroxyethyl)quinolone-2-carboxylic acid and subsequent quinaldic acid loop closure 
occur later in the biosynthesis of thiostrepton A. 
Successful production of the bioactive thiostrepton Ala4Gly encouraged us to 
more thoroughly probe the range of amino acid residues tolerated at the fourth position of 
the TsrA core peptide by the saturation mutagenesis of Ala4. This work generated sixteen 
thiostrepton analogs. To our knowledge, this is the first report that thoroughly probed the 
permissiveness of the collective biosynthetic machinery toward modifications to the 
fourth residue in the quinaldic acid loop of a series b thiopeptide, substituting the parent 
alanine residue with the remaining 19 proteinogenic amino acid residues. The in vitro 
inhibition assays of the Ala4 variants reveal that the fourth residue of this thiopeptide is 
not essential for binding either the ribosome or the proteasome.  
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Similarly, the tolerance of the thiostrepton biosynthetic pathway toward 
proteinogenic amino acid residues at the second position of TsrA core peptide was also 
probed by saturation mutagenesis. In total, eight thiostrepton Ala2 analogs were isolated, 
including the two analogs with a contracted quinaldic acid loop resulting from ΔIle1. Our 
results suggest that the thiostrepton A biosynthetic machinery is moderately permissive 
toward chemical substitutions at the second position. Production of thiostreptons 
Ala2Ile1-ΔIle1 and Ala2Val-ΔIle1 suggest that the thiostrepton A biosynthetic system 
accepts an Ile or Val residue at the second position and efficiently converted them to late-
stage intermediate. Additionally, Ile2 and Val2 are recognized by the protease or 
peptidase as new cleavage site, resulting in the formation of the two analogs with a 
shorten quinaldic acid-containing loop. In all series a and b thiopeptides reported thus far, 
only Ala and Dha appear at the second position in the four amino acid-quinaldic acid 
macrocycle. Herein, we have expanded the chemical entities observed at this position to 
include other hydrophobic residues. The nature of the second residue of thiostrepton may 
not be absolutely critical for either the antibacterial or proteasome inhibitory properties of 
a series b thiopeptide.  
The wide range of thiostrepton analogs that retain the ability to complex with the 
ribosome or the proteasome, including Ala2Dha, Ala2Dhb, Ala4Dha, Ala4Dhb, and 
Ala4Ser, provide promise for coupling an engineered thiopeptide with semisynthetic 
modification to acquire a biologically active analog with enhanced water solubility. Such 
a strategy could also facilitate the inclusion of cross-linking functional group or a 
fluorescent label to probe the mechanism of action when thiostrepton A is bound to the 
proteasome, which is currently unknown. Modifications to the C-terminal tail region of 
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thiostrepton A and other thiopeptides, often by conjugate addition to a dehydroalanine 
residue, have been utilized to increase water solubility through the introduction of polar 
side chains.
1-5
 Similar and other types of semi-synthetic modifications of a thiopeptide 
scaffold, when introduced at an amenable position, can be broadly accepted with retained 
antibacterial or antimalarial potency. To further test our hypothesis on the importance of 
the second residue for thiostrepton’s antibacterial and proteasome inhibitory activities, 
additional analogs harboring polar functional groups would need to be accessed. The 
information obtained from thiostrepton Ala2Ile1-ΔIle1 and Ala2Val-ΔIle1 could facilitate 
the design of thiostrepton analogs with either expanded or contracted quinaldic acid-
containing loop if the thiostrepton posttranslational system would collectively tolerate the 
new precursor peptide variant.  
The established biosynthetic engineering platform permits in vivo production of 
thiostrepton variants in a relatively efficient fashion. The thiostrepton analogs and shunt 
metabolites obtained from these studies provided useful insights into the late maturation 
process of thiostrepton A, in addition to the importance of TsrA core peptide second and 
fourth residues for the thiopeptide’s antibacterial and 20S proteasome inhibitory 
activities. The results described here support further examination of the quinaldic acid-
containing macrocycle of thiostrepton and related thiopeptides to generate novel analogs. 
The library of thiostrepton analogs can be used to interrogate the thiopeptide structure-
activity relationships and may be useful to address the bioavailability issues plaguing 
these otherwise promising lead molecules. 
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USED IN THIS STUDY 
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Streptomyces strains   
S. laurentii ATCC 31255 Wild-type, thiostrepton producer ATCC 
S. actuosus ATCC 25421 Wild-type, nosiheptide producer ATCC 
S. lividans TK24 A common host for Streptomyces gene 
expression and manipulation  
1
 
S. coelicolor CH999 A common host for Streptomyces gene 
expression and manipulation 
2
 
S. actuosus FZ1 S. actuosus containing int-3A10 
3
 
S. actuosus FZ2 S. actuosus containing int-pCC1FOS 
3
 
S. lividans FZ1 S. lividans containing int-3A10 
3
 










































































































































 S. laurentii NDS1 containing int-A2Y 
5
 
S. laurentii NDS1/int-A4C S. laurentii NDS1 containing int-A4C 
6
 
S. laurentii NDS1/int-A4D S. laurentii NDS1 containing int-A4D 
6
 
S. laurentii NDS1/int-A4E S. laurentii NDS1 containing int-A4E 
6
 
S. laurentii NDS1/int-A4F S. laurentii NDS1 containing int-A4F 
6
 
S. laurentii NDS1/int-A4H S. laurentii NDS1 containing int-A4H 
6
 
S. laurentii NDS1/int-A4I S. laurentii NDS1 containing int-A4I 
6
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S. laurentii NDS1/int-A4K S. laurentii NDS1 containing int-A4K 
6
 
S. laurentii NDS1/int-A4L S. laurentii NDS1 containing int-A4L 
6
 
S. laurentii NDS1/int-A4M S. laurentii NDS1 containing int-A4M 
6
 
S. laurentii NDS1/int-A4N S. laurentii NDS1 containing int-A4N 
6
 
S. laurentii NDS1/int-A4P S. laurentii NDS1 containing int-A4P 
6
 
S. laurentii NDS1/int-A4Q S. laurentii NDS1 containing int-A4Q 
6
 
S. laurentii NDS1/int-A4R S. laurentii NDS1 containing int-A4R 
6
 
S. laurentii NDS1/int-A4S S. laurentii NDS1 containing int-A4S 
6
 
S. laurentii NDS1/int-A4T S. laurentii NDS1 containing int-A4T 
6
 
S. laurentii NDS1/int-A4V S. laurentii NDS1 containing int-A4V 
6
 
S. laurentii NDS1/int-A4W S. laurentii NDS1 containing int-A4W 
6
 
S. laurentii NDS1/int-A4Y S. laurentii NDS1 containing int-A4Y 
6
 
E. coli strains   





    BW25113/pKD46 Host for PCR-targeted disruption of a gene 
from a fosmid  or plasmid 
7
 




Strains used for antibacterial assays   
Bacillus sp. ATCC 27859 Wild-type ATCC 
Escherichia coli ATCC 27856 Wild-type ATCC 
Staphylococcus aureus ATCC 10537 Methicillin-resistant ATCC 
Enterococcus faecium ATCC 12952 Vancomycin-resistant ATCC 
Plasmids   





pSC-B-amp/kan A routine vector from StrataClone Blunt 




pSET152 An integrative plasmid containing the 
apramycin resistance gene and all essential 
genes for the conjugal transfer and 




pSE34 Plasmid containing the thiostrepton 
resistance gene 
Pfizer 
pIJ778 A plasmid containing the spectinomycin/ 
streptomycin resistance cassette 
8
 
pEX100T Plasmid containing sacB gene ATCC 






 pCR4-Blunt vector harboring a 1.8 kb 
fragment PCR amplified from S. laurentii 
genomic DNA, which contains the 0.2 kb 
tsrA gene and its two flanking 0.8 kb region 
10
 
int-pCC1FOS A fosmid containing all essential genes for 




int-3A10 A fosmid containing the entire tsr gene 
cluster and all essential genes for the 






 pSC-B-amp/kan vector harboring the  
3
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1022 nt sequence upstream of tsrA 
pRight
*
 pSC-B-amp/kan vector harboring the  





 pLeft containing a 1 kb insert from the 





 A derivative of pGM160K
10
 in which a 






 A derivative of pGM160HK, in which the 
ampicillin resistance gene was replaced by 
the spectinomycin-streptomycin resistance 
cassette. It is a conjugal and temperature-





 pGM160HKss containing a 2 kb insert from 





 Vector pSC-B-amp/kan containing a 0.9 kb 
chl
R





 Vector pSC-B-amp/kan containing a 1.8 kb 
sacB gene amplified from pEX100T with 





 Plasmid containing the dual-marker cassette 
(chl
R





 Plasmid containing the tsrA variant 





 Plasmid containing the tsrA variant 





  Plasmid containing the tsrA variant 





  Plasmid containing the tsrA variant 





  Plasmid containing the tsrA variant 





  Plasmid containing the tsrA variant 





  pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 





  pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 





  pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 





  pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 
encoding the Ala2Pro mutation 
5
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pA2Q
*
 pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 





 pSC-B-amp/kan containing the tsrA variant 
encoding the Ala2Tyr mutation 
5
 
pA4C  pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Cys mutation 
6
 
pA4D pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Asp mutation 
6
 
pA4E  pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Glu mutation 
6
 
pA4F  pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Phe mutation 
6
 
pA4H  pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4His mutation 
6
 
pA4I  pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Ile mutation 
6
 
pA4K pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Lys mutation 
6
 
pA4L  pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Leu mutation 
6
 
pA4M pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Met mutation 
6
 
pA4N pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Asn mutation 
6
 
pA4P pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Pro mutation 
6
 
pA4Q pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Gln mutation 
6
 
pA4R pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Arg mutation 
6
 
pA4S pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Ser mutation 
6
 
pA4T pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Thr mutation 
6
 
pA4V pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Val mutation 
6
 
pA4W pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Trp mutation 
6
 
pA4Y pSC-B-amp/kan containing the tsrA variant 
encoding the Ala4Tyr mutation 
6
 
Fosmids   
int-3A100
*








 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
3
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encoding the Ala2Gly mutation 
int-3A102
*
 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





  Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





  Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





  Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
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cassette is replaced by the tsrA variant 
encoding the Ala2Ser mutation 
int-A2T
*
 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 





 Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala2Tyr mutation 
5
 
int-A4C  Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Cys mutation 
6
 
int-A4D Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Asp mutation 
6
 
int-A4E  Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Glu mutation 
6
 
int-A4F  Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Phe mutation 
6
 
int-A4H  Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4His mutation 
6
 
int-A4I Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Ile mutation 
6
 
int-A4K  Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Lys mutation 
6
 
int-A4L Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Leu mutation 
6
 
int-A4M Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Met mutation 
6
 
int-A4N  Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Asn mutation 
6
 
int-A4P  Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Pro mutation 
6
 
int-A4Q Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Gln mutation 
6
 
int-A4R  Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Arg mutation 
6
 
int-A4S Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Ser mutation 
6
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int-A4T Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Thr mutation 
6
 
int-A4V Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Val mutation 
6
 
int-A4W Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Trp mutation 
6
 
int-A4Y Derived from int-3A100. The chl
R
-sacB 
cassette is replaced by the tsrA variant 
encoding the Ala4Tyr mutation 
6
 
* These strains, fosmids and plasmids were generated by Dr. Chaoxuan Li.
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Table A.2. Primers used in these studies 
 
 Primer Sequence Description 
CTSR1-F 5’-TTTGAGTTATCGAGATTTTCAGGAGCTAAGG 
AAGCTAAAGCGGTGGTTTTTTTGTTTGCAAGC-3’ 
Primers for the replacement of chlR 
in pCC1FOS, or fosmids based on 
it, with genes aac(3)IV, int, attP 
and oriT amplified from pSET152. 
pSET152 sequence is underlined.  
CTSR1-R 5’-ACCAGGCGTTTAAGGGCACCAATAACTGCC 
TTAAAAAAACCGATGCAAAGTGCCGATCA-3’ 
CTSR2-F 5’-GCGGTGGTTTTTTTGTTTGCAAGC-3’ Primers for the confirmation of  





Primers for the confirmation of  
int-pCC1FOS and int-3A10. 
TSRK-F 5’-CCGATGCAAAGTGCCGATCA-3’ Primers for the amplification of 














Primers for the amplification of 
tsrN. 
DTSR1-F 5’-AAGCTTGTGAGGGTCACCACGGATCC-3’ Primers for the amplification of the 
region upstream of tsrA. Underlined 
regions are the restriction sites of 
HindIII, NdeI and SbfI. 
DTSR1-R 5’-CCTGCAGGCATATGCTCCAGGGCGGCATTGCT 
CAT-3’ 
DTSR2-F 5’-CATATGTGAGGTAACACCCGGCGCGGA-3’ Primers for the amplification of the 
region downstream of tsrA. 
Underlined regions are restriction 
sites of HindIII, NdeI and SbfI. 
DTSR2-R 5’-CCTGCAGGAAGCTTGCTCCAGGTCCGCGACGC CG-
3’ 
DTSR3-F 5’-ATCGTGTTGGGCTTGACG-3’ Primers used to confirm the 
construction of S. laurentii NDS1. DTSR3-R 5’-CGCGGTGCAATAGGACAT-3’. 
Chl-F 5’-ATTCCGGGGATCCGTCGACCAGATCTGCCGCTC 
CATGAGCTTATCG-3’ 
Primers for the amplification of 
chlR from pCC1FOS. Underlined 
regions are restriction sites of BglII, 
NdeI and SbfI.  pCC1FOS sequence 
is italicized.  
Chl-R 5’-CCTGCAGGCATATGAATTACGCCCCGCCCTGCC-3’ 
SacB-F 5’-CATATGAACTTTATGCCCATGCAACAG-3’ Primers for the amplification of 
sacB gene from pEX100T. 
Underlined regions are restriction 
sites of BglII, NdeI and SbfI.  







Primers for the amplification of the 
spectinomycin-streptomycin 
resistance cassette from pIJ778 to 
replace ampicillin resistance gene 
in pGM160HK. Underlined regions 
are sequence of pIJ778. 





Primers for the amplification of 
chlR from pCC1FOS. The SbfI and 
NdeI restriction sites are underlined 
and in italics, respectively. 
DC1-R 5’-CCTGCAGGCATATGAATTACGCCCCGCCCTG CC-3’ 
DC2-F  5’-CATATGAACTTTATGCCCATGCAACAG-3’ Primers for the amplification of 
sacB from pEX100T. The SbfI and 
NdeI restriction sites are underlined 
and in italics, respectively. 
DC2-R 5’-CCTGCAGGTGTAGGCTGGAGCTGCTTCAGA 
TCTGAGAGTGCACCATAATCGGC-3’ 
A2G-F 5’-GTCACGATGATCGGCTCCGCCTCCTGC-3’ Primers to generate TsrA Ala2Gly. 
A2G-R 5’-GCAGGAGGCGGAGCCGATCATCGTGAC-3’ 
A4G-F 5’-GATGATCGCGTCCGGCTCCTGCACCACC-3’ Primers to generate TsrA Ala4Gly. 
A4G-R 5’-GGTGGTGCAGGAGCCGGACGCGATCATC-3’ 
T7G-F 5’-GTCCGCCTCCTGCGGCACCTGCATCTGC-3’ Primers to generate TsrA Thr7Gly. 
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T7G-R 5’-GCAGATGCAGGTGCCGCAGGAGGCGGAC-3’ 
T7S-F 5’-GTCCGCCTCCTGCTCCACCTGCATCTGC-3’ Primers to generate TsrA Thr7Ser. 
T7S-R 5’-GCAGATGCAGGTGGAGCAGGAGGCGGAC-3’  
T7A-F 5’-GTCCGCC TCCTGCGGCACCTGCATCTGC-3’ Primers to generate TsrA Thr7Ala. 
T7A-R 5’-GCAGATGCAGGTGCCGCAGGAGGCGGAC-3’  
T7V-F 5’-ACTACATGGACGAGACGCTGCTC-3’ Primers for amplification of 










Chemically synthesized ultramer to 






Chemically synthesized ultramer to 
generate TsrA Ala2 mutants. 
Underlined degenerate codon 
encodes the amino acid at the 2nd 






Chemically synthesized ultramer to 
generate TsrA Ala4 mutants. 
Underlined degenerate codon 
encodes the amino acid at the 4th 
position of the TsrA core peptide. 
SD1-F 5’-GCGCGATCGACGCGACCGCAGACTTGCCGA 
AAGGTTGTGATTCCGGGGATCCGTCGACC-3’ 
Primers for the disruption of tsrA in  
int-3A10. The underlined regions 
are homologous to tsrA. SD1-R 5’-GGCGGGGAGGAACAGTCCTCCGCGCCGGGT 
GTTACCTCATGTAGGCTGGAGCTGCTTC-3’ 
SD2-F 5’-GCGCGATCGACGCGACCGCAG-3’ Primers used in the amplification of 
tsrA variants from plasmid 
templates.  
SD2-R 5’-GGCGGGGAGGAACAGTCCTCC-3’ 
SD3-F 5’-ATCGTGTTGGGCTTGACG-3’ Primers used in DNA sequencing to 
confirm int-3A10 derived fosmid 
variants. 
SD3-R 5’-CGCGGTGCAATAGGACAT-3’ 
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APPENDIX B: SPECTRAL DATA FOR THIOSTREPTON A FROM 
CHAPTER 2 
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Figure B.1. HPLC-MS of culture extracts from S. actuosus FZ1 and S. actuosus FZ2. 
 
(A) HPLC-MS of the culture extract from S. actuosus FZ1. (1) Chromatogram extracted 
for m/z 833 [M+2H]
2+
 from S. actuosus FZ1. (2) Mass spectrum of thiostrepton A from S. 
actuosus FZ1 eluting at tR = 27.8 min.  
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(B) HPLC-MS chromatogram extracted for m/z 833 [M+2H]
2+
 from the S. actuosus FZ2 
culture extract. 
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Figure B.2. HPLC-MS of culture extracts from S. lividans FZ1 and S. lividans FZ2. 
 
(A) HPLC-MS of the culture extract from S. lividans FZ1. (1) HPLC-MS chromatogram 
extracted for m/z 833 [M+2H]
2+
 from S. lividans FZ1. (2) Mass spectrum of thiostrepton 
A from S. lividans FZ1 eluting at tR = 27.8 min.  
 
(1)
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(B) HPLC-MS chromatogram extracted for m/z 833 [M+2H]
2+
 from the S. lividans FZ2 
culture extract. 
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Figure C.2. HPLC-MS of thiostrepton Ala2Gly isolated from S. laurentii NDS1 int-
3A101. 
 
(A) Total ion chromatogram of thiostrepton Ala2Gly. 
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(B) Chromatogram extracted for m/z 826 of thiostrepton Ala2Gly.  Zhang TSR A2G, 1/10 dil CHCl3, Syn C18 2x250
GT Mass Spectrometry Laboratory 03-Mar-2010   16:09:18
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(C) Mass spectrum of thiostrepton Ala2Gly eluting at tR = 25.2 min.  Zhang TSR A2G, 1/10 dil CHCl3, Syn C18 2x250
03-Mar-2010   16:09:18GT Mass Spectrometry Laboratory
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Figure C.5. DEPT-135 NMR spectrum of thiostrepton Ala2Gly (125 MHz, CDCl3-























C NMR assignments of thiostrepton Ala2Gly 
 
Position δC [ppm]; 
mult 
δH [ppm]  





173.9; C q 
  
Ile1-2 65.4; CH 2.89 (s)   
Ile1-3 37.8; CH 1.83 (m) Ile1-1 Ile1-6, Ile1-4-HB 
Ile1-4 23.9; CH2 HA: 1.16-1.15 (m) 
HB: 0.93 (m) 
 Ile1-4-HA, Ile1-5 
Ile1-3, Ile1-4-HB, Ile1-5 
Ile1-5 11.4; CH3 0.73 (t, 7.3) Ile1-3, Ile1-4 Ile1-4-HA, Ile1-4-HB 
Ile1-6 15.3; CH3 0.88 (d, 6.9) Ile1-2, Ile1-3, Ile1-4 Ile1-3 
Gly2     
Gly2-1 164.4; C q    
Gly2-2 42.4; CH2 HA: 3.55-3.46 (m) 





Dha3     
Dha3-1 162.7; C q    
Dha3-2 132.0; C q    
Dha3-3 103.4; CH2 HA: 5.65 (s) 
HB: 5.23 (bs) 




Ala4     
Ala4-1 173.3; C q    
Ala4-2 51.6; CH 4.61 (q, 6.2) Dha3-1, Ala4-1 Ala4-3 
Ala4-3 18.6; CH3 1.30 (d, 6.4) Ala4-1, Ala4-2 Ala4-2 
Pip     
Pip-2  162.0; C q    
Pip-3 23.9; CH2 2.82-2.77 (m)  Pip-4-HB 
Pip-4 29.1; CH2 HA: 3.95
c, 
HB: 2.16 (d, 13.1) 
 Pip-4-HB 
Pip-4-HA, Pip-3 
Pip-5 57.5; C q    
Pip-6 64.1; CH 5.19 (s) Pip-2, Pip-5, Thz13-2, Thz13-3, Thz15-4  
Thz6     
Thz6-1 161.7; C q    
Thz6-2 146.1; C q    
Thz6-3 125.0; CH 8.04 (s) Thz6-2, Thz6-4  
Thz6-4 169.7; C q    
Thr7     
Thr7-1 165.4; C q    
Thr7-2 55.7; CH 4.29 (d, 3.0) Thz6-1 Thr7-3, Thr7-NH  
Thr7-3 66.3; CH 1.53-1.45 (m)  Thr7-4 
Thr7-4 18.9; CH3 0.68 (d, 4.7) Thr7-2, Thr7-3 Thr7-3 
Thr7-NHd  7.00 (d, 6.2)  Thr7-2 
Dhb8     
Dhb8-2 128.3; C q    
Dhb8-3 132.7; CH 6.10 (q, 6.9) Dhb8-2, Tzn9-4 Dhb8-4 
Dhb8-4 15.7; CH3 1.49 (d, 7.0) Dhb8-2, Dhb8-3, Tzn9-4 Dhb8-3 
Tzn9     
Tzn9-1 172.0; C q    
Tzn9-2 78.8; CH 4.85 (dd, 12.3, 9.4) Tzn9-1, Tzn9-4 Tzn9-3-HA, Tzn9-3-HB 
Tzn9-3 34.8; CH2 HA: 3.55-3.46 (m) 
HB: 3.04 (t, 12.1) 
Tzn9-2, Tzn9-4 
Tzn9-1, Tzn9-2 
Tzn9-2, Tzn9-3-HB,  
Tzn9-2, Tzn9-3-HA 
Tzn9-4 170.2; C q    
Ile10     
Ile10-2 52.9; CH 5.62 (d, 9.9) Tzn9-1, Ile10-3, Thz11-4 Ile10-NH 
Ile10-3 77.2; C q    
Ile10-4 67.7; CH 3.68 (q, 6.4) Ile10-2, Ile10-3, Ile10-5, Ile10-6 Ile10-5 
Ile10-5 15.3; CH3 1.16 (d, 6.4) Ile10-3, Ile10-4, Ile10-6 Ile10-4 
Ile10-6 18.7; CH3 1.02 (s) Ile10-2, Ile10-3, Ile10-4, Ile10-5  
Ile10-NHd  7.48-7.43 (m)  Ile10-2 
Thz11     
Thz11-1 161.7; C q    
Thz11-2 150.0; C q    
Thz11-3 125.7; CH 8.16 (s) Thz11-1, Thz11-2, Thz11-4  
Thz11-4 166.3; C q    
     
155 
 
     
Position δC [ppm]; 
mult 
δH [ppm]  
(mult, J in Hz) 
HMBCa COSYb 
Thr12     
Thr12-2 55.5; CH 5.65 (s) Thz11-1, Thz13-4 Thr12-NH 
Thr12-3 71.8; CH 6.24 (m) Q-1 Thr12-4 
Thr12-4 18.7; CH3 1.59 (d, 6.4) Thr12-2, Thr12-3 Thr12-3 
Thr12-NHd  8.67 (d, 8.8)  Thr12-2 
Thz13     
Thz13-2 157.1; C q    
Thz13-3 118.3; CH 7.44 (s) Pip-6, Thz13-2, Thz13-4  
Thz13-4 170.1; C q    
Thz15     
Thz15-1 159.5; C q    
Thz15-2 149.8; C q    
Thz15-3 127.6; CH 8.16 (s) Thz15-1, Thz15-2, Thz15-4  
Thz15-4 168.2; C q    
Dha16     
Dha16-1 161.9; C q    
Dha16-2 134.0; C q    
Dha16-3 103.2; CH2 HA: 6.57 (d, 1.8)  





Dha17     
Dha17-1 166.0; C q    
Dha17-2 132.8; C q    
Dha17-3 104.3; CH2 HA: 6.40 (s)  





Q     
Q-1 160.6; C q    
Q-2 143.6; C q    
Q-3 122.5; CH 7.19 (s) Q-5  
Q-4 153.8; C q    
Q-5 127.3; C q    
Q-6 123.3; CH 6.78 (d, 9.9)  Q-5, Q-8, Q-10 Q-7 
Q-7 129.9; CH 6.29 (dd, 9.5, 5.7) Q-5 Q-6, Q-8 
Q-8 58.9; CH 3.55-3.46 (m)  Q-7 
Q-9 67.7; CH 4.25 (s)   
Q-10 154.4; C q    
Q-11 64.4; CH 5.21-5.15 (m)  Q-12 
Q-12 22.6; CH3 1.23 (d, 6.6) Q-4, Q-11 Q-11 
 
a HMBC correlations are from the proton to the indicated carbon. 
b COSY correlations are from the proton to the proton attached to the indicated position. 
c The δ of this resonance was determined by HSQC due to overlap with the methanol-d4 peak. 




























Figure C.10. HPLC-MS of thiostrepton Ala4Gly isolated from S. laurentii NDS1 int-
3A102. 
(A) Total ion chromatogram of thiostrepton Ala4Gly. 
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(B) Chromatogram extracted for m/z 826 for thiostrepton Ala4Gly.  Zhang TSR A4G, 1/10 dil CHCl3, Syn C18 2x250
GT Mass Spectrometry Laboratory 03-Mar-2010   18:52:57
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(C) Mass spectrum of thiostrepton Ala4Gly eluting at tR = 20.6 min.  
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Figure C.13. DEPT-135 NMR spectrum of thiostrepton Ala4Gly (125 MHz, CDCl3-

























C NMR assignments of thiostrepton Ala4Gly 
 
Position δC [ppm]; 
mult 
δH [ppm] 
(mult, J in Hz) 
HMBCa COSYb 
Ile1     
Ile1-1 174.1; C q     
Ile1-2 64.9; CH 2.87 (s)  Ile1-3 
Ile1-3 38.1; CH 1.83 (m) Ile1-1 Ile1-4-HB, Ile1-6 
Ile1-4 23.9; CH2 HA: 1.18-1.17 (m) 
HB: 0.97 (m)  
 Ile1-4-HB, Ile1-5 
Ile1-3, Ile1-4-HA, Ile1-5 
Ile1-5 11.4; CH3 0.77 (t, 7.3) Ile1-3, Ile1-4, Ile1-6 Ile1-4-HA, Ile1-4-HB 
Ile1-6 15.6; CH3 0.90 (d, 6.9) Ile1-1, Ile1-2, Ile1-3, Ile1-4, Ile1-5 Ile1-3 
Ala2     
Ala2-1 168.9; C q    
Ala2-2 49.3; CH 3.69 (q, 6.3)  Ala2-3 
Ala2-3 18.6; CH3 1.07 (br)  Ala2-2 
Dha3     
Dha3-1 163.0; C q    
Dha3-2 132.0; C q    
Dha3-3 103.6; CH2 HA: 5.74 (s) 
HB: 5.26 (s) 
  
Dha3-3- HA 
Gly4     
Gly4-1 173.1; C q     
Gly4-2 46.0; CH2 HA: 4.47 (br) 
HB: 3.56-3.48 (m) 
 Gly4-2-HB 
Gly4-2-HA 
Gly4-NHd  6.95 (d, 8.2)  Gly4-2-HA 
Pip     
Pip-2 161.6; C q    
Pip-3 24.7; CH2 HA: 3.34-3.30 (m) 
HB: 2.94 (m) 
  
Pip-4-HB 
Pip-4 28.8; CH2 HA: 4.00-3.93 (m)
c 
HB: 2.21-2.18 (m) 
 Pip-4-HB 
Pip-4-HA, Pip-3-HB 
Pip-5 57.4; C q    
Pip-6 63.8; CH 5.14 (s)   
Thz6      
Thz6-1 161.9; C q Thz6-1   
Thz6-2 146.2; C q    
Thz6-3 124.7; CH 8.04 (s) Thz6-2, Thz6-4  
Thz6-4 169.6; C q    
Thr7     
Thr7-1 165.3; C q    
Thr7-2 55.5; CH 4.32 (d, 2.6)  Thr7-3  
Thr7-3 66.3; CH 1.37 (br)  Thr7-4 
Thr7-4 18.8; CH3 0.73 (br s)  Thr7-3 
Dhb8     
Dhb8-2 128.2; C q    
Dhb8-3 132.5; CH 6.11 (s)  Dhb8-4 
Dhb8-4 15.2; CH3 1.50 (d, 6.4) Dhb8-2, Dhb8-3 Dhb8-3 
Tzn9     
Tzn9-1 171.7; C q    
Tzn9-2 78.6; CH 4.86 (t, 10.7)  Tzn9-3-HA, Tzn9-3-HB 
Tzn9-3 34.7; CH2 HA: 3.56-3.48 (m) 
HB: 3.06 (t, 11.2) 
Tzn9-4 Tzn9-2, Tzn9-3-HB 
Tzn9-2, Tzn9-3-HA 
Tzn9-4 169.9; C q    
Ile10     
Ile10-2 52.7; CH 5.61 (s)   
Ile10-3 77.2; C q    
Ile10-4 67.4; CH 3.69 (q, 6.3) Ile10-3, Ile10-6 Ile10-5 
Ile10-5 15.7; CH3 1.18 (d, 6.4) Ile10-3, Ile10-4, Ile10-6 Ile10-4 
Ile10-6 18.1; CH3 1.04 (s) Ile10-2, Ile10-C3, Ile10-4, Ile10-5  
Thz11     
Thz11-1 159.3; C q    
Thz11-2 149.8; C q    
Thz11-3 125.5; CH 8.18 (s)  Thz11-2, Thz11-4  
Thz11-4 168.1; C q    
     
165 
 
Position δC [ppm]; 
mult 
δH [ppm] 
(mult, J in Hz) 
HMBCa COSYb 
Thr12     
Thr12-2 55.5; CH 5.66 (s)   
Thr12-3 71.8; CH 6.26 (s)  Thr12-4 
Thr12-4 18.8; CH3 1.60 (d, 5.6)  Thr12-3 
     
Thz13     
Thz13-2 156.8; C q    
Thz13-3 118.0; CH 7.41 (s)   
Thz13-4 170.0; C q    
Thz15     
Thz15-1 161.5; C q    
Thz15-2 149.6; C q    
Thz15-3 127.5; CH 8.17 (s) Thz15-1, Thz15-C2, Thz15-C4  
Thz15-4 166.1; C q    
Dha16     
Dha16-1 161.7; C q    
Dha16-2 133.8; C q    
Dha16-3 103.1; CH2 HA: 6.58 (s) 
HB: 5.50 (s) 
 Dha3-16- HB 
Dha3-16- HA 
Dha17     
Dha17-1 165.7; C q    
Dha17-2 
Dha17-3 
132.7; C q  
Dha17-1, Dha17-2 
Dha17-1 
104.1; CH2 HA: 6.42 (s) 
HB: 5.56 (s) 
Dha3-17- HB 
Dha3-17- HA 
Q     
Q-1 160.5; C q    
Q-2 143.3; C q    
Q-3 122.2; CH 7.21 (s)   
Q-4 153.4; C q    
Q-5 127.1; C q    
Q-6 123.0; CH 6.77 (d, 9.7)  Q-7 
Q-7 129.9; CH 6.26 (s)  Q-6, Q-8 
Q-8 58.7; CH 3.56-3.48 (m)  Q-7 
Q-9 67.4; CH 4.30 (m)  Q-9-OH 
Q-10 154.3; C q    
Q-11 64.2; CH 5.19 (br)  Q-12 
Q-12 22.5; CH3 1.25 (br)  Q-11 
Q-9-OH  6.95 (d, 8.2)  Q-9 
 
a HMBC correlations are from the proton to the indicated carbon. 
b COSY correlations are from the proton to the proton attached to the indicated position. 
c The δ of this resonance was determined by HSQC due to overlap with the methanol-d4 peak. 



















Figure C.17. HPLC and UV-Vis absorption spectra from the TsrA Thr7Ala-expressing 
fermentation extract. (A)  HPLC analysis of S. laurentii NDS1 int-3A105 (TsrA Thr7Ala) 
culture extract. (B) UV-Vis absorption spectrum of SL105-1 B (tR = 16.9 min). (C) UV-
Vis absorption spectrum of thiostrepton Thr7Ala A (tR = 18.3 min). 
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Figure C.21. DEPT-135 NMR spectrum of thiostrepton Thr7Ala (125 MHz, CDCl3-
























C NMR assignments of thiostrepton Thr7Ala  
 
Position 
δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb 
Ile1    
Ile1-1 173.1; C q    
Ile1-2 65.2; CH 2.92 (d, 4.0) Ile1-1, Ile1-3, Ile1-4, Ile1-6, Q8 Ile1-3 
Ile1-3 38.2; CH 1.88-1.82 (m)  Ile1-4-HB, Ile1-6 
Ile1-4 23.9; CH2 HA: 1.32-1.26 (m) 




Ile1-3, Ile1-4-HA, Ile1-5 
Ile1-5 11.4; CH3 0.82 (t, 7.3) Ile1-3, Ile1-4 Ile1-4-HA, Ile1-4-HB 
Ile1-6 15.7; CH3 0.94 (d, 6.9) Ile1-2, Ile1-3, Ile1-4 Ile1-3 
Ala2     
Ala2-1 169.0; C q    
Ala2-2 49.4; CH 3.75 (q, 6.8) Ile1-1, Ala2-1, Ala2-3 Ala2-3 
Ala2-3 18.9; CH3 1.13 (d, 6.7) Ala2-1, Ala2-2 Ala2-2 
Ala2-NHd  7.79 (d, 5.9)  Ala2-2 
Dha3     
Dha3-1 162.8; C q    
Dha3-2 132.1; C q    
Dha3-3 103.4; CH2 HA: 5.74 (d, 2.0)  





Ala4     
Ala4-1 173.7; C q    
Ala4-2 51.6; CH 4.68 (q, 6.6) Dha3-1Ala4-1, Ala4-3 Ala4-3 
Ala4-3 19.5; CH3 1.37 (d, 6.7) Ala4-1, Ala4-2 Ala4-2 
Ala4-NHd  6.93 (d, 7.6)  Ala4-2 
Pip     
Pip-2  162.2; C q    
Pip-3 23.9; CH2 HA: 3.63-3.55 (m)  




Pip-4 27.8; CH2 HA: 3.95 (m)  
HB: 2.25 (m) 
Pip-2, Pip-3, Pip-5, Pip-6, Thz6-4, Thz13-2 
Pip-3, Pip-5, Pip-6 
Pip-4-HB 
Pip-4-HA, Pip-3-HB  
Pip-5 56.9; C q    
Pip-6 64.4; CH 5.05 (s) Ala4-1, Pip-2, Pip-3, Pip-4, Pip-5, Thz13-2,  
Thz13-3, Thz15-4 
 
Thz6     
Thz6-1 161.4; C q    
Thz6-2 146.8; C q    
Thz6-3 124.2; CH 7.99 (s) Thz6-1, Thz6-2,  Thz6-4  
Thz6-4 169.2; C q    
Ala7     
Ala7-1 169.6; C q    
Ala7-2 47.0; CH 3.89 (q, 7.0) Thz6-1, Ala7-1, Ala7-3 Ala7-3, Ala7-NH 
Ala7-3 19.1; CH3 0.70 (d, 7.2) Ala7-1, Ala7-2 Ala7-2 
Ala7-NHd  6.61 (d, 9.5)  Ala7-2 
Dhb8     
Dhb8-2 128.2; C q    
Dhb8-3 135.2; CH 6.20 (q, 7.0) Dhb8-2, Dhb8-4, Tzn9-4 Dhb8-4 
Dhb8-4 14.9; CH3 1.58 (d, 7.0) Dhb8-2, Dhb8-3, Tzn9-4 Dhb8-3 
Tzn9     
Tzn9-1 171.4; C q    
Tzn9-2 78.1; CH 4.83 (dd, 13.1, 8.9) Dhb8-2, Tzn9-1, Tzn9-3, Tzn9-4 Tzn9-3-HA, Tzn9-3-HB 
Tzn9-3 35.1; CH2 HA: 3.63-3.55 (m) 





Tzn9-4 169.8; C q    
Ile10     
Ile10-2 52.4; CH 5.63 (s) Tzn9-1, Ile10-3, Ile10-4, Thz11-4 Ile10-NH 
Ile10-3 77.0c    
Ile10-4 67.6; CH 3.68 (q, 6.4) Ile10-2, Ile10-3, Ile10-5, Ile10-6 Ile10-5 
Ile10-5 15.9; CH3 1.24 (d, 6.4) Ile10-3, Ile10-4, Ile10-6 Ile10-4 
Ile10-6 18.1; CH3 1.08 (s) Ile10-2, Ile10-3, Ile10-4  
Ile10-NHd  7.54 (d, 9.6)  Ile10-2 
     
     






δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb 
Thz11     
Thz11-1 162.1; C q    
Thz11-2 150.0; C q    
Thz11-3 125.8; CH 8.22 (s) Ile10-2, Thz11-1, Thz11-2, Thz11-4  
Thz11-4 166.5; C q    
Thr12     
Thr12-2 55.8; CH 5.72 (s) Thz11-1, Thr12-3, Thr12-4, Thz13-2,  
Thz13-3, Thz13-4 
Thr12-NH 
Thr12-3 71.7; CH 6.38 (q, 6.6) Thr12-4, Thz13-4, Q-1 Thr12-4 
Thr12-4 18.9; CH3 1.69 (d, 6.6) Thr12-2, Thr12-3 Thr12-3 
Thr12-
NHd 
 9.01 (d, 7.6)  Thr12-2 
Thz13     
Thz13-2 156.8; C q    
Thz13-3 118.3; CH 7.35 (s) Pip-6, Thz13-2, Thz13-4  
Thz13-4 170.8; C q    
Thz15     
Thz15-1 159.5; C q    
Thz15-2 149.8; C q    
Thz15-3 127.7; CH 8.25 (s) Thz15-1, Thz15-2, Thz15-4  
Thz15-4 168.2; C q    
Dha16     
Dha16-1 162.0; C q    
Dha16-2 134.0; C q    
Dha16-3 103.2; CH2 HA: 6.67 (d, 2.3)  





Dha17     
Dha17-1 166.0; C q    
Dha17-2 132.8; C q    
Dha17-3 104.3; CH2 HA: 6.50 (d, 1.9)  





Q     
Q-1 160.8; C q    
Q-2 143.7; C q    
Q-3 122.5; CH 7.22 (s) Q-1, Q-5, Q-11  
Q-4 153.1; C q    
Q-5 127.0; C q    
Q-6 123.2; CH 6.86 (d, 10.1) Q-4, Q-5, Q-8, Q-10 Q-7 
Q-7 129.9; CH 6.32 (dd, 9.7, 5.5) Q-5, Q-8, Q-9 Q-6, Q-8 
Q-8 58.9; CH 3.63-3.55 (m) Q-6, Q-7, Q-9, Q-10 Q-7, Q-9 
Q-9 67.4; CH 4.32 (s) Q-5, Q-7, Q-8, Q-10 Q-8 
Q-10 155.1; C q    
Q-11 64.2; CH 5.17 (q, 6.5) Q-3, Q-4, Q-5, Q-12 Q-12 
Q-12 22.4; CH3 1.29 (d, 6.6) Q-4, Q-11 Q-11 
 
a HMBC correlations are from the proton to the indicated carbon. 
b COSY correlations are from the proton to the proton attached to the indicated position. 
c The δ of this resonance was determined by HMBC due to overlap with the CDCl3 peak. 














APPENDIX D: SUPPORTING FIGURES AND SPECTRAL DATA 








Figure D.1. MS analysis of thiostrepton Ala4Asn isolated from S. laurentii NDS1/int-
A4N. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 854.3, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Asn. (2) Total ion chromatogram. 
A4N 10x, Syn C12 2x250
GT Mass Spectrometry Laboratory 16-Jul-2014   13:52:55
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(B) MALDI MS spectrum of thiostrepton Ala4Asn. 
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(C) MALDI MS/MS of parent ion m/z 1707.5.  
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 
of thiostrepton Ala4Asn.  
 
Fragment Expected Observed
1. M+H+-Dha17 (in situ truncation) 1638.5 1638.4
2. M-H2O+H
+ 1689.5 1689.4
3. M+H+ (Parent ion) 1707.5 1707.5
4. M+Na+ 1729.5 1729.5
5. M+Cu+ 1769.4 1769.4
6. M-QA+H+ 1474.4 1474.6
7. M-QA-Ile1-Ala2+H+ 1290.3 1290.5
8. M-QA-Ile1-Ala2-H2O+H
+ 1272.3 1272.6
9. M-QA-Ile1-Ala2-Dha3+H+ 1221.3 1221.6
10. M-QA-Ile1-Ala2-Dha3-OH+H+ 1204.3 1204.5
11. M-QA-Ile1-Ala2-Dha3-Asn4+H+ 1107.3 1107.6







Figure D.2. HPLC-MS analysis of the C-terminal truncation reactions of thiostrepton A, thiostrepton Ala4Asn, thiostrepton Ala4Cys 
F1, and thiostrepton Ala4Cys F2. 
 
(A) The C-terminal truncation reaction of thiostrepton A. The left panel includes the HPLC-MS analysis of the reaction mixture at 
t = 0 h and the right panel includes the reaction mixture at t = 24 h. 
(1) Chromatogram extracted for the calculated [M+2H]
2+
 m/z of 763.7 for thiostrepton A having lost Dha16 and Dha17. (2) 
Chromatogram extracted for the calculated [M+2H]
2+
 m/z of 798.2 for thiostrepton A having lost Dha17. (3) Chromatogram extracted 
for the calculated [M+2H]
2+
 m/z of 832.8 for thiostrepton A. (4) Total ion chromatogram.  
TsrA 24h, Syn C12 2x250
GT Mass Spectrometry Laboratory 01-Nov-2012   19:35:35
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GT Mass Spectrometry Laboratory 01-Nov-2012   18:13:24
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(B) The C-terminal truncation reaction of thiostrepton Ala4Asn. The left panel includes the HPLC-MS analysis of the reaction 
mixture at t = 0 h and the right panel includes the reaction mixture at t = 24 h. 
(1) Chromatogram extracted for the calculated [M+2H]
2+
 m/z of 785.2 for thiostrepton Ala4Asn having lost Dha16 and Dha17. (2) 
Chromatogram extracted for the calculated [M+2H]
2+
 m/z of 819.7 for thiostrepton Ala4Asn having lost Dha17. (3) Chromatogram 
extracted for the calculated [M+2H]
2+
 m/z of 854.3for thiostrepton Ala4Asn. (4) Total ion chromatogram.  
A4N 24h, Syn C12 2x250
GT Mass Spectrometry Laboratory 02-Nov-2012   06:33:03
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(C) The C-terminal truncation reaction of thiostrepton Ala4Cys F1. The left panel includes the HPLC-MS analysis of the reaction 
mixture at t = 0 h and the right panel includes the reaction mixture at t = 24 h. 
(1) Chromatogram extracted for m/z of 885.3, the calculated [M+2H]
2+
 ion of the thiostrepton Ala4Cys F1-Et2NH adduct. (2) 
Chromatogram extracted the calculated [M+2H]
2+
 m/z of 779.7 for thiostrepton Ala4Cys F1 having lost Dha16 and Dha17. (3) 
Chromatogram extracted for the calculated [M+2H]
2+
 m/z of 814.2 for thiostrepton Ala4Cys F1 having lost Dha17. (4) Chromatogram 
extracted for the calculated [M+2H]
2+
 m/z of 848.7 for thiostrepton Ala4Cys F1. (5) Total ion chromatogram. 
 
A4C F1 24h, Syn C12 2x250
GT Mass Spectrometry Laboratory 01-Nov-2012   22:19:54
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(D) The C-terminal truncation reaction of thiostrepton Ala4Cys F2. The left panel includes the HPLC-MS analysis of the reaction 
mixture at t = 0 h and the right panel includes the reaction mixture at t = 24 h. 
(1) Chromatogram extracted for m/z of 885.3, the calculated [M+2H]
2+
 ion of the thiostrepton Ala4Cys F2-Et2NH adduct. (2) 
Chromatogram extracted for the calculated [M+2H]
2+
 m/z of 779.7 for thiostrepton Ala4Cys F2 having lost Dha16 and Dha17. (3) 
Chromatogram extracted for the calculated [M+2H]
2+
 m/z of 814.2 for thiostrepton Ala4Cys F2 having lost Dha17. (4) Chromatogram 
extracted for the calculated [M+2H]
2+
 m/z of 848.7 for thiostrepton Ala4Cys F2. (5) Total ion chromatogram. 
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Figure D.3. MS analysis of thiostrepton Ala4Cys F1 isolated from S. laurentii NDS1/int-
A4C. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 848.7, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Cys F1. (2) Total ion chromatogram. 
 A4C F1, Syn C12 2x250
GT Mass Spectrometry Laboratory 04-Jun-2012   15:19:22
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(B) MALDI MS spectrum of thiostrepton Ala4Cys F1. (Peaks labeled with * are internal 
standards. Angiotensin II: [M+H]
+







 1570.7. This MALDI MS analysis was performed on Bruker
®
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 





2. M+H+ (Parent ion) 1696.5 1696.5
3. M+Na+ 1718.5 1718.5
4. M+K+ 1734.4 1734.4
5. M+Cu+ 1758.4 1758.5
6. M-Ala2-CO+H+ 1597.4 1597.5
7. M-QA+H+ 1463.4 1463.2
8. M-QA-Ile1-Ala2+H+ 1279.3 1279.0
9. M-QA-Ile1-Ala2-H2O+H
+ 1261.3 1261.1













Figure D.4. Structure and numbering system used for thiostreptons Ala4Cys F1 and F2.  
 
Thiostrepton Ala4Cys F1 and F2 are proposed to be diastereomers differing in 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































H NMR spectrum of thiostrepton Ala4Cys F1 (500 MHz, CDCl3-CD3OD 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































C NMR spectrum of thiostrepton Ala4Cys F1 (125 MHz, CDCl3-CD3OD 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure D.7. DEPT-135 NMR spectrum of thiostrepton Ala4Cys F1 (125 MHz, CDCl3-




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure D.8. gHSQC spectrum of thiostrepton Ala4Cys F1 (500 MHz, CDCl3-CD3OD 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure D.9. gCOSY spectrum of thiostrepton Ala4Cys F1 (500 MHz, CDCl3-CD3OD 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure D.10. gHMBC spectrum of thiostrepton Ala4Cys F1 (500 MHz, CDCl3-CD3OD 







C NMR assignments of thiostrepton Ala4Cys F1  
 
Position 
δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb   
Ile1    
Ile1-1 173.3; C q    
Ile1-2 65.3; CH 2.83 (d, 4.4) Ile1-1; Ile1-3; Ile1-4; Ile1-6; Q-8 Ile1-3 
Ile1-3 38.2; CH 1.82-1.74 (m)  Ile1-6 
Ile1-4 24.0; CH2 HA: 1.22-1.16 (m)  
HB: 0.99-0.90 (m)  
Ile1-5; Ile1-6 
Ile1-3; Ile1-5; Ile1-6 
Ile1-4-HB; Ile1-5 
Ile1-4-HA; Ile1-5 
Ile1-5 11.4; CH3 0.75 (t, 7.4) Ile1-3; Ile1-6 Ile1-4-HA; Ile1-4-HB 
Ile1-6 15.6; CH3 0.86 (d, 6.9) Ile1-2; Ile1-3; Ile1-5 Ile1-3 
Ala2     
Ala2-1 169.0; C q    
Ala2-2 49.4; CH 3.70-3.63 (m) Ala2-1; Ala2-3 Ala2-3 
Ala2-3 18.7; CH3 1.03 (d, 6.7)  Ala2-1; Ala2-2 Ala2-2 
Dha3     
Dha3-1 162.6; C q    
Dha3-2 131.9; C q    
Dha3-3 
 
103.7; CH2 HA: 5.73 (d, 1.7)  





Dha3-NHd  7.86 (s) Ala2-1  
Ala4     
Ala4-1 170.1; C q     
Ala4-2 54.9; CH 4.43 (dd, 11.7, 3.3)  Ala4-3-HA; Ala4-3-HB 
Ala4-3 36.5; CH2 HA: 3.27 (t, 11.2)  





Pip     
Pip-2  162.8; C q    
Pip-3 26.0; CH2  HA: 3.42-3.36 (m)  
HB: 3.07-3.00 (m)  
 Pip-3-HB; Pip-4-HA; Pip-4-HB; Pip-6 
Pip-3-HA; Pip-4-HB 
Pip-4 29.8; CH2 HA: 3.96-3.90 (m)  
HB: 2.20-2.13 (m)  
Ala4-1; Pip-2; Pip-3; Pip-5; Pip-6 
 
Pip-3-HA; Pip-4-HB 
Pip-3-HA; Pip-3-HB; Pip-4-HA 
Pip-5 58.2; C q    
Pip-6 64.1; CH 5.21-5.18 (m) Pip-2; Thz13-2 Pip-3-HA 
Thz6     
Thz6-1 161.6; C q    
Thz6-2 146.2; C q    
Thz6-3 125.0; CH 8.05 (s) Thz6-2; Thz6-4  
Thz6-4 169.4 ; C q    
Thr7     
Thr7-1 165.4; C q    
Thr7-2 55.7; CH  4.28 (dd, 8.2, 4.2) Thr7-1; Thr7-3 Thr7-3; Thr7-NH 
Thr7-3 66.3; CH  1.49-1.42 (m)  Thr7-1; Thr7-4 Thr7-4 
Thr7-4 18.9; CH3  0.65 (d, 6.2) Thr7-2; Thr7-3 Thr7-3 
Thr7-NHd   7.00 (d, 7.5) Thz6-1; Thr7-1 Thr7-2 
Dhb8     
Dhb8-2 128.3; C q    
Dhb8-3 132.7; CH  6.10 (q, 7.0) Dhb8-2; Tzn9-4 Dhb8-4 
Dhb8-4 15.3; CH3  1.49 (d, 7.1) Dhb8-2; Dhb8-3; Tzn9-4 Dhb8-3 
Tzn9     
Tzn9-1 172.0; C q    
Tzn9-2 78.8; CH 4.84 (dd, 12.9, 9.0) Tzn9-1; Tzn9-3; Tzn9-4 Tzn9-3-HA; Tzn9-3-HB 
Tzn9-3 34.8; CH2 HA: 3.51 (dd, 12.6, 9.9) 





Tzn9-4 170.2; C q    
Ile10     
Ile10-2 52.8; CH 5.61 (d, 10.1) Tzn9-1; Ile10-3; Thz11-4 Ile10-NH 
Ile10-3 77.0c; C q    
Ile10-4 67.7; CH 3.70-3.63 (m) Ile10-2; Ile10-3; Ile10-5; Ile10-6 Ile10-5 
Ile10-5 15.8; CH3 1.16 (d, 6.4) Ile10-3; Ile10-4; Ile10-6 Ile10-4 




δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb   
Ile10-6 18.4; CH3 1.01 (s) Ile10-2; Ile10-3; Ile10-4; Ile10-5  
Ile10-NHd  7.44 (d, 9.8)  Ile10-2 
Thz11     
Thz11-1 162.1; C q    
Thz11-2 150.1; C q    
Thz11-3 125.6; CH 8.13 (s) Thz11-2; Thz11-4  
Thz11-4 166.2; C q    
Thr12     
Thr12-2 55.5; CH 5.62 (d, 7.2) Thz11-1; Thz13-2; Thz13-4 Thr12-NH 
Thr12-3 71.8; CH 6.14 (q, 7.3) Thr12-4; Thz13-4; Q-1 Thr12-4 
Thr12-4 18.7; CH3 1.57 (d, 6.6) Thr12-2; Thr12-3 Thr12-3 
Thr12-NHd  8.68 (d, 8.8)  Thr12-2 
Thz13     
Thz13-2  157.1; C q    
Thz13-3  118.0; CH  7.44 (s) Pip-6; Thz13-2; Thz13-4  
Thz13-4  170.2; C q    
Thz15     
Thz15-1 159.4; C q    
Thz15-2 149.1; C q    
Thz15-3 127.0; CH  8.14 (s) Thz15-2; Thz15-4  
Thz15-4 168.0; C q    
Dha16     
Dha16-1 164.3; C q    
Dha16-2 132.7; C q    
Dha16-3 115.4; CH2  HA: 6.07 (br s)  





Ala17     
Ala17-1 170.0; C q    
Ala17-2 54.9; CH 4.66 (t, 3.8)  Ala17-3-HA; Ala17-3-HB 
Ala17-3 36.5; CH2 HA: 3.13 (dd, 14.6, 3.7)  
HB: 2.91 (dd, 14.6, 3.5) 
 Ala17-2; Ala17-3-HB 
Ala17-2; Ala17-3-HA 
Q     
Q-1 160.6; C q    
Q-2 143.4; C q    
Q-3 122.3; CH 7.14 (s) Q-1; Q-5; Q-11  
Q-4 153.5; C q    
Q-5 127.1; C q    
Q-6 123.2; CH 6.75 (d, 10.1) Q-5; Q-8; Q-10 Q-7 
Q-7 130.0; CH 6.25 (dd, 9.4, 5.5) Q-5; Q-8; Q-9 Q-6; Q-8 
Q-8 58.8; CH 3.51-3.46 (m) Ile1-2; Q-6; Q-7; Q-9; Q-10 Q-7 
Q-9 67.4; CH 4.27 (br s) Q-5; Q-7; Q-8; Q-10 Q-8 
Q-10 154.4; C q    
Q-11 64.4; CH 5.21-5.18 (m) Q-3; Q-12 Q-12 
Q-12 22.6; CH3 1.25 (d, 6.6) Q-4; Q-11 Q-11 
 
a HMBC correlations are from the proton to the indicated carbon. 
b COSY correlations are from the proton to the proton attached to the indicated position. 
c The δ of this resonance was determined by HMBC due to overlap with the CDCl3 resonance. 
















Figure D.11. MS analysis of thiostrepton Ala4Cys F2 isolated from S. laurentii 
NDS1/int-A4C. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 848.7, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Cys F2. (2) Total ion chromatogram. 
 A4C F2, Syn C12 2x250
GT Mass Spectrometry Laboratory 04-Jun-2012   16:41:31
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2.83e6
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TIC
1.39e8
A4C F2, Syn C12 2x250

























(B) MALDI MS spectrum of thiostrepton Ala4Cys F2. (Peaks labeled with * are internal 
standards. Angiotensin II: [M+H]
+







 1570.7. This MALDI MS analysis was performed on Bruker
®
 





































































































































(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 
of thiostrepton Ala4Cys F2.  
 
Fragment Expected Observed
1. M+H+ (Parent ion) 1696.5 1696.5
2. M+Na+ 1718.5 1718.4
3. M+K+ 1734.4 1734.5
4. M-Ala2-CO+H+ 1597.4 1597.6
5. M-QA+H+ 1463.4 1463.3
6. M-QA-Ile1-Ala2+H+ 1279.3 1279.1
7. M-QA-Ile1-Ala2-H2O+H
+ 1261.3 1261.1
8. M-QA-Ile1-Ala2-Dha3+H+ 1210.3 1210.0
9. M-QA-Ile1-Ala2-Dha3-H-H2O+H










Figure D.12. Structure and numbering system used for thiostreptons Ala4Cys F1 and F2.  
 
Thiostrepton Ala4Cys F1 and F2 are proposed to be diastereomers differing in 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































H NMR spectrum of thiostrepton Ala4Cys F2 (500 MHz, CDCl3-CD3OD 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































C NMR spectrum of thiostrepton Ala4Cys F2 (125 MHz, CDCl3-CD3OD 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure D.15. DEPT-135 NMR spectrum of thiostrepton Ala4Cys F2 (125 MHz, CDCl3-




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure D.16. gHSQC spectrum of thiostrepton Ala4Cys F2 (500 MHz, CDCl3-CD3OD 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure D.17. gCOSY spectrum of thiostrepton Ala4Cys F2 (500 MHz, CDCl3-CD3OD 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure D.18. gHMBC spectrum of thiostrepton Ala4Cys F2 (500 MHz, CDCl3-CD3OD 







C NMR assignments of thiostrepton Ala4Cys F2  
 
Position 
δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb   
Ile1    
Ile1-1 173.3; C q    
Ile1-2 65.4; CH 2.85 (d, 4.4) Ile1-1;Ile1-3; Ile1-4; Ile1-6; Q-8 Ile1-3 
Ile1-3 38.2; CH 1.83-1.75 (m)  Ile1-2; Ile1-4-HB; Ile1-6 
Ile1-4 24.1; CH2 HA: 1.24-1.19 (m)  
HB: 1.10-0.92 (m) 
Ile1-2; Ile1-3; Ile1-5; Ile1-6 
Ile1-2; Ile1-3; Ile1-6 
Ile1-3; Ile1-4-HB; Ile1-5 
Ile1-3; Ile1-4-HA; Ile1-5 
Ile1-5 11.4; CH3 0.76 (t, 7.3) Ile1-3; Ile1-4; Ile1-6 Ile1-4-HA; Ile1-4-HB 
Ile1-6 15.6; CH3 0.88 (d, 6.9) Ile1-2; Ile1-3; Ile1-4 Ile1-3 
Ile1-NHd  8.11 (d, 2.8) Ile-1  
Ala2     
Ala2-1 169.1; C q    
Ala2-2 49.4; CH 3.71-3.64 (m) Ala2-1; Ala2-3 Ala2-3; Ala2-NH 
Ala2-3 18.7; CH3 1.05 (d, 6.7)  Ala2-1; Ala2-2 Ala2-2 
Ala2-
NHd 
 7.70 (d, 5.3)  Ala2-2 
Dha3     
Dha3-1 162.5; C q    
Dha3-2 132.0; C q    
Dha3-3 
 
103.7; CH2 HA: 5.76 (d, 1.9)  







 7.84 (s) Ala2-1; Dha3-1; Dha3-3  
Ala4     
Ala4-1 170.2; C q    
Ala4-2 54.4; CH 4.59-4.52 (m)  Ala4-3-HA; Ala4-3-HB; Ala4-NH 
Ala4-3 36.3; CH2 HA: 3.13-3.08 (m)  




Ala4-2; Ala4-3-HA   
Ala4-
NHd 
 7.20 (d, 8.3) Dha3-1; Ala4-2 Ala4-2 
Pip     
Pip-2  162.7; C q    
Pip-3 26.2; CH2 HA: 3.48-3.43 (m)   
HB: 2.99-2.86 (m)  
 Pip-4-HA; Pip-4-HB; Pip-6 
 
Pip-4 29.4; CH2  HA: 4.00-3.94 (m)  
HB: 2.22-2.14 (m) 
Pip-2; Pip-3; Pip-5; Pip-6; Thz6-4; Thz13-2 
Pip-3 
Pip-3-HA; Pip-4-HB 
Pip-3-HA; Pip-3-HB; Pip-4-HA 
Pip-5 58.1; C q    
Pip-6 64.3; CH 5.23-5.17 (m) Pip-2; Thz13-2 Pip-3-HA 
Pip-NHd  9.62 (s) Ala4-1  
Thz6     
Thz6-1 161.7; C q    
Thz6-2 146.2; C q    
Thz6-3 125.0; CH 8.04 (s) Thz6-2; Thz6-4  
Thz6-4 169.0; C q    
Thr7     
Thr7-1 165.4; C q    
Thr7-2 55.8; CH  4.31-4.25 (m) Thr7-1; Thr7-3; Thr7-4 Thr7-3; Thr7-NH 
Thr7-3 66.2; CH 1.50-1.45 (m)  Thr7-4 Thr7-2; Thr7-4 
Thr7-4 18.9; CH3 0.66 (d, 6.1) Thr7-2; Thr7-3 Thr7-3 
Thr7-
NHd 
 7.03 (d, 7.5) Thz6-1; Thr7-1; Thr7-2 Thr7-2 
Dhb8     
Dhb8-2 128.3; C q    
Dhb8-3 132.7; CH  6.11 (q, 6.8) Dhb8-2; Dhb8-4; Tzn9-4 Dhb8-4 
Dhb8-4 15.3; CH3  1.50 (d, 7.0)  Dhb8-2; Dhb8-3; Tzn9-4 Dhb8-3 
Tzn9     
Tzn9-1 172.1; C q    
Tzn9-2 78.9; CH 4.85 (dd, 12.8, 9.0) Tzn9-1; Tzn9-3; Tzn9-4 Tzn9-3-HA; Tzn9-3-HB 
Tzn9-3 34.7; CH2 HA: 3.56-3.51 (m) 





Tzn9-4 170.2; C q    
 
 
    




δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb   
Ile10     
Ile10-2 52.9; CH 5.62 (d, 9.9) Tzn9-1; Ile10-3; Thz11-4 Ile10-NH 
Ile10-3 77.0c; C q    
Ile10-4 67.7; CH 3.71-3.64 (m) Ile10-2; Ile10-3; Ile10-5; Ile10-6 Ile10-5 
Ile10-5 15.8; CH3 1.17 (d, 6.4) Ile10-3; Ile10-4; Ile10-6 Ile10-4 
Ile10-6 18.4; CH3 1.02 (s) Ile10-2; Ile10-3; Ile10-4; Ile10-5  
Ile10-
NHd 
 7.45 (d, 9.5) Tzn9-1; Ile10-2; Ile10-3 Ile10-2 
Thz11     
Thz11-1 162.5; C q    
Thz11-2 148.9; C q     
Thz11-3 125.6; CH 8.14 (s) Thz11-2; Thz11-4  
Thz11-4 166.2; C q    
Thr12     
Thr12-2 55.5; CH 5.61 (d, 8.6) Thz11-1; Thz13-4 Thr12-NH 
Thr12-3 71.7; CH 6.14 (q, 6.4) Thr12-4; Q-1 Thr12-4 
Thr12-4 18.7; CH3 1.58 (d, 6.6) Thr12-2; Thr12-3 Thr12-3 
Thr12-
NHd 
 8.74 (d, 8.8)  Thr12-2 
Thz13     
Thz13-2 157.2; C q    
Thz13-3 117.9; CH 7.45 (s) Pip-6; Thz13-2; Thz13-4  
Thz13-4 170.2; C q    
Thz15     
Thz15-1 159.2; C q    
Thz15-2 150.0; C q     
Thz15-3 126.4; CH 8.14 (s) Thz15-2; Thz15-4  
Thz15-4 168.1; C q    
Dha16     
Dha16-1 165.2; C q    
Dha16-2 133.5; C q    
Dha16-3 
 
111.7; CH2 HA: 5.96 (d, 2.6)  





Ala17     
Ala17-1 172.0; C q    
Ala17-2 52.9; CH 4.75 (t, 4.7) Ala17-1 Ala17-3-HA;  Ala17-3-HB 
Ala17-3 37.3; CH2 HA: 3.16-3.10 (m)  





Q     
Q-1 160.6; C q    
Q-2 143.4; C q    
Q-3 122.2; CH 7.17 (s) Q-1; Q-5; Q-11  
Q-4 153.5; C q    
Q-5 127.1; C q    
Q-6 123.1; CH 6.76 (d, 10.1) Q-5; Q-8; Q-10 Q-7 
Q-7 129.9; CH 6.27 (dd, 9.5, 5.2) Q-5; Q-8; Q-9 Q-6; Q-8 
Q-8 58.8; CH 3.51-3.48 (m) Ile1-2; Q-6; Q-7; Q-9; Q-10 Q-7 
Q-9 67.4; CH 4.28 (s) Q-5; Q-7; Q-8; Q-10 Q-8 
Q-10 154.4; C q    
Q-11 64.4; CH 5.23-5.17 (m) Q-3; Q-5; Q-12 Q-12 
Q-12 22.6; CH3 1.26 (d, 6.6) Q-4; Q-11 Q-11 
 
a HMBC correlations are from the proton to the indicated carbon. 
b COSY correlations are from the proton to the proton attached to the indicated position. 
c The δ of this resonance was determined by HMBC due to overlap with the CDCl3 resonance. 








Figure D.19. MS analysis of thiostrepton Ala4Dha isolated from S. laurentii NDS1/int-
A4S. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 831.7, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Dha. (2) Total ion chromatogram. 
 A4Dha, Syn C12 2x250
GT Mass Spectrom try Laboratory 11-Dec-2013   18:17:54
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(B) MALDI MS spectrum of thiostrepton Ala4Dha. 
8 0 0 1 0 4 0 1 2 8 0 1 5 2 0 1 7 6 0 2 0 0 0
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(C) MALDI MS/MS of parent ion m/z 1662.3.  
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 





2. M+H+ (Parent ion) 1662.5 1662.3
3. M+Na+ 1684.5 1684.3
4. M+K+ 1700.4 1700.3
5. M+Cu+ 1724.4 1724.4
6. M-QA+H+ 1429.4 1429.4
7. M-QA-Ile1-Ala2+H+ 1245.3 1245.3
8. M-QA-Ile1-Ala2-OH+H+ 1228.3 1228.2
9. M-QA-Ile1-Ala2-Dha3+H+ 1176.3 1176.2
10. M-QA-Ile1-Ala2-Dha3-OH+H+ 1159.3 1159.2
11. M-QA-Ile1-Ala2-Dha3-H2O-OH+H
+ 1141.3 1141.2
12. M-QA-Ile1-Ala2-Dha3-Dha4+H+ 1107.3 1107.2






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































C NMR spectrum of thiostrepton Ala4Dha (125 MHz, CDCl3-CD3OD 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure D.23. DEPT-135 NMR spectrum of thiostrepton Ala4Dha (125 MHz, CDCl3-


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































C NMR assignments of thiostrepton Ala4Dha 
Position 
δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb   
Ile1    
Ile1-1 173.1; C q    
Ile1-2 64.6; CH 2.86 (d, 3.3) Ile1-1; Ile1-3; Ile1-4; Ile1-6; Q-8 Ile1-3 
Ile1-3 38.3; CH 1.91-1.84 (m)  Ile1-2; Ile1-6 
Ile1-4 23.7; CH2  HA: 1.18-1.14 (m) 
HB: 0.99-0.93 (m) 
Ile1-5; Ile1-6 
Ile1-3; Ile1-5; Ile1-6 
Ile1-4-HB; Ile1-5 
Ile1-3; Ile1-4-HA; Ile1-5 
Ile1-5 11.5; CH3 0.76 (t, 7.3) Ile1-3; Ile1-4; Ile1-6 Ile1-4-HA; Ile1-4-HB 
Ile1-6 15.8; CH3 0.90 (d, 6.8) Ile1-2; Ile1-3; Ile1-4; Ile1-5 Ile1-3 
Ala2     
Ala2-1 169.2; C q    
Ala2-2 49.4; CH 3.80-3.73 (m) Ala2-1; Ala2-3 Ala2-3 
Ala2-3 18.9; CH3 1.05 (d, 6.6)  Ala2-1; Ala2-2 Ala2-2 
Dha3     
Dha3-1 162.5; C q    
Dha3-2 133.0; C q    
Dha3-3 
 
104.6; CH2 HA: 5.70 (br s)  





Dha4     
Dha4-1 168.3; C q    
Dha4-2 138.2; C q    
Dha4-3 102.9; CH2 HA: 5.82 (br s)  




Pip     
Pip-2  161.8; C q    
Pip-3 23.8; CH2 HA: 3.56-3.48 (m) 
HB: 3.06-2.99 (m)  
  
Pip-4 27.6; CH2 HA: 3.80-3.73 (m)  
HB: 2.28-2.22 (m)  




Pip-5 56.8; C q    
Pip-6 63.8; CH 5.03 (s) Ala4-1; Pip-2; Pip-3; Thz13-2; Thz15-4  
Thz6     
Thz6-1 162.0; C q    
Thz6-2 147.0; C q    
Thz6-3 124.5; CH 7.98 (s) Thz6-1; Thz6-2; Thz6-4  
Thz6-4 169.8; C q    
Thr7     
Thr7-1 165.5; C q    
Thr7-2 55.4; CH 4.34 (dd, 9.3, 1.8) Thr7-1; Thr7-3 Thr7-3; Thr7-NH 
Thr7-3 66.7; CH 1.07-1.04 (m)   
Thr7-4 19.2; CH3 0.81 (d, 5.9) Thr7-2; Thr7-3 Thr7-3 
Thr7-NHd  6.64 (d, 8.1)  Thr7-2 
Dhb8     
Dhb8-2 128.3; C q    
Dhb8-3 132.5; CH 6.08 (q, 7.0) Dhb8-2; Dhb8-4; Tzn9-4 Dhb8-4 
Dhb8-4 15.3; CH3 1.48 (d, 6.9) Dhb8-2; Dhb8-3; Tzn9-4 Dhb8-3 
Tzn9     
Tzn9-1 172.1; C q    
Tzn9-2 78.7; CH 4.85 (dd, 12.6, 9.2) Tzn9-1; Tzn9-3; Tzn9-4 Tzn9-3-HA; Tzn9-3-HB 
Tzn9-3 34.8; CH2 HA: 3.57-3.51 (m) 





Tzn9-4 170.2; C q    
Ile10     
Ile10-2 52.9; CH 5.63 (d, 6.9) Tzn9-1; Ile10-3; Thz11-4 Ile10-NH 
Ile10-3 77.0c; C q    
Ile10-4 67.2; CH 3.70 (q, 6.2) Ile10-2; Ile10-3; Ile10-5; Ile10-6 Ile10-5 
Ile10-5 15.7; CH3 1.18 (d, 6.3) Ile10-3; Ile10-4 Ile10-4 
Ile10-6 17.9; CH3 1.02 (s) Ile10-2; Ile10-3; Ile10-4; Ile10-5 Ile10-5 




δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb   
Thz11     
Thz11-1 162.0; C q    
Thz11-2 149.9; C q    
Thz11-3 125.6; CH 8.16 (s) Thz11-2; Thz11-4  
Thz11-4 166.2; C q    
Thr12     
Thr12-2 55.4; CH 5.62 (d, 8.1) Thz11-1; Thr12-4; Thz13-4 Thr12-3; Thr12-NH 
Thr12-3 72.3; CH 6.26-6.21 (m)  Thr12-4 
Thr12-4 18.3; CH3 1.44 (d, 6.5) Thr12-2; Thr12-3 Thr12-3 
Thr12-NHd  8.47 (d, 8.5)  Thr12-2 
Thz13     
Thz13-2  156.3; C q    
Thz13-3  117.9; CH 7.34 (s) Pip-6; Thz13-2; Thz13-4  
Thz13-4  169.7; C q    
Thz15     
Thz15-1 159.5; C q    
Thz15-2 149.9; C q    
Thz15-3 127.6; CH 8.18 (s) Thz15-1; Thz15-2; Thz15-4  
Thz15-4 168.1; C q    
Dha16     
Dha16-1 162.0; C q    
Dha16-2 134.0; C q    
Dha16-3 103.2; CH2 HA: 6.58 (d, 1.1)  





Dha17     
Dha17-1 166.0; C q    
Dha17-2 132.8; C q    
Dha17-3 104.4; CH2 HA: 6.41 (d, 1.1)  





Q     
Q-1 161.2; C q    
Q-2 143.6; C q    
Q-3c 122.7; CH 7.26 (s) Q-1; Q-5; Q-11  
Q-4 153.7; C q    
Q-5 127.4; C q    
Q-6 123.1; CH 6.79 (d, 9.9) Q-5; Q-8; Q-10 Q-7 
Q-7 130.2; CH 6.27 (dd, 9.1, 5.8) Q-5; Q-8; Q-9 Q-6; Q-8 
Q-8 58.8; CH 3.54-3.48 (m) Ile1-2; Q-6; Q-7; Q-9; Q-10 Q-7; Q-9 
Q-9 67.4; CH 4.28 (br s) Q-5; Q-7; Q-8; Q-10 Q-8 
Q-10 154.4; C q    
Q-11 64.3; CH 5.18 (q, 6.4) Q-3; Q-5; Q-12 Q-12 
Q-12 22.6; CH3 1.25 (d, 6.5) Q-4; Q-11 Q-11 
 
a HMBC correlations are from the proton to the indicated carbon. 
b COSY correlations are from the proton to the proton attached to the indicated position. 
c The δ of this resonance was determined either by HMBC or HSQC due to overlap with the CDCl3 resonance. 













Figure D.27. MS analysis of thiostrepton Ala4Dhb isolated from S. laurentii NDS1/int-
A4T. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 838.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Dhb. (2) Total ion chromatogram. 
 A4Dhb, Syn C12 2x250
GT Mass Spectrometry Laboratory 11-Dec-2013   19:40:07
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(B) MALDI MS spectrum of thiostrepton Ala4Dhb. 
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(C) MALDI MS/MS of parent ion m/z 1676.5.  
2 0 0 5 2 0 8 4 0 1 1 6 0 1 4 8 0 1 8 0 0
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 
of thiostrepton Ala4Dhb.  
 
Fragment Expected Observed
1. M-OH+H+ 1659.5 1659.3
2. M+H+ (Parent ion) 1676.5 1676.5
3. M+Na+ 1698.5 1698.4
4. M+K+ 1714.5 1714.4
5. M-QA+H+ 1443.4 1443.5
6. M-QA-H2O+H
+ 1425.4 1425.5
7. M-QA-Ile1-Ala2+H+ 1259.3 1259.4
8. M-QA-Ile1-Ala2-H2O+H
+ 1241.3 1241.4
9. M-QA-Ile1-Ala2-Dha3+H+ 1190.3 1190.5
10. M-QA-Ile1-Ala2-Dha3-H2O+H
+ 1172.3 1172.5
11. M-QA-Ile1-Ala2-Dha3-Dhb4+H+ 1107.3 1107.4
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































C NMR spectrum of thiostrepton Ala4Dhb (125 MHz, CDCl3-CD3OD 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure D.31. DEPT-135 NMR spectrum of thiostrepton Ala4Dhb (125 MHz, CDCl3-




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































C NMR assignments of thiostrepton Ala4Dhb 
Position 
δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb 
Ile1    
Ile1-1 173.2; C q    
Ile1-2 64.6; CH 2.87 (d, 3.4) Ile1-1; Ile1-3; Ile1-4; Ile1-6; Q-8 Ile1-3 
Ile1-3 38.3; CH 1.88-1.83 (m)  Ile1-2; Ile-4-HA; Ile1-4-HB; Ile1-6 
Ile1-4 23.8; CH2 HA: 1.20-1.16 (m)  
HB: 1.01-0.92 (m)  
Ile1-5; Ile1-6 
Ile1-5 
Ile1-3; Ile1-4-HB; Ile1-5 
Ile1-3; Ile1-4-HA; Ile1-5 
Ile1-5 11.5; CH3 0.77 (t, 7.3) Ile1-3; Ile1-4; Ile1-6 Ile1-4-HA; Ile1-4-HB 
Ile1-6 15.7; CH3 0.90 (d, 6.8) Ile1-2; Ile1-3; Ile1-4; Ile1-5 Ile1-3 
Ala2     
Ala2-1 169.3; C q    
Ala2-2 49.7; CH 3.75-3.68 (m) Ala2-1 Ala2-3 
Ala2-3 18.9; CH3 1.05 (d, 6.9)  Ala2-1; Ala2-2 Ala2-2 
Dha3     
Dha3-1 160.9; C q    
Dha3-2 132.2; C q    
Dha3-3 
 
105.0; CH2 HA: 5.76 (br s)  





Dhb4     
Dhb4-1 169.4; C q     
Dhb4-2 131.8; C q    
Dhb4-3 121.8; CH 5.87 (q, 6.8)  Dhb4-1 Dhb4-4 
Dhb4-4 15.2; CH3 1.65 (d, 6.8) Dhb4-1; Dhb4-2; Dhb4-3 Dhb4-3 
Pip     
Pip-2  161.7; C q    
Pip-3 23.8; CH2 HA: 3.42-3.37 (m)  
HB: 3.00-2.95 (m) 
 
Pip-4-HB 
Pip-4-HA; Pip-4-HB  
Pip-4 27.6; CH2 HA: 3.80-3.73 (m) 
HB: 2.30-2.22 (m)  
Pip-2; Pip-3; Pip-5; Pip-6; Thz6-4 
Pip-3;  Pip-6 
Pip-3-HB; Pip-4-HB 
Pip-3-HA; Pip-4-HA; Pip-3-HB  
Pip-5 56.5; C q     
Pip-6 63.9; CH 5.00 (br s) Pip-2; Thz13-2  
Thz6     
Thz6-1 162.2; C q     
Thz6-2 146.8; C q     
Thz6-3 124.4; CH 7.97 (s) Thz6-2, Thz6-4  
Thz6-4 170.3; C q    
Thr7     
Thr7-1 165.5; C q     
Thr7-2 55.3; CH 4.36 (dd, 7.9, 3.1) Thr7-1; Thr7-3 Thr7-3; Thr7-NH 
Thr7-3 66.7; CH 1.08-1.01 (m)  Thr7-2; Thr7-4 
Thr7-4 19.2; CH3 0.82 (d, 5.8) Thr7-2; Thr7-3 Thr7-3 
Thr7-NHd  6.63-6.58 (m)  Thr7-2 
Dhb8     
Dhb8-2 128.3; C q    
Dhb8-3 132.4; CH 6.08 (q, 6.7) Tzn9-4 Dhb8-4 
Dhb8-4 15.4; CH3 1.49 (d, 6.9) Dhb8-2; Dhb8-3; Tzn9-4 Dhb8-3 
Tzn9     
Tzn9-1 172.1; C q    
Tzn9-2 78.7; CH 4.85 (dd, 12.8, 9.2) Tzn9-1; Tzn9-4 Tzn9-3-HA; Tzn9-3-HB 
Tzn9-3 34.9; CH2 HA: 3.57-3.52 (m) 





Tzn9-4 170.3; C q    
Ile10     
Ile10-2 53.0; CH 5.63 (d, 9.8) Tzn9-1; Ile10-3; Thz11-4 Ile10-NH 
Ile10-3 77.0c; C q    
Ile10-4 67.3; CH 3.75-3.68 (m) Ile10-2; Ile10-3; Ile10-5; Ile10-6 Ile10-5 
Ile10-5 15.7; CH3 1.20 (d, 6.3) Ile10-3; Ile10-4 Ile10-4 
Ile10-6 17.9; CH3 1.04 (s) Ile10-2; Ile10-3; Ile10-4; Ile10-5  






δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb 
Thz11     
Thz11-1 161.9; C q    
Thz11-2 149.9; C q    
Thz11-3 125.6; CH 8.17 (s) Thz11-1; Thz11-2; Thz11-4  
Thz11-4 166.2; C q    
Thr12     
Thr12-2 55.7; CH 5.63 (d, 9.8) Thz11-1; Thr12-4; Thz13-2; Thz13-4 Thr12-3; Thr12-NH 
Thr12-3 72.3; CH 6.22 (q, 6.8)  Thr12-2; Thr12-4 
Thr12-4 18.6; CH3 1.57 (d, 6.2) Thr12-2; Thr12-3 Thr12-3 
Thr12-NHd  8.43 (d, 8.6)  Thr12-2 
Thz13     
Thz13-2 156.3; C q    
Thz13-3 117.8; CH 7.31 (s) Pip-6; Thz13-2; Thz13-4  
Thz13-4 169.7; C q    
Thz15     
Thz15-1 159.6; C q    
Thz15-2 150.0; C q    
Thz15-3 127.6; CH 8.20 (s) Thz15-1; Thz15-2; Thz15-4  
Thz15-4 168.2; C q    
Dha16     
Dha16-1 162.0; C q    
Dha16-2 134.0; C q    
Dha16-3 103.2; CH2 HA: 6.53 (br s)  





Dha17     
Dha17-1 166.0; C q    
Dha17-2 132.8; C q    
Dha17-3 104.3; CH2 HA: 6.43 (br s)  





Q     
Q-1 160.7; C q    
Q-2 144.0; C q    
Q-3 122.5; CH 7.21 (s) Q-1; Q-5; Q-11  
Q-4 153.7; C q    
Q-5 127.3; C q    
Q-6 123.2; CH 6.80 (d, 9.9) Q-5; Q-8; Q-10 Q-7 
Q-7 130.0; CH 6.26 (dd, 9.2, 5.6) Q-5; Q-8; Q-9 Q-6; Q-8 
Q-8 58.8; CH 3.54-3.48 (m) Ile1-2; Q-9; Q-10 Q-7; Q-9 
Q-9 67.4; CH 4.30 (br s)  Q-8 
Q-10 154.3; C q    
Q-11 64.2; CH 5.16 (q, 5.8) Q-12 Q-12 
Q-12 22.5; CH3 1.23 (d, 6.4) Q-4, Q-11 Q-11 
 
a HMBC correlations are from the proton to the indicated carbon. 
b COSY correlations are from the proton to the proton attached to the indicated position. 
c The δ of this resonance was determined by HMBC due to overlap with the CDCl3 resonance. 





















Figure D.35. MS analysis of thiostrepton Ala4Gln isolated from S. laurentii NDS1/int-
A4Q. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 861.3, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Gln. (2) Total ion chromatogram. 
 A4Q 10x, Syn C12 2x250
GT Mass Spectrometry Laboratory 11-Nov-2013   19:25:16
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(B) MALDI MS spectrum of thiostrepton Ala4Gln. 
8 0 0 1 0 4 0 1 2 8 0 1 5 2 0 1 7 6 0 2 0 0 0
M a s s  (m /z )


















































(C) MALDI MS/MS of parent ion m/z 1721.4.  
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 
of thiostrepton Ala4Gln.  
 
Fragment Expected Observed
1. M+H+ (Parent ion) 1721.5 1721.4
2. M+Na+ 1743.5 1743.3
3. M-Dha16-Dha17-NH2-C4H9+H
+ 1510.4 1510.5
4. M-QA-Ile1-Ala2+H+ 1304.3 1304.4
5. M-QA-Ile1-Ala2-H2O+H
+ 1286.3 1286.4
6. M-QA-Ile1-Ala2-Dha3-OH+H+ 1218.3 1218.3
7. M-QA-Ile1-Ala2-Dha3-Gln4+H+ 1107.3 1107.3








Figure D.36. MS analysis of thiostrepton Ala4His isolated from S. laurentii NDS1/int-
A4H. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 865.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4His. (2) Total ion chromatogram. 
 Tsr A4H, Syn C12 2x250
GT Mass Spectrometry Laboratory 14-Oct-2011   15:10:40
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(B) MALDI MS spectrum of thiostrepton Ala4His. 
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(C) MALDI MS/MS of parent ion m/z 1730.4.  
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 
of thiostrepton Ala4His.  
 
Fragment Expected Observed
1. M+H+-Dha17 (in situ truncation) 1661.5 1661.3
2. M+H+ (Parent ion) 1730.5 1730.4
3. M+Na+ 1752.5 1752.3
4. M-Ile1-Ala2+H+ 1546.4 1546.4
5. M-QA+H+ 1497.5 1497.5
6. M-QA-Ile1-Ala2+H+ 1313.3 1313.3
7. M-QA-Ile1-Ala2-Dha3+H+ 1244.3 1244.3
8. M-QA-Ile1-Ala2-Dha3-OH+H+ 1227.3 1227.3














Figure D.37. MS analysis of thiostrepton Ala4Ile isolated from S. laurentii NDS1/int-
A4I. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 853.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Ile. (2) Total ion chromatogram. 
 Purified A4I, Syn C18 2x250
GT Mass Spectrom try Laboratory 24-Sep-2010   17:48:46
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(B) MALDI MS spectrum of thiostrepton Ala4Ile. 
8 0 0 1 0 4 0 1 2 8 0 1 5 2 0 1 7 6 0 2 0 0 0
M a s s  (m /z )



































































(C) MALDI MS/MS of parent ion m/z 1706.6.  
2 0 0 5 2 0 8 4 0 1 1 6 0 1 4 8 0 1 8 0 0
M a s s  (m /z )









































































(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 





2. M+H+ (Parent ion) 1706.5 1706.6
3. M+Na+ 1728.5 1728.5
4. M+K+ 1744.5 1744.5
5. M+Cu+ 1768.5 1768.5
6. M-QA+H+ 1473.5 1473.6
7. M-QA-Ile1-Ala2+H+ 1289.4 1289.5
8. M-QA-Ile1-Ala2-H2O+H
+ 1271.3 1271.5
9. M-QA-Ile1-Ala2-Dha3+H+ 1220.3 1220.6
10. M-QA-Ile1-Ala2-Dha3-Ile4+H+ 1107.3 1107.5










Figure D.38. MS analysis of thiostrepton Ala4Leu isolated from S. laurentii NDS1/int-
A4L. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 853.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Leu. (2) Total ion chromatogram. 
 A4L, Syn C12 2x250
GT Mass Spectr metry Laboratory 24-Jan-2014   13:26:24
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(B) MALDI MS spectrum of thiostrepton Ala4Leu. 
8 0 0 1 0 4 0 1 2 8 0 1 5 2 0 1 7 6 0 2 0 0 0
M a s s  (m /z )



























































(C) MALDI MS/MS of parent ion m/z 1706.6.  
2 0 0 5 2 0 8 4 0 1 1 6 0 1 4 8 0 1 8 0 0
M a s s  (m /z )
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 





2. M+H+ (Parent ion) 1706.5 1706.6
3. M+Na+ 1728.5 1728.6
4. M+Cu+ 1768.5 1768.6
5. M-QA+H+ 1473.5 1473.6
6. M-QA-Ile1-Ala2+H+ 1289.4 1289.5
7. M-QA-Ile1-Ala2-OH+H+ 1272.4 1272.5
8. M-QA-Ile1-Ala2-Dha3+H+ 1220.3 1220.6
9. M-QA-Ile1-Ala2-Dha3-Leu4+H+ 1107.3 1107.5









Figure D.39. MS analysis of thiostrepton Ala4Met isolated from S. laurentii NDS1/int-
A4M. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 862.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Met. (2) Total ion chromatogram. 
 A4M, 1/10 dil., Syn C12 2x250
GT Mass Spectrom try Laboratory 20-Sep-2012   16:22:22
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(B) MALDI MS spectrum of thiostrepton Ala4Met. 
8 0 0 1 0 4 0 1 2 8 0 1 5 2 0 1 7 6 0 2 0 0 0
M a s s  (m /z )
























































(C) MALDI MS/MS of parent ion m/z 1724.6.  
2 0 0 5 2 0 8 4 0 1 1 6 0 1 4 8 0 1 8 0 0
M a s s  (m /z )
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 
of thiostrepton Ala4Met.  
 
Fragment Expected Observed
1. M-OH+H+ 1707.5 1707.5
2. M+H+ (Parent ion) 1724.5 1724.6
3. M+Na+ 1746.5 1746.6
4. M-QA+H+ 1491.4 1491.6
5. M-QA-Ile1-Ala2+H+ 1307.3 1307.5
6. M-QA-Ile1-Ala2-H2O+H
+ 1289.3 1289.5
7. M-QA-Ile1-Ala2-Dha3+H+ 1238.3 1238.5
8. M-QA-Ile1-Ala2-Dha3-OH+H+ 1221.3 1221.5
9. M-QA-Ile1-Ala2-Dha3-Met4+H+ 1107.3 1107.5










Figure D.40. MS analysis of thiostrepton Ala4Phe isolated from S. laurentii NDS1/int-
A4F. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 870.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Phe. (2) Total ion chromatogram. 
 
  
A4F, Syn C12 2x250 
GT Mass Spectrom try Laboratory 09-Jan-2014   16:01:35 
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(B) MALDI MS spectrum of thiostrepton Ala4Phe. 
8 0 0 1 0 4 0 1 2 8 0 1 5 2 0 1 7 6 0 2 0 0 0
M a s s  (m /z )


































































(C) MALDI MS/MS of parent ion m/z 1740.3.  
2 0 0 5 2 0 8 4 0 1 1 6 0 1 4 8 0 1 8 0 0
M a s s  (m /z )
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 





2. M+H+ (Parent ion) 1740.5 1740.3
3. M+Na+ 1762.5 1762.2
4. M+K+ 1778.5 1778.2
5. M+Cu+ 1802.5 1802.2
6. M-QA+H+ 1507.5 1507.7
7. M-QA-Ile1-Ala2+H+ 1323.3 1323.7
8. M-QA-Ile1-Ala2-H2O+H
+ 1305.3 1305.6
9. M-QA-Ile1-Ala2-Dha3+H+ 1254.3 1254.7
10. M-QA-Ile1-Ala2-Dha3-Phe4+H+ 1107.3 1107.6










Figure D.41. MS analysis of thiostrepton Ala4Ser isolated from S. laurentii NDS1/int-
A4S. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 840.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Ser. (2) Total ion chromatogram. 
 A4S, Syn C12 2x250
GT Mass Spectrom try Laboratory 12-Dec-2013   01:09:03
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(B) MALDI MS spectrum of thiostrepton Ala4Ser. 
8 0 0 1 0 4 0 1 2 8 0 1 5 2 0 1 7 6 0 2 0 0 0
M a s s  (m /z )



























































(C) MALDI MS/MS of parent ion m/z 1680.5.  
2 0 0 5 2 0 8 4 0 1 1 6 0 1 4 8 0 1 8 0 0
M a s s  (m /z )












































































(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 
of thiostrepton Ala4Ser.  
 
Fragment Expected Observed
1. M-OH+H+ 1663.5 1663.5
2. M+H+ (Parent ion) 1680.5 1680.5
3. M+Na+ 1702.5 1702.5
4. M+K+ 1718.5 1718.5
5. M-QA+H+ 1447.4 1447.3
6. M-QA-Ile1-Ala2+H+ 1263.3 1263.2
7. M-QA-Ile1-Ala2-OH+H+ 1246.3 1246.2
8. M-QA-Ile1-Ala2-OH-H2O+H
+ 1228.3 1228.2
9. M-QA-Ile1-Ala2-Dha3+H+ 1194.3 1194.2
10. M-QA-Ile1-Ala2-Dha3-Ser4+H+ 1107.3 1107.2










Figure D.42. MS analysis of thiostrepton Ala4Trp isolated from S. laurentii NDS1/int-
A4W. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 890.3, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Trp. (2) Total ion chromatogram. 
 A4W, Syn C12 2x250
GT Mass Spectrometry Laboratory 19-Sep-2012   20:22:46
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(B) MALDI MS spectrum of thiostrepton Ala4Trp. 
8 0 0 1 0 4 0 1 2 8 0 1 5 2 0 1 7 6 0 2 0 0 0
M a s s  (m /z )


































































(C) MALDI MS/MS of parent ion m/z 1779.7.  
2 0 0 5 2 0 8 4 0 1 1 6 0 1 4 8 0 1 8 0 0
M a s s  (m /z )
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 
of thiostrepton Ala4Trp.  
 
Fragment Expected Observed
1. M-OH+H+ 1762.5 1762.6
2. M+H+ (Parent ion) 1779.5 1779.7
3. M+Na+ 1801.5 1801.6
4. M+K+ 1817.5 1817.6
5. M+Cu+ 1841.5 1841.6
6. M-QA+H+ 1546.5 1546.4
7. M-QA-Ile1-Ala2+H+ 1362.4 1362.3
8 M-QA-Ile1-Ala2-OH+H+ 1345.3 1345.3
9. M-QA-Ile1-Ala2-Dha3+H+ 1293.3 1293.3
10. M-QA-Ile1-Ala2-Dha3-OH+H+ 1276.3 1276.2
11. M-QA-Ile1-Ala2-Dha3-Trp4+H+ 1107.3 1107.2










Figure D.43. MS analysis of thiostrepton Ala4Tyr isolated from S. laurentii NDS1/int-
A4Y. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 878.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Tyr. (2) Total ion chromatogram 
 A4Y, Syn C12 2x250
GT Mass Spectrometry Laboratory 09-Jan-2014   20:48:06
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(C) MALDI MS/MS of parent ion m/z 1756.5.  
2 0 0 5 2 0 8 4 0 1 1 6 0 1 4 8 0 1 8 0 0
M a s s  (m /z )




















4700 MS/MS Precursor 1756.5 Spec #1 MC[BP = 1339.3, 49071]



















































(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 




1. M+H+ (Parent ion) 1756.5 1756.3
2. M+Na+ 1778.5 1778.3
3. M+K+ 1794.5 1794.3
4. M-QA+H+ 1523.5 1523.4
5. M-QA-Ile1-Ala2+H+ 1339.3 1339.3
6. M-QA-Ile1-Ala2-H2O+H
+ 1321.3 1321.3
7. M-QA-Ile1-Ala2-Dha3+H+ 1270.3 1270.3
8. M-QA-Ile1-Ala2-Dha3-Tyr4+H+ 1107.3 1107.2









Figure D.44. MS analysis of thiostrepton Ala4Val isolated from S. laurentii NDS1/int-
A4V. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 846.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala4Val. (2) Total ion chromatogram. 
 Purified A2V, Syn C18 2x250
GT Mass Spectr metry Laboratory 24-Sep-2010   19:31:16
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(C) MALDI MS/MS of parent ion m/z 1692.7.  
2 0 0 5 2 0 8 4 0 1 1 6 0 1 4 8 0 1 8 0 0
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 





2. M+H+ (Parent ion) 1692.5 1692.7
3. M+Na+ 1714.5 1714.7
4. M-QA+H+ 1459.5 1459.6
5. M-QA-Ile1-Ala2+H+ 1275.3 1275.5
6. M-QA-Ile1-Ala2-H2O+H
+ 1257.3 1257.5
7. M-QA-Ile1-Ala2-Dha3+H+ 1206.3 1206.4
8. M-QA-Ile1-Ala2-Dha3-OH+H+ 1189.3 1189.3
9. M-QA-Ile1-Ala2-Dha3-Val4+H+ 1107.3 1107.5














Figure D.46. Thiostrepton A, Ala4Cys F1 and F2 bound to the ribosome. 
Measurements of the distances between Thr7 and quinaldic acid hydroxyl groups in 
thiostrepton A, thiostrepton Ala4Cys F1 and F2. (A) Thiostrepton A (Cyan) bound to the 
ribosome adapted from PDB 3CF5.
1
 (B) Thiostrepton Ala4Cys with the R configuration 
at the α-carbon of the 17
th
 residue (magenta) modeled into the ribosome. (C) Thiostrepton 
Ala4Cys with the S configuration at the α-carbon of the 17
th
 residue (blue) modeled into 
the ribosome. Helices 43 and 44 of 23S rRNA are colored in orange and the ribosomal 
protein L11 is shown in green. 
 
(A)








1. Harms, J. M.; Wilson, D. N.; Schluenzen, F.; Connell, S. R.; Stachelhaus, T.; 
Zaborowska, Z.; Spahn, C. M.; Fucini, P., Translational regulation via L11: Molecular 
switches on the ribosome turned on and off by thiostrepton and micrococcin. Mol. Cell. 




APPENDIX E: SUPPORTING FIGURES AND SPECTRAL DATA 




Figure E.1. MS analysis of thiostrepton Ala2Dha isolated from S. laurentii NDS1/int-
A2S. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 831.7, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala2Dha. (2) Total ion chromatogram. 
 A2Dha 2x, Syn C12 2x250
GT Mass Spectr metry Laboratory 31-Jul-2014   19:22:11
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(B) MALDI MS spectrum of thiostrepton Ala2Dha. 


































































(C) MALDI MS/MS of parent ion m/z 1662.5.  
2 0 0 5 2 0 8 4 0 1 1 6 0 1 4 8 0 1 8 0 0
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 




1. M-OH+H+ 1645.5 1645.3
2. M+H+ (Parent ion) 1662.5 1662.5
3. M+Na+ 1684.5 1684.4
4. M+K+ 1700.4 1700.4
5. M+Cu+ 1724.4 1724.4
6. M-QA+H+ 1429.4 1429.1
7. M-QA-Ile1+H+ 1316.3 1316.0
8. M-QA-Ile1-OH+H+ 1299.3 1299.0
9. M-QA-Ile1-Dha2+H+ 1247.3 1247.0
10. M-QA-Ile1-Dha2-OH+H+ 1230.3 1230.0
11. M-QA-Ile1-Dha2-Dha3+H+ 1178.3 1178.0
12. M-QA-Ile1-Dha2-Dha3-OH+H+ 1161.3 1161.0
13. M-QA-Ile1-Dhaa2-Dha3-Dha4+H+ 1107.3 1107.0





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure E.5. DEPT-135 NMR spectrum of thiostrepton Ala2Dha (125 MHz, CDCl3-





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































C NMR assignments of thiostrepton Ala2Dha
 Position 
δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb 
Ile1    
Ile1-1 173.0; C q    
Ile1-2 66.3; CH 2.93 (d, 3.8) Ile1-1; Ile1-3; Ile-4; Ile1-6; Q8 Ile1-3 
Ile1-3 38.1; CH 2.00-1.94 (m)  Ile1-2; Ile1-4-HA; Ile1-4-HB; Ile1-6 
Ile1-4 23.8; CH2 HA: 1.14-1.10 (m) 
HB: 0.99-0.94 (m) 
Ile1-5 
 
Ile1-3; Ile1-4-HB; Ile1-5 
Ile1-3, Ile1-4-HA; Ile1-5 
Ile1-5 11.5; CH3 0.73 (t, 7.1) Ile1-3; Ile1-4 Ile1-4-HA; Ile1-4-HB 
Ile1-6 15.7; CH3 0.92 (d, 6.9) Ile1-2; Ile1-3; Ile1-4 Ile1-3 
Dha2     
Dha2-1 160.7; C q    
Dha2-2 134.2; C q    
Dha2-3 100.1; 
CH2 
HA: 6.27 (br s)  





Dha3     
Dha3-1 162.8; C q    





HA: 5.65 (d, 2.2)  





Dha3-NHd  8.40 (s) Dha2-1; Dha3-1; Dha3-3 Dha3-3-HB 
Ala4     
Ala4-1 173.1; C q    
Ala4-2 51.8; CH 4.65 (q, 6.6) Dha3-1; Ala4-1; Ala4-3 Ala4-3; Ala4-NH 
Ala4-3 18.8; CH3 1.32 (d, 6.7) Ala4-1; Ala4-2 Ala4-2 
Ala4-NHd  7.10 (d, 8.2)  Ala4-2 
Pip     
Pip-2  161.9; C q    
Pip-3 24.5; CH2 HA: 3.36-3.32 (m)  
HB: 2.83-2.77 (m) 
 
Pip-4-HB 
Pip-4-HA;  Pip-4-HB  
Pip-4 28.9; CH2 HA: 3.95 (m)  
HB: 2.17 (m) 
Pip-2; Pip-3; Pip-5; Pip-6; Thz6-4; Thz13-2 
Pip-3; Pip-6 
Pip-4-HB 
Pip-3-HA; Pip-4-HA; Pip-3-HB  
Pip-5 57.3; C q    
Pip-6 64.1; CH 5.17 (s) Pip-2; Pip-4; Pip-5; Thz13-2; Thz13-3; 
Thz15-4 
Pip-3-HA;  Pip-3-HB 
Thz6     
Thz6-1 161.7; C q    
Thz6-2 146.2; C q    
Thz6-3 124.9; CH 8.04 (s) Thz6-1; Thz6-2;  Thz6-4  
Thz6-4 169.6; C q    
Thr7     
Thr7-1 165.4; C q    
Thr7-2 55.7; CH 4.30 (dd, 7.7, 3.6) Thz6-1; Thr7-1; Thr7-3; Thr7-4 Thr7-3; Thr7-NH 
Thr7-3 66.3; CH 1.46-1.40 (m) Thr7-4 Thr7-2; Thr7-4 
Thr7-4 18.8; CH3 0.68 (d, 6.3) Thr7-2; Thr7-3 Thr7-3 
Thr7-NHd  6.95 (d, 7.6) Thz6-1; Thr7-1 Thr7-2 
Dhb8     
Dhb8-2 128.3; C q    
Dhb8-3 132.7; CH 6.10 (q, 7.0) Dhb8-2; Dhb8-4; Tzn9-4 Dhb8-4 
Dhb8-4 15.3; CH3 1.48 (d, 7.3) Dhb8-2; Dhb8-3; Tzn9-4 Dhb8-3 
Tzn9     
Tzn9-1 172.0; C q    
Tzn9-2 78.8; CH 4.85 (dd, 12.8, 9.0) Tzn9-1; Tzn9-3; Tzn9-4 Tzn9-3-HA; Tzn9-3-HB 
Tzn9-3 34.8; CH2 HA: 3.52 (dd, 11.2, 9.0) 





Tzn9-4 170.2; C q    
Ile10     
Ile10-2 52.9; CH 5.62 (d, 5.1) Tzn9-1; Ile10-3; Thz11-4 Ile10-NH 
Ile10-3 77.1c; C q    
Ile10-4 67.6; CH 3.68 (q, 6.4) Ile10-2; Ile10-3; Ile10-5; Ile10-6 Ile10-5 
Ile10-5 15.8; CH3 1.17 (d, 6.3) Ile10-3; Ile10-4 Ile10-4 
Ile10-6 18.5; CH3 1.02 (s) Ile10-2; Ile10-3; Ile10-4  






δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb 
Thz11     
Thz11-1 162.0; C q    
Thz11-2 150.0; C q    
Thz11-3 125.7; CH 8.16 (s) Thz11-1; Thz11-2; Thz11-4  
Thz11-4 166.2; C q    
Thr12     
Thr12-2 55.5; CH 5.64 (d, 4.1) Thz11-1; Thr12-4; Thz13-2; Thz13-4 Thr12-3, Thr12-NH 
Thr12-3 71.8; CH 6.25 (q, 6.7) Thr12-4; Thz13-4; Q-1 Thr12-2, Thr12-4 
Thr12-4 18.8; CH3 1.52 (d, 6.3) Thr12-2; Thr12-3 Thr12-3 
Thr12-NHd  8.60 (d, 8.9)  Thr12-2 
Thz13     
Thz13-2 157.1; C q    
Thz13-3 118.3; CH 7.43 (s) Pip-6; Thz13-2; Thz13-4  
Thz13-4 170.0; C q    
Thz15     
Thz15-1 159.5; C q    
Thz15-2 149.8; C q    
Thz15-3 127.6; CH 8.17 (s) Thz15-1; Thz15-2; Thz15-4  
Thz15-4 168.2; C q    
Dha16     
Dha16-1 162.0; C q    
Dha16-2 134.0; C q    
Dha16-3 103.2; 
CH2 
HA: 6.58 (d, 2.2)  





Dha17     
Dha17-1 166.0; C q    
Dha17-2 132.8; C q    
Dha17-3 104.3; 
CH2 
HA: 6.41 (d, 1.2)  





Q     
Q-1 160.6; C q    
Q-2 143.5; C q    
Q-3 122.5; CH 7.18 (s) Q-1; Q-5; Q-11  
Q-4 153.8; C q    
Q-5 127.4; C q    
Q-6 123.5; CH 6.80 (d, 10.1) Q-5; Q-8; Q-10 Q-7 
Q-7 129.5; CH 6.30 (dd, 9.8, 5.7) Q-5; Q-8; Q-9 Q-6; Q-8; Q-9 
Q-8 59.2; CH 3.48 (dd, 5.9, 1.8) Q-6; Q-7; Q-9; Q-10; Ile1-2 Q-7; Q-9 
Q-9 67.7; CH 4.25 (s) Q-5; Q-7; Q-8; Q-10 Q-7; Q-8 
Q-10 154.3; C q    
Q-11 64.3; CH 5.19 (q, 6.6) Q-3; Q-5; Q-12 Q-12 
Q-12 22.6; CH3 1.25 (d, 6.6) Q-4; Q-11 Q-11 
 
a HMBC correlations are from the proton to the indicated carbon. 
b COSY correlations are from the proton to the proton attached to the indicated position. 
c The δ of this resonance was determined by HMBC due to overlap with the CDCl3 resonance. 











Figure E.9. MS analysis of thiostrepton Ala2Dhb isolated from S. laurentii NDS1/int-
A2T. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 838.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala2Dhb. (2) Total ion chromatogram. 
 A2Dhb, Syn C12 2x250
GT Mass Spectrom try Laboratory 22-Nov-2013   12:31:19







Zhang_131122_04 Scan ES+ 
838.8
8.12e6
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(C) MALDI MS/MS of parent ion m/z 1676.5.  
2 0 0 5 2 0 8 4 0 1 1 6 0 1 4 8 0 1 8 0 0
M a s s  (m /z )





































































































(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 







2. M+H+ (Parent ion) 1676.5 1676.5
3. M+Na+ 1698.5 1698.5
4. M+Cu+ 1738.4 1738.4
5. M-Ile1-Dhb2+H+ 1480.4 1480.2
6. M-QA+H+ 1443.4 1443.2
7. M-QA-H2O+H
+ 1425.4 1425.2
8. M-Ile1-Dhb2-Dha3-Ala4+H+ 1340.3 1340.1
9. M-QA-Ile1+H+ 1330.3 1330.2
10. M-QA-Ile1-Dhb2+H+ 1247.3 1247.1
11. M-QA-Ile1-Dhb2-H2O+H
+ 1229.3 1229.2
12. M-QA-Ile1-Dhb-Dha3+H+ 1178.3 1178.1
13. M-QA-Ile1-Dhb2-Dha3-OH+H+ 1161.3 1161.1
14. M-QA-Ile1-Dhb2-Dha3-Ala4+H+ 1107.3 1107.1






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































C NMR spectrum of thiostrepton Ala2Dhb (125 MHz, CDCl3-CD3OD 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure E.13. DEPT-135 NMR spectrum of thiostrepton Ala2Dhb (125 MHz, CDCl3-





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































C NMR assignments of thiostrepton Ala2Dhb
 Position 
δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb 
Ile1    
Ile1-1 171.3; C q    
Ile1-2 67.3; CH 2.87 (d, 4.1) Ile1-1; Ile1-3; Ile1-4; Ile1-6; Q-8 Ile1-3 
Ile1-3 38.5; CH 1.70-1.63 (m) Ile1-6 Ile1-2; Ile1-4-HA; Ile1-4-HB; Ile1-6 
Ile1-4 25.1; CH2 HA: 1.41-1.33 (m) 
HB: 1.12-1.07 (m) 
Ile1-2; Ile1-5; Ile1-6 
Ile1-2; Ile1-3; Ile1-5; Ile1-6 
Ile1-3; Ile1-4-HB; Ile1-5 
Ile1-3; Ile1-4-HA; Ile1-5 
Ile1-5 11.2; CH3 0.80 (t, 6.9) Ile1-3; Ile1-4 Ile1-4-HA; Ile1-4-HB 
Ile1-6 15.3; CH3 0.86 (d, 6.7) Ile1-2; Ile1-3; Ile1-4 Ile1-3 
Dhb2     
Dhb2-1 162.1; C q    
Dhb2-2 128.4; C q    
Dhb2-3 119.4; CH 5.64-5.60 (m) Dhb2-1; Dhb2-4 Dhb2-4 
Dhb2-4 18.5; CH3 1.55 (d, 7.0) Dhb2-1; Dhb2-2; Dhb2-3 Dhb2-3 
Dhb2-NHd  7.02-6.94 (m) Dha2-1; Dhb2-3  
Dha3     
Dha3-1 163.0; C q    
Dha3-2 132.0; C q    
Dha3-3 102.1; 
CH2 
HA: 5.54 (s) 





Ala4     
Ala4-1 173.2; C q    
Ala4-2 51.9; CH 4.60 (q, 6.0) Dha3-1; Ala4-1; Ala4-3 Ala4-3; Ala4-NH 
Ala4-3 18.8; CH3 1.30 (d, 6.2) Ala4-1; Ala4-2 Ala4-2 
Ala4-NHd  7.02-6.94 (m)  Ala4-2 
Pip     
Pip-2  161.9; C q    
Pip-3 24.1; CH2 HA: 3.34-3.30 (m) 




Pip-4 29.0; CH2 HA: 3.94-3.87 (m) 
HB: 2.21-2.12 (m) 
Pip-2; Pip-3; Pip-5; Pip-6; Thz6-4 
Pip-3; Pip-6 
Pip-4-HB 
Pip-3-HA; Pip-3-HB; Pip-4-HA 
Pip-5 57.5; C q    
Pip-6 
64.1; CH 5.17 (br s) Pip-2; Pip-4; Pip-5; Thz13-2; Thz13-3; 
Thz15-4 
Pip-3-HB 
Thz6     
Thz6-1 161.8; C q    
Thz6-2 146.3; C q    
Thz6-3 124.9; CH 7.98 (s) Thz6-1; Thz6-2; Thz6-4  
Thz6-4 169.6; C q    
Thr7     
Thr7-1 165.5; C q    
Thr7-2 55.8; CH 4.32-4.27 (m) Thr7-3; Thr7-4 Thr7-3; Thr7-NH 
Thr7-3 66.3; CH 1.52-1.45 (m) Thr7-2 Thr7-4 
Thr7-4 18.7; CH3 0.68 (d, 5.5) Thr7-2; Thr7-3 Thr7-3 
Thr7-NHd  7.02-6.94 (m) Thr7-1 Thr7-2 
Dhb8     
Dhb8-2 128.4; C q    
Dhb8-3 132.6; CH 6.08 (q, 6.6) Dhb8-2; Dhb8-4; Tzn9-4 Dhb8-4 
Dhb8-4 15.3; CH3 1.48 (d, 7.8) Dhb8-2; Dhb8-3; Tzn9-4 Dhb8-3 
Tzn9     
Tzn9-1 172.0; C q    
Tzn9-2 78.8; CH 4.84 (dd, 11.8, 9.8) Dhb8-2; Tzn9-1; Tzn9-3; Tzn9-4 Tzn9-3-HA; Tzn9-3-HB 
Tzn9-3 34.8; CH2 HA: 3.54-3.46 (m) 





Tzn9-4 170.1; C q    
Ile10     
Ile10-2 52.9; CH 5.59 (s) Ile10-3; Thz11-4 Ile10-NH 
Ile10-3 77.2c; C q    
Ile10-4 67.8; CH 3.67 (q, 6.3) Ile10-2; Ile10-3; Ile10-5; Ile10-6 Ile10-5 
Ile10-5 15.7; CH3 1.17 (d, 6.2) Ile10-3; Ile10-4; Ile10-6 Ile10-4 
Ile10-6 18.5; CH3 1.02 (s) Ile10-2; Ile10-3; Ile10-4  




δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb 
Thz11     
Thz11-1 162.4; C q    
Thz11-2 150.0; C q    
Thz11-3 125.5; CH 8.13 (s) Thz11-1; Thz11-2; Thz11-4  
Thz11-4 166.2; C q    
Thr12     
Thr12-2 55.5; CH 5.62 (s) Thr12-3; Thr12-4; Thz13-2; Thz13-4 Thr12-3; Thr12-NH 
Thr12-3 71.9; CH 6.17 (q, 6.2) Thr12-4; Thz13-4; Q-1 Thr12-4 
Thr12-4 18.7; CH3 1.49 (d, 7.4) Thr12-2; Thr12-3 Thr12-3 
Thr12-NHd  8.65 (d, 9.1)  Thr12-2 
Thz13     
Thz13-2 157.0; C q    
Thz13-3 118.3; CH 7.43 (s) Pip-6; Thz13-2; Thz13-4  
Thz13-4 170.1; C q    
Thz15     
Thz15-1 159.6; C q    
Thz15-2 149.8; C q    
Thz15-3 127.6; CH 8.15 (s) Thz15-1; Thz15-2; Thz15-4  
Thz15-4 168.3; C q    
Dha16     
Dha16-1 162.0; C q    
Dha16-2 134.0; C q    
Dha16-3 103.2; 
CH2 
HA: 6.56 (s) 





Dha17     
Dha17-1 166.0; C q    
Dha17-2 132.8; C q    
Dha17-3 104.3; 
CH2 
HA: 6.39 (s) 





Q     
Q-1 160.8; C q    
Q-2 143.5; C q    
Q-3 122.4; CH 7.16 (s) Q-1; Q-5; Q-11  
Q-4 153.2; C q    
Q-5 127.3; C q    
Q-6 123.3; CH 6.76 (d, 9.9) Q-5; Q-8; Q-10 Q-7 
Q-7 129.6; CH 6.25 (dd, 9.0, 5.8) Q-5; Q-8; Q-9 Q-6; Q-8; Q-9 
Q-8 59.2; CH 3.54-3.46 (m) Ile1-2; Q-6; Q-7; Q-9; Q-10 Q-7; Q-9 
Q-9 67.7; CH 4.36 (s) Q-5; Q-7; Q-8; Q-10 Q-7; Q-8 
Q-10 154.3; C q    
Q-11 64.4; CH 5.17 (br s) Q-3; Q-12 Q-12 
Q-12 22.5; CH3 1.24 (d, 6.4) Q-4; Q-11 Q-11 
 
a HMBC correlations are from the proton to the indicated carbon. 
b COSY correlations are from the proton to the proton attached to the indicated position. 
c The δ of this resonance was determined by HMBC due to overlap with the CDCl3 resonance. 


















Figure E.17. MS analysis of thiostrepton Ala2Ile-∆Ile1 isolated from S. laurentii 
NDS1/int-A2I. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 797.2, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala2Ile-∆Ile1. (2) Total ion chromatogram. 
 Tsr A2I-I1, 1/10 dil., Syn C12 2x250
GT Mass Spectrometry Laboratory 17-Dec-2012   20:41:47
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(B) MALDI MS spectrum of thiostrepton Ala2Ile-∆Ile1. 
8 0 0 1 0 4 0 1 2 8 0 1 5 2 0 1 7 6 0 2 0 0 0
M a s s  (m /z )





























































(C) MALDI MS/MS of parent ion m/z 1593.4.  
2 0 0 .0 4 9 6 .2 7 9 2 .4 1 0 8 8 .6 1 3 8 4 .8 1 6 8 1 .0
M a s s  (m /z )






































































































(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 







2. M+H+ (Parent ion) 1593.5 1593.4
3. M+Na+ 1615.4 1615.4
4. M+Cu+ 1655.4 1655.3
5. M-Dhb8-Tzn9+H+ 1425.4 1425.3
6. M-Ile2-Dha3+H+ 1411.4 1411.2
7. M-QA+H+ 1360.4 1360.2
8. M-QA-H2O+H
+ 1342.4 1342.2
9. M-QA-(Ile2-CO)+H+ 1275.3 1275.1
10. M-QA-Ile2+H+ 1247.3 1247.1
11. M-QA-Ile2-H2O+H
+ 1229.3 1229.2
12. M-QA-Ile2-Dha3+H+ 1178.3 1178.1
13. M-QA-Ile2-Dha3-OH+H+ 1161.3 1161.1
14. M-QA-Ile2-Dha3-Ala4+H+ 1107.3 1107.1































































































































































































































































































































































































































































































































































































































































































































































































































































































































































H NMR spectrum of thiostrepton Ala2Ile-∆Ile1 (500 MHz, CDCl3-CD3OD 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































C NMR spectrum of thiostrepton Ala2Ile-∆Ile1 (125 MHz, CDCl3-





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure E.21. DEPT-135 NMR spectrum of thiostrepton Ala2Ile-∆Ile1 (125 MHz, 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure E.22. gHSQC NMR spectrum of thiostrepton Ala2Ile-∆Ile1 (500 MHz, CDCl3-








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure E.23. gCOSY NMR spectrum of thiostrepton Ala2Ile-∆Ile1 (125 MHz, CDCl3-














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure E.24. gHMBC NMR spectrum of thiostrepton Ala2Ile-∆Ile1 (125 MHz, CDCl3-







C NMR assignments of thiostrepton Ala2Ile-∆Ile1
 Position 
δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb   
Ile2   
 
Ile2-1 174.7; C q    
Ile2-2 69.4; CH 3.15 (d, 3.8) Ile2-3; Ile2-4; Ile2-6 Ile2-3 
Ile2-3 39.3; CH 1.82-1.78 (m) Ile2-1 Ile2-2; Ile2-4-HA; Ile2-4-HB; Ile2-6 
Ile2-4 24.9; CH2 HA: 1.48-1.39 (m) Ile2-3; Ile2-5; Ile2-6 Ile2-3; Ile2-4-HB; Ile2-5 
  HB: 1.21-1.16 (m) Ile2-2 Ile2-3; Ile2-4-HA; Ile2-5 
Ile2-5 11.6; CH3 0.83 (t, 7.3) Ile2-3; Ile2-4; Ile2-6 Ile2-4-HA; Ile2-4-HB 
Ile2-6 15.5; CH3 0.93 (d, 6.9) Ile2-2; Ile2-3; Ile2-4; Ile2-5 Ile2-3 
Dha3    
 
Dha3-1 163.4; C q    
Dha3-2 135.6; C q    
Dha3-3 
 
115.2; CH2 HA: 5.79 (br s) 




Ala4    
 
Ala4-1 172.5; C q    
Ala4-2 49.3; CH 4.14 (q, 7.4) Ala4-1; Ala4-3 Ala4-3 
Ala4-3 16.8; CH3 0.84 (d, 7.3) Ala4-1; Ala4-2 Ala4-2 
Pip     
Pip-2  159.2; C q    
Pip-3 22.3; CH2 HA: 3.50-3.40 (m) 




Pip-4 29.3; CH2 HA: 3.86-3.80 (m) 





Pip-5 57.5; C q    
Pip-6 63.6; CH 5.23 (br s)   
Thz6     
Thz6-1 161.1; C q    
Thz6-2 149.8; C q    
Thz6-3 127.1; CH 7.99 (s) Thz6-2; Thz6-4  
Thz6-4 168.2; C q    
Thr7     
Thr7-1 169.5; C q    
Thr7-2 58.8; CH 4.56 (d, 2.0) Thz6-1; Thr7-1; Thr7-3 Thr7-3 
Thr7-3 67.3; CH 4.23-4.18 (m)  Thr7-2; Thr7-4 
Thr7-4 19.2; CH3 1.12 (d, 6.0) Thr7-2; Thr7-3 Thr7-3 
Dhb8     
Dhb8-2 127.4; C q    
Dhb8-3 135.7; CH 6.08-6.03 (m) Dhb8-2 Dhb8-4 
Dhb8-4 19.2; CH3 1.13-1.09 (m)   
Tzn9     
Tzn9-1 171.3; C q    
Tzn9-2 78.4; CH 4.90 (dd, 11.4, 9.8) Tzn9-1; Tzn9-3; Tzn9-4 Tzn9-3-HA; Tzn9-3-HB 
Tzn9-3 36.1; CH2 HA: 3.58 (dd, 11.1; 9.2) 





Tzn9-4 169.5; C q    
Ile10     
Ile10-2 53.7; CH 5.45 (s) Ile10-3; Thz11-4  
Ile10-3 75.8; C q    
Ile10-4 69.3; CH 3.86-3.80 (m)  Ile10-5 
Ile10-5 16.4; CH3 1.15 (d, 6.5) Ile10-3; Ile10-4 Ile10-4 
Ile10-6 18.8; CH3 1.07 (s) Ile10-2; Ile10-3; Ile10-4; Ile10-5  
Thz11    
 
Thz11-1 162.7; C q    
Thz11-2 149.8; C q    
Thz11-3 121.9; CH 8.09 (s)  Thz11-1; Thz11-4  
Thz11-4 168.3; C q    
Thr12     
Thr12-2 51.6; CH 5.79 (br s)  Thr12-3 
Thr12-3 69.3; CH 5.53 (pentet, 6.1) Q-1 Thr12-2; Thr12-4 
Thr12-4 13.8; CH3 1.26-1.21 (m)  Thr12-3 




δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb   
Thz13    
 
Thz13-2 159.2; C q    
Thz13-3 125.5; CH 8.00 (s) Thz13-4  
Thz13-4 168.2; C q    
Thz15     
Thz15-1 160.4; C q    
Thz15-2 148.2; C q    
Thz15-3 126.0; CH 8.07 (s) Thz15-2; Thz15-4  
Thz15-4 168.3; C q    
Dha16     
Dha16-1 161.8; C q    
Dha16-2 133.9; C q    
Dha16-3 103.2; CH2 HA: 6.49 (d, 2.2) 





Dha17    
 
Dha17-1 165.9; C q    
Dha17-2 132.7; C q    
Dha17-3 104.4; CH2 HA: 6.29 (d, 1.4) 





Q    
 
Q-1 162.7; C q    
Q-2 152.7; C q    
Q-3 117.4; CH 7.23 (s) Q-1; Q-2; Q-10  
Q-4 151.7; C q    
Q-5 127.4; C q    
Q-6 122.0; CH 6.81 (dd, 10.1,2.3) Q-5; Q-8; Q-10 Q-7; Q-8 
Q-7 135.0 CH 5.98 (m) Q-5; Q-9 Q-6; Q-8 
Q-8 62.9; CH 3.50-3.40 (m) Q-7; Q-9 Q-6; Q-7; Q-9 
Q-9 73.9; CH 4.52 (d, 12.4) Q-8; Q-10 Q-8 
Q-10 154.0; C q    
Q-11 65.7; CH 4.95 (q, 6.5) Q-4; Q-5; Q-6; Q-12 Q-12 
Q-12 23.8; CH3 1.33 (d, 6.6) Q-4; Q-11 Q-11 
 
a HMBC correlations are from the proton to the indicated carbon. 



























Figure E.25. MS analysis of thiostrepton Ala2Met isolated from S. laurentii NDS1/int-
A2M. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 862.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala2Met. (2) Total ion chromatogram. 
 Tsr A2M, Syn C12 2x250
GT Mass Spectrom try Laboratory 18-Dec-2012   02:29:45
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(B) MALDI MS spectrum of thiostrepton Ala2Met. 
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(C) MALDI MS/MS of parent ion m/z 1724.4.  
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 
of thiostrepton Ala2Met.  
 
Fragment Expected Observed
1. M-OH+H+ 1707.5 1707.2
2. M+H+ (Parent ion) 1724.5 1724.4
3. M+Na+ 1746.5 1746.4
4. M+Cu+ 1786.4 1786.3
5. M-Met2-CO+H+ 1565.5 1565.3
6. M-(Ile1-NH)-Met2+H+ 1495.4 1495.3
7. M-Ile1-Met2+H+ 1480.4 1480.3
8. M-QA-Ile1-Met2+H+ 1247.3 1247.2
9. M-QA-Ile1-Met2-H2O+H
+ 1229.3 1229.2
10. M-QA-Ile1-Met2-Dha3+H+ 1178.3 1178.2
11. M-QA-Ile1-Met-Dha3-OH+H+ 1161.3 1161.2
12. M-QA-Ile1-Met2-Dha3-Ala4+H+ 1107.3 1107.2











Figure E.26. MS analysis of thiostrepton Ala2Phe isolated from S. laurentii NDS1/int-
A2F. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 870.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala2Phe. (2) Total ion chromatogram. 
 A2F, Syn C12 2x250
GT Mass Spectrom try Laboratory 16-Jul-2014   03:18:16
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(C) MALDI MS/MS of parent ion m/z 1740.5.  
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 
of thiostrepton Ala2Phe.  
 
Fragment Expected Observed
1. M+H+ (Parent ion) 1740.5 1740.5
2. M+Na+ 1762.5 1762.4
3. M+K+ 1778.5 1778.5
4. M-Phe2-CO+H+ 1565.5 1565.3
5. M-Dhb8-Tzn9-CO-NH+H+ 1529.5 1529.3
6. M-QA+H+ 1507.5 1507.3
7. M-QA-Ile1-Phe2+H+ 1247.3 1247.2
8. M-QA-Ile1-Phe2-H2O+H
+ 1229.3 1229.3
9. M-QA-Ile1-Phe2-Dha3+H+ 1178.3 1178.2
10. M-QA-Ile1-Phe2-Dha3-OH+H+ 1161.3 1161.2
11. M-QA-Ile1-Phe2-Dha3-Phe4+H+ 1107.3 1107.2














Figure E.27. MS analysis of thiostrepton Ala2Tyr isolated from S. laurentii NDS1/int-
A2Y. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 878.8, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala2Tyr. (2) Total ion chromatogram 
 A2Y, Syn C12 2x250
GT Mass Spectrom try Laboratory 16-Jul-2014   05:41:44
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(B) MALDI MS spectrum of thiostrepton Ala2Tyr. 
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(C) MALDI MS/MS of parent ion m/z 1756.4.  
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 






1. M+H+ (Parent ion) 1756.5 1756.4
2. M+Na+ 1778.5 1778.4
3. M-Tyr2-CO+H+ 1565.5 1565.3
4. M-Dhb8-Tzn9-CO-NH+H+ 1545.5 1545.3
5. M-QA+H+ 1523.5 1523.4
6. M-QA-Ile1-Tyr2+H+ 1247.3 1247.3
7. M-QA-Ile1-Tyr2-H2O+H
+ 1229.3 1229.3
8. M-QA-Ile1-Tyr2-Dha3+H+ 1178.3 1178.3
9. M-QA-Ile1-Tyr2-Dha3-H2O+H
+ 1160.3 1160.2
10. M-QA-Ile1-Tyr2-Dha3-Ala4+H+ 1107.3 1107.3









Figure E.28. MS analysis of thiostrepton Ala2Val-∆Ile1 isolated from S. laurentii 
NDS1/int-A2V. 
 
(A) HPLC-MS analysis. (1) Chromatogram extracted for m/z 790.2, the calculated 
[M+2H]
2+
 ion of thiostrepton Ala2Val-∆Ile1. (2) Total ion chromatogram. 
 
 A2V-I1, Syn C12 2x250
GT Mass Spectrometry Laboratory 01-Aug-2014   01:10:47
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(B) MALDI MS spectrum of thiostrepton Ala2Val-∆Ile1. 
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(C) MALDI MS/MS of parent ion m/z 1579.4.  
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(D) Table and structure showing key ions and fragments in the MALDI MS and MS/MS 







2. M+H+ (Parent ion) 1579.4 1579.4
3. M+Na+ 1601.4 1601.4
4. M+K+ 1617.4 1617.4
5. M-Dhb8-Tzn9+H+ 1411.4 1411.0
6. M-Val2-Dha3-(Ala4-CO)+H+ 1368.3 1368.2
7. M-QA+H+ 1346.4 1346.3
8. M-QA-H2O+H
+ 1328.4 1328.3
9. M-QA-Val2+H+ 1247.3 1247.2
10. M-QA-Val2-OH+H+ 1230.3 1230.1
11. M-QA-Val2-OH-OH+H+ 1213.3 1213.0
12. M-QA-Val2-Dha3+H+ 1178.3 1178.2
13. M-QA-Val2-Dha3-OH+H+ 1161.3 1161.0
14. M-QA-Val2-Dha3-Ala4+H+ 1107.3 1107.2
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































H NMR spectrum of thiostrepton Ala2Val-∆Ile1 (500 MHz, CDCl3-































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































C NMR spectrum of thiostrepton Ala2Val-∆Ile1 (125 MHz, CDCl3-





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure E.32. DEPT-135 NMR spectrum of thiostrepton Ala2Val-∆Ile1 (125 MHz, 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure E.33. gHSQC NMR spectrum of thiostrepton Ala2Val-∆Ile1 (500 MHz, CDCl3-








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure E.34. gCOSY NMR spectrum of thiostrepton Ala2Val-∆Ile1 (125 MHz, CDCl3-














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure E.35. gHMBC NMR spectrum of thiostrepton Ala2Val-∆Ile1 (125 MHz, CDCl3-







C NMR assignments of thiostrepton Ala2Val-∆Ile1
 Position 
δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb   
Val2   
 
Val2-1 176.1; C q    
Val2-2 70.2; CH 3.11 (d, 3.6) Val2-1; Val2-3; Val2-4B; Q-8 Val2-3 
Val2-3 31.9; CH 2.17-2.09 (m) Val2-1 Val2-2; Val2-4A; Val2-4B 
Val2-4A 19.3; CH3 0.98 (d, 6.9) Val2-2; Val2-3; Val2-4B Val2-3 
Val2-4B 17.5; CH3 0.92 (d, 6.9) Val2-2; Val2-3; Val2-4A Val2-3 
Dha3    
 
Dha3-1 163.3; C q    
Dha3-2 135.4; C q    
Dha3-3 
 
115.6; CH2 HA: 5.81 (br s) 




Ala4    
 
Ala4-1 172.5; C q    
Ala4-2 49.4; CH 4.16 (q, 7.3) Ala4-1; Ala4-3 Ala4-3 
Ala4-3 16.8; CH3 0.87 (d, 5.8) Ala4-1; Ala4-2 Ala4-2 
Pip     
Pip-2  159.1; C q    
Pip-3 23.0; CH2 HA: 3.53-3.48 (m) 




Pip-4 29.4; CH2 HA: 3.88-3.81 (m) 
HB: 2.47-2.42 (m) 
 
Pip-2; Pip-3; Pip-5; Pip-6 
 
Pip-3-HB 
Pip-5 57.3; C q    
Pip-6 63.1; CH 5.26 (br s)   
Thz6     
Thz6-1 161.0; C q    
Thz6-2 149.7; C q    
Thz6-3 127.1; CH 8.01 (s) Thz6-2; Thz6-4  
Thz6-4 167.9; C q    
Thr7     
Thr7-1 169.5; C q    
Thr7-2 58.7; CH 4.59 (d, 2.0) Thz6-1; Thr7-1; Thr7-3 Thr7-3 
Thr7-3 67.1; CH 4.26-4.20 (m)  Thr7-2; Thr7-4 
Thr7-4 19.3; CH3 1.13 (d, 5.5) Thr7-2; Thr7-3 Thr7-3 
Dhb8     
Dhb8-2 127.3; C q    
Dhb8-3 135.7; CH 6.08-6.03 (m) Dhb8-2 Dhb8-4 
Dhb8-4 19.0; CH3 1.13-1.09 (m)   
Tzn9     
Tzn9-1 171.2; C q    
Tzn9-2 78.3; CH 4.92 (dd, 11.5, 9.6) Tzn9-1; Tzn9-3; Tzn9-4 Tzn9-3-HA; Tzn9-3-HB 
Tzn9-3 36.1; CH2 HA: 3.60 (dd, 11.2; 9.1) 
HB: 3.17-3.12 (m) 




Tzn9-4 169.5; C q    
Ile10     
Ile10-2 52.8; CH 5.46 (s) Ile10-3; Thz11-4  
Ile10-3 75.8; C q    
Ile10-4 69.0; CH 3.88-3.81 (m)  Ile10-5 
Ile10-5 16.4; CH3 1.17 (d, 6.5) Ile10-3; Ile10-4 Ile10-4 
Ile10-6 19.0; CH3 1.08 (s) Ile10-3; Ile10-4  
Thz11    
 
Thz11-1 162.6; C q    
Thz11-2 149.7; C q    
Thz11-3 121.9; CH 8.11 (s)  Thz11-1; Thz11-2; Thz11-4  
Thz11-4 168.2; C q    
Thr12    
 
Thr12-2 51.3; CH 5.84-5.77 (m)  Thr12-3 
Thr12-3 69.0; CH 5.55 (pentet, 6.0) Thz11-1; Thr12-2; Thr12-4; Q-1 Thr12-2; Thr12-4 
Thr12-4 13.9; CH3 1.28-1.21 (m)  Thr12-3 
     
     
     




δC [ppm];  
mult 
δH [ppm];  
(mult, J in Hz) 
HMBCa COSYb   
Thz13    
Thz13-2 159.1; C q   
Thz13-3 125.7; CH 8.01 (s) Thz13-4  
Thz13-4 167.9; C q    
Thz15     
Thz15-1 160.3; C q    
Thz15-2 148.1; C q    
Thz15-3 126.1; CH 8.09 (s) Thz15-1; Thz15-2; Thz15-4  
Thz15-4 168.2; C q    
Dha16     
Dha16-1 161.6; C q    
Dha16-2 133.6; C q    
Dha16-3 103.2; CH2 HA: 6.52 (d, 2.3) 





Dha17    
 
Dha17-1 165.8; C q    
Dha17-2 132.5; C q    
Dha17-3 104.3; CH2 HA: 6.32 (d, 1.7) 





Q    
 
Q-1 162.6; C q    
Q-2 151.6; C q    
Q-3 117.4; CH 7.27 (s) Q-1; Q-2; Q-4; Q-10  
Q-4 152.3; C q    
Q-5 127.3; C q    
Q-6 121.9; CH 6.83 (dd, 10.2; 2.5) Q-5; Q-8; Q-10 Q-7; Q-8 
Q-7 134.9; CH 6.01 (m) Q-5; Q-8; Q-9 Q-6; Q-8 
Q-8 62.8; CH 3.50-3.45 (m) Q-6; Q-7; Q-9; Q-10 Q-6; Q-7; Q-9 
Q-9 73.8; CH 4.54 (d, 12.3) Q-8; Q-10 Q-8 
Q-10 153.8; C q    
Q-11 65.6; CH 4.97 (q, 6.5) Q-2; Q-5; Q-6; Q-12 Q-12 
Q-12 23.9; CH3 1.35 (d, 6.6) Q-4; Q-11 Q-11 
 
a HMBC correlations are from the proton to the indicated carbon. 




Figure E.36. Thiostrepton A, Ala2Ile-∆Ile1 and Ala2Val-∆Ile1 bound to the ribosome. 
Measurements of the distances between Thr7 and quinaldic acid hydroxyl groups in 
thiostrepton A, thiostrepton Ala2Ile-∆Ile1 and Ala2Val-∆Ile1. (A) Thiostrepton A (Cyan) 
bound to the ribosome adapted from PDB 3CF5.
1
 (B) Model of thiostrepton Ala2Ile-
ΔIle1 (magenta) bound to the ribosome. (C) Model of thiostrepton Ala2Val-ΔIle1 (blue) 
bound to the ribosome. Helices 43 and 44 of 23S rRNA are colored in orange and 
ribosomal protein L11 is shown in green. 
 
(A)
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Table F.1. Summary of HR-MS results of thiostrepton analogs 











Thiostrepton Ala2Dha HR-ESI-MS C72H83N19O18S5 1684.4665 1684.4718 
Thiostrepton Ala2Gly HR-ESI-MS C71H83O18N19S5 1672.4670 1672.4689 
Thiostrepton Ala4Gly HR-ESI-MS C71H83O18N19S5 1672.4670 1672.4664 
Thiostrepton Thr7Val HR-ESI-MS C73H87N19O17S5 1684.5029 1684.5087 
     











SL105-1 HR-MALDI-MS C62H66N16O15S5 1435.3575 1435.3618 
SL106-1 HR-MALDI-MS C64H70N16O15S5 1463.3888 1463.3890 
Thiostrepton Ala2Dhb HR-MALDI-MS C73H85N19O18S5 1676.5002 1676.5043 
Thiostrepton Ala2Ile-∆Ile1 HR-MALDI-MS C69H80N18O17S5 1593.4631 1593.4673 
Thiostrepton Ala2Met HR-MALDI-MS C74H89N19O18S6 1724.5036 1724.4999 
Thiostrepton Ala2Phe HR-MALDI-MS C78H89N19O18S5 1740.5315 1740.5244 
Thiostrepton Ala2Tyr HR-MALDI-MS C78H89N19O19S5 1756.5264 1756.5267 
Thiostrepton Ala2Val-∆Ile1 HR-MALDI-MS C68H78N18O17S5 1579.4474 1579.4519 
Thiostrepton Ala4Asn HR-MALDI-MS C73H86N20O19S5 1707.5060 1707.5106 
Thiostrepton Ala4Cys F1 HR-MALDI-MS C72H85N19O18S6 1696.4723 1696.4725 
Thiostrepton Ala4Cys F2 HR-MALDI-MS C72H85N19O18S6 1696.4723 1696.4704 
Thiostrepton Ala4Dha HR-MALDI-MS C72H83N19O18S5 1662.4845 1662.4830 
Thiostrepton Ala4Dhb HR-ESI-MS C73H85N19O18S5 1676.5002 1676.5064 
Thiostrepton Ala4Gln HR-MALDI-MS C74H88N20O19S5 1721.5217 1721.5255 
Thiostrepton Ala4His HR-MALDI-MS C75H87N21O18S5 1730.5220 1730.5193 
Thiostrepton Ala4Ile HR-ESI-MS C75H91N19O18S5 1706.5471 1706.5460 
Thiostrepton Ala4Leu HR-ESI-MS C75H91N19O18S5 1706.5471 1706.5550 
Thiostrepton Ala4Met HR-ESI-MS C74H89N19O18S6 1724.5036 1724.5088 
Thiostrepton Ala4Phe HR-MALDI-MS C78H89N19O18S5 1740.5315 1740.5394 
Thiostrepton Ala4Ser HR-MALDI-MS C72H85N19O19S5 1680.4951 1680.5016 
Thiostrepton Ala4Trp HR-MALDI-MS C80H90N20O18S5 1779.5424 1779.5558 
Thiostrepton Ala4Tyr HR-MALDI-MS C78H89N19O19S5 1756.5264 1756.5343 
Thiostrepton Ala4Val HR-ESI-MS C74H89N19O18S5 1692.5315 1692.5348 
Thiostrepton Thr7Ala HR-MALDI-MS C71H83N19O17S5 1634.4896 1634.4906 
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Table F.2. Titers of thiostrepton analogs 
 
Fermentation of each S. laurentii variant strain was carried out in two sets of triplicate. The yields 
of all thiostrepton analogs were quantified by HPLC against a standard calibration curve of 
thiostrepton A assuming similar spectral properties for each derivative. 
Compound Titer (mg/L) 
Thiostrepton A 115 ± 35 
Ala2Dha 301 ± 7 
Ala2Dhb 39 ± 9 
Ala2Gly 19 ± 3 
Ala2Ile-∆Ile1 34 ± 4 
Ala2Met 3.1 ± 0.2 
Ala2Phe 2.5 ± 0.6 
Ala2Tyr 1.7 ± 0.6 
Ala2Val-∆Ile1 51 ± 16 
Ala4Asn 41.5 ± 11.5 
Ala4Cys F1 4.9 ± 1.4 
Ala4Cys F2 5.3 ± 1.2 
Ala4Dha 41.9 ± 12.3 
Ala4Dhb 24.7 ± 4.8 
Ala4Gln 3.8 ± 0.5 
Ala4Gly 19.2 ± 4.6 
Ala4His 4.7 ± 0.9 
Ala4Ile 47.0 ± 24.5 
Ala4Leu 90.6 ± 39.5 
Ala4Met 82.0 ± 10.8 
Ala4Phe 4.7 ± 2.1 
Ala4Ser 3.0 ± 1.2 
Ala4Trp 3.1 ± 1.5 
Ala4Tyr 4.4 ± 2.6 






APPENDIX G: ONE SAMPLE CALCULATION FOR IC50 VALUES 




Figure G.1. One sample calculation for IC50 values. 
 
Here is showing the calculation of thiostrepton Ala2Met’s IC50 value against the proteasome chymotrypsin-like function. 
 
Fluorescence was measured using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Emissions were 
documented every 50 s for 1 h and the arbitrary fluorescence units (AFU) were plotted against time for each compound to acquire the 
slope of the linear fit. 
 

























































TSR Ala2Met-50 µM-set 1













TSR Ala2Met-50 µM-set 2































TSR Ala2Met-25 µM-set 1













TSR Ala2Met-25 µM-set 2













TSR Ala2Met-25 µM-set 3
 
 













TSR Ala2Met-12.5 µM-set 1













TSR Ala2Met-12.5 µM-set 2













TSR Ala2Met-12.5 µM-set 3
 
 













TSR Ala2Met-6.25 µM-set 1













TSR Ala2Met-6.25 µM-set 2






























TSR Ala2Met-3.13 µM-set 1













TSR Ala2Met-3.13 µM-set 2













TSR Ala2Met-3.13 µM-set 3
 
 













TSR Ala2Met-1.56 µM-set 1













TSR Ala2Met-1.56 µM-set 2













TSR Ala2Met-1.56 µM-set 3
 
 













TSR Ala2Met-0.78 µM-set 2













TSR Ala2Met-0.78 µM-set 1






























TSR Ala2Met-0.39 µM-set 1













TSR Ala2Met-0.39 µM-set 2













TSR Ala2Met-0.39 µM-set 3
 
 













TSR Ala2Met-0.20 µM-set 1













TSR Ala2Met-0.20 µM-set 1













TSR Ala2Met-0.20 µM-set 3
 
 













TSR Ala2Met-0.098 µM-set 1













TSR Ala2Met-0.098 µM-set 2






























TSR Ala2Met-0.049 µM-set 2













TSR Ala2Met-0.049 µM-set 1













TSR Ala2Met-0.049 µM-set 3
 
 













TSR Ala2Met-0.024 µM-set 1













TSR Ala2Met-0.024 µM-set 2













TSR Ala2Met-0.024 µM-set 3
 
 













TSR Ala2Met-0.012 µM-set 1













TSR Ala2Met-0.012 µM-set 2






























TSR Ala2Met-0.006 µM-set 1













TSR Ala2Met-0.006 µM-set 2













TSR Ala2Met-0.006 µM-set 3
 
 













TSR Ala2Met-0.003 µM-set 2













TSR Ala2Met-0.003 µM-set 1













TSR Ala2Met-0.003 µM-set 3
 
 













TSR Ala2Met-0.0015 µM-set 1













TSR Ala2Met-0.0015 µM-set 2


















Relative activity was obtained by normalizing the compound slope to the DMSO control slope. 
 
 
Slope (Set 1) Slope (Set 2) Slope (Set 3) Average DMSO slope 





 Concentration (µM) 
Slope 
 (Set 1) 
Slope 
 (Set 2) 
Slope 
 (Set 3) 
Average 
 DMSO slope 
Relative activity 
%; (Set 1) 
Relative activity 
%; (Set 2) 
Relative activity 
%; (Set 3) 
50 374231 462718 528044 7080396 5.2855 6.5352 7.4578 
25 329215 356623 394587 7080396 4.6497 5.0368 5.5730 
12.5 317681 308177 332674 7080396 4.4868 4.3525 4.6985 
6.25 348448 409440 405217 7080396 4.9213 5.7827 5.7231 
3.13 781453 827647 900844 7080396 11.0369 11.6893 12.7231 
1.56 2548379 2488499 2600221 7080396 35.9920 35.1463 36.7242 
0.78 3222663 3476127 3612606 7080396 45.5153 49.0951 51.0227 
0.39 4247503 4341528 4525839 7080396 59.9896 61.3176 63.9207 
0.2 5307697 5217995 5521361 7080396 74.9633 73.6964 77.9810 
0.098 6544753 6261134 6535033 7080396 92.4348 88.4292 92.2976 
0.049 6661966 6545959 7034840 7080396 94.0903 92.4519 99.3566 
0.024 6060892 6074714 6411207 7080396 85.6010 85.7962 90.5487 
0.012 7458598 7907249 8231171 7080396 105.3415 111.6781 116.2530 
0.006 6952608 7227772 7004992 7080396 98.1952 102.0815 98.9350 
0.003 7102736 7338884 7646628 7080396 100.3155 103.6508 107.9972 








 Concentration (µM) 
Relative activity 
%; (Set 1) 
Relative activity 
%; (Set 2) 
Relative activity 
%; (Set 3) 
50 5.2855 6.5352 7.4578 
25 4.6497 5.0368 5.5730 
12.5 4.4868 4.3525 4.6985 
6.25 4.9213 5.7827 5.7231 
3.13 11.0369 11.6893 12.7231 
1.56 35.9920 35.1463 36.7242 
0.78 45.5153 49.0951 51.0227 
0.39 59.9896 61.3176 63.9207 
0.20 74.9633 73.6964 77.9810 
0.098 92.4348 88.4292 92.2976 
0.049 94.0903 92.4519 99.3566 
0.024 85.6010 85.7962 90.5487 
0.012 105.3415 111.6781 116.2530 
0.006 98.1952 102.0815 98.9350 
0.003 100.3155 103.6508 107.9972 
0.0015 99.5866 95.9116 104.4274 
Thiostrepton Ala2Met-Chymotrypsin




























Figure G.2. In vitro translation inhibition curves for compounds from chapter 4. 
 
Thiostrepton A























































































































































































































































































































































































































































































































































































































































































































































Thiostrepton Ala4Cys F1 
Thiostrepton Ala4Cys F1-Trypsin























































































Thiostrepton Ala4Cys F2 
Thiostrepton Ala4Cys F2-Trypsin











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure G.4. In vitro translation inhibition curves for compounds from chapter 5. 
 
Thiostrepton Ala2Dha
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